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Background: Historically, lack of evidence for effective management of decay in primary teeth has caused
uncertainty, but there is emerging evidence to support alternative strategies to conventional fillings, which
are minimally invasive and prevention orientated.
Objectives: The objectives were (1) to assess the clinical effectiveness and cost-effectiveness of three
strategies for managing caries in primary teeth and (2) to assess quality of life, dental anxiety, the acceptability
and experiences of children, parents and dental professionals, and caries development and/or progression.
Design: This was a multicentre, three-arm parallel-group, participant-randomised controlled trial.
Allocation concealment was achieved by use of a centralised web-based randomisation facility hosted by
Newcastle Clinical Trials Unit.
Setting: This trial was set in primary dental care in Scotland, England and Wales.
Participants: Participants were NHS patients aged 3–7 years who were at a high risk of tooth decay and
had at least one primary molar tooth with decay into dentine, but no pain/sepsis.
Interventions: Three interventions were employed: (1) conventional with best-practice prevention
(local anaesthetic, carious tissue removal, filling placement), (2) biological with best-practice prevention
(sealing-in decay, selective carious tissue removal and fissure sealants) and (3) best-practice prevention
alone (dietary and toothbrushing advice, topical fluoride and fissure sealing of permanent teeth).
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Main outcome measures: The clinical effectiveness outcomes were the proportion of children with at
least one episode (incidence) and the number of episodes, for each child, of dental pain or dental sepsis or
both over the follow-up period. The cost-effectiveness outcomes were the cost per incidence of, and cost
per episode of, dental pain and/or dental sepsis avoided over the follow-up period.
Results: A total of 72 dental practices were recruited and 1144 participants were randomised
(conventional arm, n = 386; biological arm, n = 381; prevention alone arm, n = 377). Of these, 1058 were
included in an intention-to-treat analysis (conventional arm, n = 352; biological arm, n = 352; prevention
alone arm, n = 354). The median follow-up time was 33.8 months (interquartile range 23.8–36.7 months).
The proportion of children with at least one episode of pain or sepsis or both was 42% (conventional arm),
40% (biological arm) and 45% (prevention alone arm). There was no evidence of a difference in incidence
or episodes of pain/sepsis between arms. When comparing the biological arm with the conventional arm,
the risk difference was –0.02 (97.5% confidence interval –0.10 to 0.06), which indicates, on average,
a 2% reduced risk of dental pain and/or dental sepsis in the biological arm compared with the conventional
arm. Comparing the prevention alone arm with the conventional arm, the risk difference was 0.04 (97.5%
confidence interval –0.04 to 0.12), which indicates, on average, a 4% increased risk of dental pain and/or
dental sepsis in the prevention alone arm compared with the conventional arm. Compared with the
conventional arm, there was no evidence of a difference in episodes of pain/sepsis for children in the
biological arm (incident rate ratio 0.95, 97.5% confidence interval 0.75 to 1.21, which indicates that
there were slightly fewer episodes, on average, for the biological arm than the conventional arm) or in the
prevention alone arm (incident rate ratio 1.18, 97.5% confidence interval 0.94 to 1.48, which indicates
that there were slightly more episodes in the prevention alone arm than the conventional arm). Over the
willingness-to-pay values considered, the probability of the biological treatment approach being considered
cost-effective was approximately no higher than 60% to avoid an incidence of dental pain and/or dental
sepsis and no higher than 70% to avoid an episode of pain/sepsis.
Conclusions: There was no evidence of an overall difference between the three treatment approaches for
experience of, or number of episodes of, dental pain or dental sepsis or both over the follow-up period.
Future work: Recommendations for future work include exploring barriers to the use of conventional
techniques for carious lesion detection and diagnosis (e.g. radiographs) and developing and evaluating
suitable techniques and strategies for use in young children in primary care.
Trial registration: Current Controlled Trials ISRCTN77044005.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. X.
See the NIHR Journals Library website for further project information.
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Glossary
B+P Biological management of carious lesions with best-practice prevention.
C+P Conventional management of carious lesions with best-practice prevention.
MACRO An electronic clinical data management system (Elsevier, Amsterdam, the Netherlands).
PA Best-practice prevention alone.
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Plain English summary
What was the question?
Tooth decay is common; it can lead to pain, days off school for children and days off work for parents and
is a financial burden to the NHS. There is uncertainty about the best way of managing decay in young
children. This trial aimed to find out whether or not there was a difference in the amount of pain and/or
infection suffered by children having their decay treated with one of the following: fillings, having decay
sealed in or using preventative treatment alone. Which method represented the best value was also explored.
What did we do?
For young children with decay, the Filling Children’s Teeth: Indicated Or Not? (FiCTION) trial compared the
difference between fillings, sealing in the decay and using preventative treatment alone over 3 years in
NHS dental practices in Scotland, England and Wales. We recruited 1144 children aged 3–7 years with one
or more holes in their baby back teeth (molars), but without pain/infection, and placed them at random
into one of three groups: (1) tooth numbing, removing decay and filling(s) with preventative treatment;
(2) sealing in decay with fillings or caps and preventative treatment but no numbing; or (3) preventative
treatment alone.
What did we find?
Recruitment was challenging but was achieved. There was no evidence of a difference in children’s
experience of pain or infection, quality of life or dental anxiety between groups. All three ways of treating
decay were acceptable to children, parents and dental professionals. Sealing in with preventative treatment
was most likely to be considered the best way of managing children’s decay if we are willing to pay a
minimum of £130 to avoid an episode of pain or infection.
What does this mean?
As there was no evidence of a difference between the three treatment groups in pain/infection experienced,
treatment choice should continue to be based on shared decision-making between the child, parent and
clinician to agree the best option for the individual child.
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Scientific summary
Background
Dental caries (decay) is the most common disease of childhood and carries a large health and economic impact.
In the UK, the majority of dental care for children takes place in primary care and is carried out by general dental
practitioners, rather than by specialists. The lack of evidence on effective and efficient management of dental
decay in children’s primary teeth continues to cause uncertainty for the dental profession, parents and
children. The apparent failure of conventional dental restorations (fillings) to prevent dental pain and/or
dental sepsis for UK children in primary care has prompted much debate. Strategies for managing decay that
are minimally invasive and biologically orientated (sealing in decay with a restoration or crown, rather than
drilling it all out), or prevention focused, can be effective. Much of the evidence for the effectiveness of
treating decay has been derived from studies comparing the effect at the tooth level. Evidence of different
strategies for the individual child is lacking and was the basis for this commissioned research.
Aim
The aim of this trial was to compare the clinical effectiveness and cost-effectiveness of the following three
treatment strategies: (1) conventional management of decay, with best-practice prevention; (2) biological
management of decay, with best-practice prevention; and (3) best-practice prevention alone.
Objectives
The objectives were (1) to assess the clinical effectiveness and cost-effectiveness of three treatment
strategies for managing dental caries in primary teeth and (2) to assess children’s quality of life and
dental anxiety, the acceptability and experiences of children, parents and dental professionals, and the
development and/or progression of caries.
Methods
Design
This was a multicentre, three-arm, parallel-group, participant-randomised controlled trial. Participants were
randomised to one of the three arms in a 1 : 1 : 1 ratio using a central web-based system with stratification
by site (dental practice).
Setting
This trial was set in primary dental care in Scotland, England and Wales.
Participants
Participants were NHS child patients.
The inclusion criteria were children:
l aged 3–7 years
l at a high risk of dental caries, with at least one primary molar tooth with a carious lesion into dentine
but no dental pain and/or dental sepsis
l willing to be dentally examined and known to be a regular attendee or, if new to the practice,
considered likely to return for follow-up.
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The exclusion criteria were children who:
l were aged < 3 or > 7 years
l were accompanied by an adult who lacked the legal or mental capacity to give informed consent
l presented with dental pain and/or sepsis
l had a medical condition requiring special considerations with their dental management
l were in families who knew they would be leaving the area during the 3-year follow-up, or involved in
research that might have affected the Filling Children's Teeth: Indicated Or Not? (FiCTION) trial.
Interventions
Conventional management of decay, with best-practice prevention
Based on what has been considered standard practice for management of carious lesions for > 50 years,
this comprised the use of local anaesthetic and complete removal of carious tissue using rotary instruments
and placing a restoration. Best-practice prevention was carried out in line with current guidelines.
Biological management of decay, with best-practice prevention
Sealing in carious lesions is a minimally invasive approach based on recent understanding that carious
tooth tissue does not need to be completely removed to stop disease progression. This arm used a variety
of techniques, including restorative materials or crowns, to seal the carious lesion and prevent progression.
Best-practice prevention was carried out in line with current guidelines.
Best-practice prevention alone
Avoiding restorative intervention, the four ‘pillars’ or components of prevention are promoted to arrest
existing carious lesions and prevent any more from developing: (1) reducing frequency of sugars intake,
(2) effective twice-daily brushing with fluoridated toothpaste (steps 1 and 2 involve behaviour change by
the parents/guardians and children to reduce the cariogenic challenge), (3) application of topical fluoride
varnish and (4) placement of fissure sealants on the first permanent molar teeth.
Practices were recruited across three UK nations to reflect the sociodemographic mix of the catchment
communities and include the range of social deprivation, water fluoridation, ethnicity and funding systems.
Dental professionals were provided with training in the three treatment management strategies prior to
recruitment of participants. This included face-to-face training in clinical procedures that may have been
unfamiliar: recording dental caries using the International Caries Detection and Assessment System, taking
radiographs in children, the Hall Technique and conventional crown provision. Subsequently, further
training needs were identified and resources provided to support dental professionals practically in taking
radiographs and in using the Hall Technique.
Main outcome measures
Clinical effectiveness outcomes
The clinical effectiveness outcomes were the proportion of children with at least one episode (incidence) and
the number of episodes, for each child, of dental pain or dental sepsis or both, over the follow-up period.
Cost-effectiveness outcomes
The cost-effectiveness outcomes were the incremental cost per incidence and the incremental cost per
episode of dental pain or dental sepsis or both, that was avoided over the follow-up period.
SCIENTIFIC SUMMARY
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Other outcomes
The other outcomes measured were the change in quality of life (measured by the Parental–Caregivers
Perceptions Questionnaire-16 items) and dental anxiety [measured by the Modified Child Dental Anxiety
Scale (faces) questionnaire], acceptability and experiences (explored using a qualitative evaluation) and
caries development and/or progression (assessed using the International Caries Detection and Assessment
System) over the follow-up period.
Results
A total of 72 dental practices were recruited; 7699 children were screened, of whom 1144 were randomised
(conventional arm, n = 386; biological arm, n = 381; prevention alone arm, n = 377). The primary reason
for ineligibility was the lack of identified decay into dentine in one or more primary molar teeth. The 1058
participants in the intention-to-treat analysis set (conventional arm, n = 352; biological arm, n = 352; prevention
alone arm, n = 354) were all randomised children with at least one trial visit. There was no evidence of
differential attrition, with 67% attending a final trial visit. The median follow-up period was 33.8 months.
There was balance between arms for all demographic and participant-based characteristics at baseline.
The mean d3mft [caries experience 2.71 (standard deviation 2.66)] and d3 [untreated decay 2.04 (standard
deviation 2.15)] at baseline was also balanced across arms. Most children (90%) received treatment
without major cross-arm treatment deviations for ≥ 80% of treatment visits; among the options available
in the protocol, dental professionals chose to use materials and techniques most familiar to them. Fewer
than half of the children (48%) had a radiograph taken at any stage of the trial.
Clinical effectiveness
Overall, 43% of the 1058 children experienced at least one episode of dental pain and/or dental sepsis
over a median follow-up period of 33.8 months (interquartile range 23.8–36.7 months) (ever having dental
pain, 36%; dental sepsis, 25%). The proportion of children with at least one episode of dental pain or
dental sepsis or both during the follow-up period was 42% (conventional arm), 40% (biological arm)
and 45% (prevention alone arm). There was no evidence of a difference in the incidence or number of
episodes of pain/sepsis between the three arms. Comparing participants in the biological arm to those
in the conventional arm for incidence of pain/sepsis, the risk difference was –0.02 (97.5% confidence
interval –0.10 to 0.06), which indicates, on average, a 2% reduced risk of dental pain and/or dental sepsis
in the biological arm compared with the conventional arm. Comparing participants in the prevention
alone arm with those in the conventional arm, the risk difference was 0.04 (97.5% confidence interval
–0.04 to 0.12), which indicates, on average, a 4% increased risk of dental pain and/or dental sepsis in the
prevention alone arm compared with the conventional arm. Compared with the conventional arm, there
was no evidence of a difference in the number of episodes for children in the biological arm (incidence
rate ratio 0.95, 97.5% confidence interval 0.75 to 1.21, which indicates that there were slightly fewer
episodes, on average, for the biological arm than the conventional arm) or for children in the prevention
alone arm (incidence rate ratio 1.18, 97.5% confidence interval 0.94 to 1.48, which indicates that there
were slightly more episodes in the prevention alone arm than the conventional arm). A similar pattern was
noted in the pre-planned per-protocol analyses, which removed children with treatment deviations on
> 20% of visits from the analysis.
Cost-effectiveness
The prevention alone arm was, on average, the least costly treatment but the least effective for both
of the co-primary outcomes. A judgement is required as to what value the NHS places on avoiding pain
and/or sepsis. If the willingness to pay to avoid an episode of pain and/or sepsis is ≥ £130, then biological
management would have the highest probability (49%) of being considered cost-effective compared with
prevention alone (45%) and conventional management (6%). A willingness-to-pay threshold of ≥ £330 to
avoid an incidence of pain and/or sepsis would be needed for biological management to have the highest
probability (47%) of being considered cost-effective.
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Other outcomes
Child oral health-related quality of life remained high (median score of 5–7 on the Parental–Caregivers
Perceptions Questionnaire-16 items) and dental anxiety [measured with the Modified Child Dental Anxiety
Scale (faces)] remained low to moderate (median score of 14–15) throughout the trial. There was no
evidence of a difference in the child oral health-related quality of life or dental anxiety measures between
treatment arms at the end of the trial. However, parent-reported child anticipatory anxiety was, on
average, 6% lower in the prevention alone arm than in the conventional arm (risk difference –0.06, 97.5%
confidence interval –0.11 to –0.003).
The qualitative interviews with children/parents indicated that each treatment arm was felt to be generally
acceptable to children and parents, but trust in the dental professional played a significant role. Certain
procedures, including local anaesthetic and extractions, were most likely to be viewed negatively. The
qualitative interviews with dental professionals illustrated how managing carious lesions was a recognised
activity, involving the dental professional selecting the most appropriate treatment option to act in the
best interests of the child. Parents/guardians shared this understanding, trusting dental professionals to
treat each child in the ‘best’ way possible. Although the results of the FiCTION trial will form part of their
knowledge base, dental professionals will also continue to draw on what they know about an individual
child and their own clinical experience in order to engage in the activity of managing carious lesions.
Dental caries development or progression throughout the trial was considered for teeth that were entirely
sound or had non-cavitated carious lesions restricted to enamel at baseline (‘sound/reversible’). This analysis
was on a subset of the intention-to-treat analysis set (61.7%), and so must be treated with caution. Overall,
399 out of 653 (61.1%) participants with complete International Caries Detection and Assessment System
data exhibited development or progression of dental caries in one or more primary teeth (conventional arm,
57.9%; biological arm, 61.6%; and prevention alone arm, 64.1%). There was no statistical evidence of a
difference in the development/progression of caries in primary teeth. Comparing the biological arm with the
conventional arm, the risk difference was 0.03 (97.5% confidence interval –0.06 to 0.11); the risk difference
was, on average, 5% higher in the prevention alone arm than in the conventional arm (risk difference 0.05,
97.5% confidence interval –0.03 to 0.14). Of the 399 participants with development/progression of caries
in primary teeth, 69% had one (42%) or two (28%) teeth, which were ‘sound/reversible’ at baseline
[mean 1.3 (standard deviation 1.4) teeth per child]. There was no statistical evidence of a difference
in development/progression of caries in the first permanent molars between the three arms.
Limitations
Participants, parents and dental professionals were not blinded to trial arm; therefore, their self-reported
responses and the measurement of caries development and/or progression by dental professionals could
have been influenced. Recruitment challenges were overcome to achieve the target sample size.
Radiographs were taken in 11% of visits; cross-arm treatment deviations occurred in 6% of visits.
Harms
No serious adverse events were reported.
Conclusions
There was no evidence of an overall difference between the three treatment approaches for incidence, or
number of episodes, of dental pain or dental sepsis, or both. There was also no evidence of a difference
for quality of life or dental anxiety. All three strategies were acceptable to children, parents and dental
professionals and did not provoke anxiety or discomfort.
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The prevention alone arm was, on average, the least costly and least clinically effective treatment with
respect to the co-primary outcomes. A judgement is required as to what value the NHS places on avoiding
dental pain and/or dental sepsis. Over the willingness-to-pay values considered, the probability of biological
management being considered cost-effective was approximately no higher than 60% to avoid an incidence,
and no higher than 70% to avoid an episode, of pain/sepsis.
The level of dental pain and/or dental sepsis observed emphasises the importance of early prevention for
young children. The outcomes of the FiCTION trial were for the individual child and we suspect that the
low number of radiographs taken may have led to undetected and misdiagnosed dental caries. This, together
with dental professionals’ preferences for familiar materials and techniques, will have contributed to the
overall findings.
Because there was no evidence of a difference between the three treatment arms in the dental pain or
dental sepsis experienced, treatment choice should continue to be based on shared decision-making,
with a conversation between the child, parent and clinician to agree the best option for the individual child.
Implications for health care
l The results of the FiCTION trial emphasise the importance of preventing disease before it occurs to
avoid dental pain and/or dental sepsis. Prevention must start early to avoid the need for operative
management of disease.
l The FiCTION trial results indicate that, for successful management of carious lesions in young children,
the health-care system may require adjustment to ensure effective detection and diagnosis of dental
caries and the use of effective materials and techniques.
l The FiCTION trial findings open the debate around (1) where dental care for children at high risk of
dental caries is best provided, (2) the most appropriate way of identifying children at high risk of dental
caries and (3) the optimal clinical and funding environment for children at high risk of dental caries.
Implications for parents and practice
l Parental and dental professional roles are key to ensure that prevention starts early at home, and early
attendance at a dental practice is an opportunity for reinforcement of prevention, monitoring of oral
health, provision of effective advice and early intervention if necessary.
l The FiCTION trial results indicate that treatment of carious lesions in young children can be tailored to
meet their behavioural and clinical needs; therefore, the role of shared decision-making is important.
Although there is no evidence of a difference in clinical outcome between arms, the biological
approach may offer an advantage when taking into account the disease process, the child’s needs and
the technical requirements, and is the most probable strategy to provide value for money if preventing
dental pain/sepsis is valued.
Implications for dental education/teaching and training
l There appears to be a need for knowledge tools, key evidence-based guidance and additional clinical
training and support of dental professionals to address their clinical skills with regard to use of
radiographs and choice of restorative materials and techniques.
l The FiCTION trial provides evidence of facilitators of and barriers to the investigation, detection,
diagnosis and management of carious lesions, learnt through the qualitative study, which could inform
implementation strategies for Public Health England and Scottish Dental Clinical Effectiveness
Programme guidance. Messages and techniques need to be clear, evidence-based and tailored for
delivery and uptake in the primary care environment.
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l The undergraduate and postgraduate curricula in all dental schools may need to be reviewed to ensure
that all caries management strategies evidenced as suitable for use in young children are included,
along with competencies in managing the dental care of young children and shared decision-making.
Recommendations for research
l Explore the barriers to the use of conventional carious lesion detection and diagnosis tools (e.g.
radiographs) and develop and evaluate suitable tools for use in young children, in primary dental care.
l Explore individual tooth outcomes descriptively by treatment provided, including dental materials and
techniques, through further analysis of the FiCTION trial data set.
l Identify the appropriate service structure necessary to provide cost-effective and acceptable prevention
for young children in a primary care setting.
l Explore clinicians’ decision-making around the use of minimally invasive techniques for caries management
in young children treated in primary care.
Trial registration
This trial is registered as ISRCTN77044005.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Background
Scientific background
Dental caries (decay) is the most common disease of childhood, and carries a large health and economic
impact for the UK.1–4 Treating oral disease is expensive, costing NHS England £3.4B annually.5 Extraction
of decayed primary teeth alone, carried out under general anaesthesia, costs an estimated £36M annually.
In the UK, the majority of dental care for children takes place in primary care and is carried out by general
dental practitioners (GDPs) rather than by specialists. GDPs’ remuneration under the general dental service
(GDS) funding system varies depending on the nation. In Scotland, a capitation and fee per item of service
system operates, whereas in England and Wales, GDPs claim ‘units of dental activity’ (UDAs) to treat
dental patients. Against this background, there is a long-standing debate about the best way of managing
decay in children’s primary teeth.
In 2002, the results of two studies6,7 questioned the success of conventional restorative interventions
[placing local anaesthesia (injections), removal of carious lesions (decay) and placement of a restoration
(filling)] carried out in UK primary dental care practices, in preventing pain and infection in children with
decayed primary teeth. This apparent lack of effective management has caused considerable uncertainty
for the dental profession and for patients and parents. There is universal agreement that guidance for
the effective practice-based prevention and management of dental caries is needed, with that evidence
drawn from primary dental care. This prompted the National Institute for Health Research (NIHR) Health
Technology Assessment (HTA) panel to commission the research that resulted in the Filling Children's
Teeth: Indicated Or Not? (FiCTION) trial, a three-arm participant-randomised controlled trial (RCT)
investigating three approaches to dental care for children with carious lesions in their primary teeth:
1. Conventional treatment with best-practice prevention (C+P) arm. Based on what has been considered
standard practice for management of carious lesions for > 50 years, this comprises the use of local
anaesthetic, complete removal of carious tissue using rotary instruments and placing a restoration.
2. Biological treatment with best-practice prevention (B+P) arm. Sealing-in carious lesions is a minimally
invasive approach, based on recent understanding that carious tooth tissue does not need to be
completely removed to stop disease progression, and uses a variety of sealing techniques, including
restorative materials or crowns, to seal the carious lesion and prevent progression.
3. Best-practice prevention alone (PA) arm. Avoiding restorative intervention, the four ‘pillars’ or components
of prevention are promoted to arrest existing carious lesions and prevent any more from developing:
(1) reducing frequency of sugars intake, (2) effective twice-daily brushing with fluoridated toothpaste
(steps 1 and 2 involve behaviour change by the parents/guardians and children to reduce the cariogenic
challenge), (3) application of topical fluoride varnishes and (4) placement of fissure sealants on first
permanent molar (FPM) teeth.
Dental caries (decay) experiences of children (globally and in the UK)
Dental caries remains an important public health problem globally,8 recognised by the World Health
Organization as a disease that affects 60–90% of school children and the vast majority of adults,
contributing to extensive loss of natural teeth in older people.9,10
The social gradient in health inequity means that the poorest have the worst health,11 and there is strong
evidence relating oral health (especially dental caries) and socioeconomic status; children in lower
socioeconomic groups are disproportionately affected by the disease, which has a linear relationship with
poverty.12 Disease levels vary starkly in the UK, with 56% of 5-year-old children in Blackburn and Darwen
but only 4% of children in less deprived South Gloucester showing visible carious lesions.13 In England,
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dental caries remains the primary reason for children’s admissions to hospital.1 In 2013/14, a total of
62,747 children and young people were admitted to hospital in England, Scotland and Wales with a
diagnosis of dental caries; the most common age group was 5–9 years.1–3
Dental caries and its consequences are not limited to young children or the primary dentition. There is
evidence surrounding the trajectory of disease, showing that children who experience carious lesions in
their primary dentition carry a much greater burden of disease into adolescence and beyond.14 Dental
caries also affects one in three UK 12-year-olds, is positively associated with deprivation15 and is
experienced by almost half of those aged 12–15 years in deprived areas. In 2013 in England, 32% of
12-year-olds experienced dental caries and required treatment, ranging from 46% of those eligible for
free school meals to 30% of those ineligible.16
Changing strategies for management of carious lesions in primary teeth
Until recently, dental caries was considered an infectious disease. As a result, treatment required removal
of all bacteria, biofilm and affected tooth tissue before restoration. However, the disease is now understood
to result from an ecological shift in the varying proportions of different commensal bacteria, resulting in a
dysbiotic microflora in the dental biofilm.17 Acidogenic, aciduric and cariogenic bacteria are highly competitive
within the biofilm and, where there is a frequent supply of fermentable (dietary) carbohydrates, conditions
develop that favour them, supporting their domination of the biofilm ecology. This ecological shift in biofilm
composition leads to a concurrent shift in bacterial activity, with long periods of acidity and net mineral loss
from the dental enamel and dentine resulting in the carious lesion.18
This more recent view of the disease has allowed a rationale for the development of alternative treatments,
rather than the traditional complete surgical excision (drill-and-fill) model. These alternative treatments
involve controlling precipitating factors for the disease, through carbohydrate restriction (diet change to
reduce sugars intake), biofilm removal (through tooth-brushing), promoting tooth tissue remineralisation
(through professional- and home-applied fluoride) and biofilm sealing from substrate (using restorative
techniques).19 A resultant shift away from cariogenic- to non-cariogenic biofilm promotes remineralisation,
inactivates the disease process and preserves tooth tissue. This minimal intervention dentistry approach20
follows the contemporary tenet of quaternary prevention. In addition, it avoids, or slows down, the cycle
of re-restoration21 and is less invasive for patients.
The evidence for effective management of carious lesions in primary teeth
Teaching in UK dental schools has been based on guidance from the British Society of Paediatric Dentistry
(BSPD). Until recently, the BSPD recommended that the optimum treatment of carious lesions in primary
teeth should be complete removal of the carious tissue, followed by the placement of a conventional
restoration (filling) to repair lost tooth tissue.22,23 However, these recommendations were largely based on
evidence from studies conducted in either a secondary care or a specialist paediatric dental practice
setting,24 rather than the primary dental care environment where the vast majority of children are treated.
More recently, the Scottish Dental Clinical Effectiveness Programme (SDCEP) has recognised the growing
evidence for minimally invasive, biologically based approaches to carious lesion management and has
developed national guidance for the management of caries in children,25 which is based on this approach.
Despite long-standing teaching in paediatric dentistry and high-quality guidance for primary dental care
in the UK, the proportion of primary teeth with visible carious lesions that are restored (the Care Index)
remains low. In Scotland it is 13%,26 whereas in England it is 14%.27 The perceived ineffectiveness of
the traditional ‘drill-and-fill’ methods of managing decayed primary teeth has been hypothesised as one
reason why this approach is unpopular with GDPs.28
Evidence from conventional/traditional approaches to managing carious lesions
Traditional approaches to carious lesion management involve complete carious tissue removal and placement
of a restoration. However, a myriad of treatment options are available to dentists when they are deciding
how to restore carious primary molars. Clinical decisions are required with respect to how much carious
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tooth tissue to remove, given the changing face of cariology, as well as which material to use to restore the
tooth, in the light of the ongoing advances in dental materials. Restorations provided in specialist clinical
environments can be effective, with studies conducted in secondary care showing high success rates for
restorations in primary teeth;29,30 subsequent guidance has largely been based on this research. However,
both the research quality and its generalisability to a primary dental setting is limited7,31 and a closer look
at the evidence shows less clarity, because a limitation in its interpretation is the lack of an agreed core
outcome set.32,33 Cariology studies use a variety of different outcomes and different outcomes measures,
making it often impossible to synthesise or directly compare materials and techniques. Few studies have
measured caries-related pain and infection as an outcome when comparing different treatment approaches
and fewer still have compared conventional (complete) carious lesion removal and restoration approaches
with other approaches to managing carious lesions. Two RCTs have compared conventional restorative
techniques with other approaches and recorded pain and/or infection as an outcome. One trial,34 a split-mouth
RCT set in general dental practice, involved 18 GDPs in Scotland and compared the Hall Technique35 (a biological
approach in which carious lesions are sealed in) with conventional restorations. Children, parents and
dentists preferred the Hall Technique and it outperformed the conventional restorations, with the 2-year
follow-up showing that for 2% of teeth treated with the Hall Technique and for 15% of teeth treated with
conventional restorations, participants experienced pain and/or infection.34 The relatively high failure rates
for pain and/or infection after conventional restorations continued at the 5-year follow-up, with 3% failure
for the Hall Technique and 17% for conventional restorations.36 In terms of restoration longevity, the Hall
Technique showed a 5% failure rate at 5 years, compared with 42% for conventional restorations. The lack
of effectiveness for conventional restorations in multisurface lesions in primary teeth was replicated in a
second study in Germany, in which specialists and experienced postgraduate trainees carried out treatment
in a secondary care environment.37 Conventional restorations were compared with the Hall Technique and
a non-restorative cavity control (NRCC) approach (using a prevention alone approach with brushing of
carious lesions to arrest them) for management of multisurface cavities [International Caries Detection
and Assessment System (ICDAS) codes 3 to 5]. After 2.5 years, for 9% of teeth treated in each of the
conventional and NRCC arms participants experienced pain and infection, compared with 2.5% of teeth
treated in the Hall Technique arm.
Evidence from non-destructive/minimally invasive approaches to managing
carious lesions
Managing carious lesions using a biological approach is based on evidence that began to emerge in the
1990s, which increasingly supports the idea that carious tissue does not require complete removal38 to
achieve success in the management of decay. There are advantages to this minimally invasive approach:
less tooth tissue is lost, there is less likelihood of irreversible damage to the dental pulp and children
tolerate it more easily as there is less use of injections and rotary instruments. These biological approaches
include sealing-in a carious lesion with preformed metal crowns (PMCs) via the Hall Technique and sealing
in carious lesions under a fissure sealant material.
These minimally invasive strategies and their respective evidence are summarised in the following sections.
Selective carious lesion removal
Selective removal of carious dentine is carried out to avoid damage to the dental pulp resulting in ingress
of oral bacteria and pulpal death. A Cochrane review29 compared complete with selective caries removal
strategies and found that selective excavation of carious lesions (sealing some of the decay in the tooth
rather than drilling it all out) was effective; in symptomless, vital, primary or permanent teeth this approach
reduced the incidence of pulp exposure. Selective carious tissue removal is therefore advocated for primary
teeth with the definitive restoration placed at the first visit.
Atraumatic restorative treatment
Atraumatic restorative treatment (ART) comprises removal of softened carious tooth structure with dental
excavators and then placement of adhesive materials, usually glass ionomer cement (GIC), to restore
cavities, pits and fissures.39 ART is generally accepted as being less anxiety-provoking than conventional
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restorative techniques.20,40,41 However, a recent Cochrane systematic review42 has cast some doubt on
earlier conclusions regarding restoration longevity. The review included 11 trials on primary teeth (children
aged 3–13 years) comparing ART with conventional restorations and found an odds ratio for restoration
failure of 1.60 [95% confidence interval (CI) 1.13 to 2.27] for ART compared with conventional
restorations over a follow-up period of 12–24 months for 643 participants. No evidence was found for a
difference in cavity types, whether single or multiple surface. Only one study,43 with 40 participants,
reported on pain (children aged 4–7 years) and found that children whose teeth were treated with ART
reported less pain (on the Wong–Baker FACES® Pain Rating Scale44) than those treated with conventional
restorations, with a mean difference of –0.65 (95% CI –1.38 to 0.07).
No carious tissue removal and no restoration (non-restorative cavity control)
This option was initially considered for lesions with no viable repair option using sealing-in methods, either
because the lesion or cavity is too extensive to repair or because the child has limited ability to tolerate
treatment. In these cases, tooth-brushing and remineralisation strategies remove the biofilm and arrest the
decay, maintaining the tooth and avoiding an extraction. NRCC relies on frequent, effective tooth-brushing
to physically debride tooth tissue and disrupt the ecology and composition of the cariogenic plaque
biofilm, causing it to shift to a more balanced, non-cariogenic and healthy state.45 The aim is to minimise
the time that any substrate and cariogenic microorganisms have in contact with a susceptible tooth
surface. NRCC as a carious lesion management strategy relies heavily on a child’s parents/guardians to
change behaviour and adopt effective preventative strategies. Moreover, although biofilm removal with a
toothbrush is theoretically possible, gaining adequate access to a lesion to scrub it effectively enough to
remove the biofilm is challenging. This problem is compounded when trying to remove biofilm from
dentine when it is embedded in the exposed collagen matrix. The RCT37 that found a 29% failure rate for
NRCC after 2.5 years in the hands of specialists in secondary care and a prospective observational study
in a community dental setting46 seem to confirm the purported difficulties found with NRCC.
No carious tissue removal and restoration with a crown using the Hall Technique
Several observational studies47,48 and RCTs with short-term follow-up49,50 support this technique but the
strongest evidence comes from two RCTs with long-term follow-up (see Evidence from conventional/
traditional approaches to managing carious lesions). The first RCT by Innes et al.34,36 supported the use
of the Hall Technique in primary dental care; however, the practitioners involved were from a single
geographical area, limiting the generalisability of the findings. The second hospital-based RCT51 in Germany
found lower failure rates (based on longevity of restoration and pain/infection) after 1 year with the Hall
Technique (0%) than with conventional restorations (9%) or prevention alone with NRCC (8%); after
2.5 years, the respective failure rates were 7%, 33% and 29%.37
The high success rate of the Hall Technique compared with conventional restorations is also evident in
secondary care and private practice. A recent systematic review and meta-analysis52 of adhesive restorations
in primary molars found that the mean survival times of restorations range from 20 to 42 months, with
composite resin, compomer and resin-modified glass ionomer (RMGI) performing similarly. A Cochrane
review30 that included the Hall Technique supported this, concluding that crowns placed on primary molar
teeth, regardless of technique, were likely to reduce pain and infection compared with fillings and that
crowns placed using the Hall Technique reduced discomfort at the time of crown fitting.
Fissure sealants applied over non-cavitated carious lesions
Fissure sealants (low viscosity, unfilled resins) successfully prevent carious lesions occurring on the occlusal
(biting) surfaces of teeth.53 They are also effective at stopping the progression of carious lesions54,55 in
permanent teeth, as they prevent lesion access to the carbohydrate that is necessary for the biofilm to
thrive and stay actively cariogenic.56,57 Although the pathophysiological evidence supports the efficacy of
sealing-in to slow or stop progression of carious lesions, the clinical evidence for fissure sealants shows
mixed success in permanent teeth. Fissure sealant materials wear and fracture and regularly need to be
replaced and, therefore, require continual observation to ensure that the seal is maintained. Similarly, for
primary teeth, there is little direct evidence to inform recommendations for the size of lesion that can be
sealed or the best sealant material to use.58
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Evidence from Good Practice Prevention approaches to managing caries
The four main approaches to preventing dental caries are well established and represent the four ‘pillars
of prevention’. These are:
1. dietary investigation, analysis and intervention to reduce fermentable carbohydrates in the diet
2. tooth-brushing twice daily with a fluoridated toothpaste
3. fissure sealants for permanent teeth
4. topical fluoride varnish applied to primary and permanent teeth by a dental professional.
There is substantial and high-quality evidence from Cochrane reviews on the effectiveness of tooth-
brushing,59 fissure sealants60 and fluoride varnish59 in preventing dental caries. However, the evidence base
supporting the effectiveness of behaviour change to enact fluoride use at home (tooth-brushing with
fluoride toothpaste) and of dietary change to reduce the intake of fermentable carbohydrates (primarily
sugars) is more tenuous.61
Pain and dental infection (sepsis)
Although a highly prevalent condition, the impact of childhood dental caries is often under-appreciated,
as the disease itself is rarely life-threatening or overtly limiting on daily activities. However, the consequences
of the disease, including pain62, interference with sleep and reduced school attendance,63 can have significant
effects on children’s daily lives. In 2013, 6% of 12-year-olds and 3% of 15-year-olds reported difficulty with
schoolwork because of the condition of their teeth and mouth over the previous 3 months.16 Dental caries
can also affect the general health and quality of life (QoL) of children, impairing growth and cognitive
development,64 as well as interfering with nutritional status,63 and may even have an effect on attainment.65
Estimates of pain and infection from dental caries in children are difficult to establish. However, the 2016
National Dental Inspection Programme26 epidemiological study in Scotland, in which 86% of Primary One
children were inspected (at approximately 5 years of age), reported that 7.5% of the children examined
had a dental status that required them to be issued with a letter indicating that they ‘should seek
immediate dental care on account of severe decay or abscess’.
One of the difficulties with measuring pain and infection in young children is their limited ability to
communicate. Young children do not find it easy to describe and report pain.66 Cognitively, the ability to
understand pain and differentiate a chronic pain from the absence of pain is a complex phenomenon.
Young children, who grow up with pain from an early age, may not realise that this is not normal. When
they do realise they have pain, it can be difficult to have them describe this precisely to help with reaching
an accurate diagnosis.
Dental caries incidence
Since the turn of the millennium, it has been widely acknowledged that the commonly used threshold for
the measurement of dental caries in clinical trials is no longer appropriate, because this level represents
disease that is already well advanced (into dentine).67,68 The National Institutes of Health (US) (NIH)
Consensus Development Conference in Bethesda, MD, USA, in 200167 identified the benefits of including
the recording of early dental caries in clinical trials, stating ‘There was a paradigm shift in the management
of dental caries toward improved diagnosis of early non-cavitated lesions and treatment for prevention and
arrest of such lesions’. In addition, the panel recommended that ‘clinical trials of established and new
treatment methods . . . should conform to contemporary standards of design implementation, analysis and
reporting’. Many technical adjuncts to carious lesion detection and diagnosis have become available over
the years,69 but their use is not widespread in clinical dentistry and they remain, primarily, a clinical
research tool.
The most widely used adjunct for carious lesion detection, which is in general use in clinical dentistry,
is radiographs. The mandatory use of radiographs as part of a clinical dental research trial is universally
agreed as unethical. However, they are recommended at risk-based intervals in UK guidelines.70
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Nevertheless, it is clear from the literature,71 and was highlighted in the FiCTION pilot trial and feasibility
study,72,73 that radiograph use in children does not follow the expected frequency.
Child- and parent-reported outcomes: oral health-related quality of life
The value of patient-reported observations on their dental treatment experiences is becoming widely
accepted and patients’ perspectives are seen as valuable. Patient-reported outcome measures (PROMs) are
now included in the vast majority of trials to evaluate changes in the impact of the condition following
treatment from the patient’s perspective.
Many PROMs have been produced to measure oral health-related quality of life (OHRQoL), which was
defined by Locker and Allen74 as ‘the impact of oral diseases and disorders on aspects of everyday life that
a patient or person values, that are of sufficient magnitude, in terms of frequency, severity or duration to
affect their experience and perception of their life overall’. Most existing measures of OHRQoL in children,
including the Child Perceptions Questionnaire (CPQ), the Child – Oral Impacts on Daily Performances
(C-OIDP) index and the Child – Oral Health Impact Profile (C-OHIP), are designed to cover a variety of oral
conditions, such as dental caries, malocclusion and craniofacial anomalies. Although these measures have
been developed for children to self-report, for young children (< 8 years of age) most studies rely on
parental reports of the impact of their child’s health on their daily lives.75
Child- and parent-reported outcomes: dental anxiety and worry
The prevalence of child dental anxiety, across Europe, ranges from 3% to 21%,76–78 with 14% of children
experiencing extreme dental anxiety.78 These findings suggest a continuum of child dental fear across
populations of children, including those who attend for dental treatment.79
The literature suggests that younger preschool children may find any form of dental intervention frightening;
consequently, they may be disruptive during treatment.80 For the younger, preschool child, it is not the actual
dental intervention or seriousness of the treatment that is important, but the imaginings or fantasies stirred
up by it.81 These imaginings include feeling helpless, having to submit passively to treatment, fear of pain
and being separated from their parent. Similar observations are made for children who experience dental
pain and for those who suffer from high dental anxiety.79
With psychological development, the once fearful and disruptive preschool child usually becomes able
to manage dental treatment.80 Therefore, it is important when investigating different dental treatment
modalities, for preschool and primary school-aged children, to assess child dental anxiety and to examine
how their dental anxiety status changes with chronological age. Different dental treatment modalities may
also influence children’s dental fear and some may be more appropriate for children with dental anxiety.
Therefore, it is important to assess not only dental trait anxiety (anxiety that is more stable) but also dental
state anxiety (anxiety that is associated with specific situations) to assess the effect of the treatment on the
dental anxiety experienced by the child patient during and after treatment.
In summary, to assess child dental anxiety in the FiCTION trial, to demonstrate how this affect changed
with the experience of pain and chronological age and to identify the most appropriate treatment modality
to treat carious lesions in the dentally anxious child, state measures of dental fear were chosen. The
justification for choice of measures to assess child dental anxiety is described in Chapter 2, Child- and
parent-reported outcomes: participant dental anxiety, worry and discomfort during dental treatment.
Economic analysis to determine the cost-effectiveness of different treatment approaches
(See Chapter 2, Cost-effectiveness of managing dental decay in primary teeth, and Chapter 4). Dental care
for dental caries has high direct costs for the NHS;82 therefore, we need to ensure that health benefits are
being maximised within the budget. An economic evaluation was conducted alongside the FiCTION trial
to determine the cost-effectiveness of the different treatment approaches. These results can be used to
facilitate efficient resource allocation for managing carious lesions in primary teeth.
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Acceptability and associated experiences of the FiCTION trial arms for children,
parents/guardians and dental professionals
Dental treatments vary in their degree of acceptability to patients. The more acceptable a treatment is to
the patient, parent or care-deliverer, the more likely it is to be delivered and received. The value of children’s
opinions on their dental treatment experiences has become more widely accepted and their perspectives are
seen as credible. Although a vast body of research has compared different types of treatment to manage
carious lesions, most of the research has focused on outcomes related to choice and characteristics of dental
materials;33 very little research has included the preferences or perspectives of participants as outcomes.
Rationale for the FiCTION trial
As a pragmatic, parallel-group, patient-RCT in general dental practice, the aim of the FiCTION trial was
to provide evidence for the most clinically effective and cost-effective approach to managing caries in
children’s primary teeth in primary dental care. Such evidence would remove persistent uncertainty among
dental practitioners when treating and managing carious lesions in children’s primary teeth and support
dental practitioners in treatment decision-making for child patients to minimise pain and infection in
primary teeth.
The implication of this research is likely to be a change in policy for service and education in the NHS
and beyond.
As described earlier (see Scientific background), there is growing evidence in favour of less-invasive
management of dental decay, informed by the principles of minimal-intervention dentistry83 and based
around sealing-in carious lesions or removing biofilms and supporting remineralisation strategies with a
NRCC approach. The natural separation of these interventions, therefore, into conventional management,
less-invasive sealing management options and non-restorative management options provided the basis for
the three arms of the FiCTION RCT.
Design and key findings of the FiCTION trial pilot phase
The FiCTION trial was delivered in two phases: Phase I comprised a pilot trial, qualitative study72 and
feasibility survey84 and Phase II was the FiCTION main trial. Phase II was dependent on the success and
recommendations of Phase I.
As planned, purposively selected primary dental care practices in Dundee, Newcastle and Sheffield were
recruited to the pilot trial. The target patient participant recruitment figure was 200 children, aged
3–7 years, with carious lesions into dentine in primary molar teeth. Once recruited, participants were
randomised to a three-arm pilot trial with allocation to the caries treatment strategies described in
Scientific background. Trial procedures mirrored those planned for employment in the FiCTION main trial,
with the exception that follow-up was for 6 months only.
Appendix 1 presents the 26 recommendations from the pilot phase of the FiCTION trial, made to inform
Phase II, the main FiCTION trial.
In summary, the experience of undertaking the FiCTION pilot trial and the feasibility study [HTA number
07/44/03, Newcastle Clinical Trials Unit (NCTU) number FS77044005] resulted in minor refinements to
the design and conduct of the main trial, including changes to the presentation of parent and child
information and streamlining of the recruiting process. This preparatory work enhanced our confidence
in being able to recruit the target number of dental practices for the main trial, and confirmed our
expectations that the time scale for recruiting the required number of participants aged 3–7 years would
be challenging.
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Dentists in the pilot trial were reimbursed for their time, following a detailed costing framework developed
by the Primary Care Research Network (PCRN) Northern and Yorkshire; participating practices’ feedback
about the process and value of the reimbursement was positive. Primary care trusts (PCTs) were also
supportive of the trial and agreed that the FiCTION trial work and ‘accrual’ reimbursement would not
interfere with the practice contract or UDAs (current payment system). The opportunity cost of treatment
sessions forgone as a result of trial participation was not an issue for the dentists.
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Chapter 2 Randomised controlled trial methods
Aims and objectives of the trial
The aim of the FiCTION trial was to compare the clinical effectiveness and cost-effectiveness of three
treatment strategies for the management of dental caries in primary teeth over a period of up to 3 years
(minimum 23 months) in children aged 3–7 years at the time of initiation of treatment. The three
strategies compared were as follows:
l conventional management of decay, with best-practice prevention
l biological management of decay, with best-practice prevention
l best-practice prevention alone.
These strategies are described in detail in Interventions.
Objectives
The objectives were to assess:
l the clinical effectiveness and cost-effectiveness of three treatment strategies for managing dental caries
in primary teeth
l the three treatment strategies with respect to –
¢ child- and parent-reported outcomes, including child OHRQoL, dental anxiety, worry and discomfort
during treatment
¢ acceptability and associated experiences for children, parents and members of the dental team
¢ caries development and/or progression in primary and permanent teeth.
Summary/overview of trial design
The FiCTION trial was a multicentre, three-arm, parallel-group, participant-randomised controlled trial, with
an integrated economic evaluation (see Chapter 4) and qualitative evaluation (see Chapter 5).
Trial registration and protocol availability
The FiCTION pilot trial was initially registered in the International Standard Randomised Controlled Trial
Number (ISRCTN) registry on 27 January 2009; it was extended to include the main trial on 8 May 2013.
The protocol was published in BioMed Central Oral Health in 201385 and is also available on the NIHR
HTA project web page [see www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)].
Over the course of the trial, five protocol amendments were made (see Appendix 2).
Ethics and governance
The University of Dundee acted as sponsor for this trial. Favourable ethics opinion was obtained from
the East of Scotland Research Ethics Committee (REC) 1 on 30 July 2012. All subsequent substantial
amendments were also approved by the same REC.
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All members of the trial team and practice staff had training in Good Clinical Practice (GCP), in keeping
with their role in the trial. Practice staff directly involved with recruitment and consent received further
training in taking informed consent in a paediatric setting.
Dental practices were required to maintain an investigator site file containing details of staff involved in
the FiCTION trial, their training and their delegated roles. Dentists were named as practice leads once they
satisfied the GCP/Research Governance Framework requirements.
Trial setting
The trial was conducted in primary dental care, reflecting the setting within which the vast majority of
children’s dentistry is carried out. General dental practices across three of the four UK nations (Scotland,
England and Wales) were grouped into five clinical centres (CCs) for management purposes:
l Scotland, with one CC covering Tayside, Glasgow, Edinburgh and the Borders (hereafter referred to
as Scotland)
l England, with three CCs covering –
¢ North East England/Cumbria (hereafter referred to as Newcastle)
¢ Leeds, Sheffield, Derbyshire, Manchester and Liverpool (hereafter referred to as Leeds/Sheffield)
¢ London
l Wales, with one CC covering Cardiff (hereafter referred to as Wales).
To be eligible for participation in the trial, practices had to:
l see and treat children aged 3–7 years under NHS contracts
l see children with carious lesions in primary teeth (around one child per week was considered an
appropriate frequency)
l have the infrastructure to support the trial, preferably to include electronic patient management systems
and internet access.
Practice recruitment
The initial target was to recruit 50 practices, 10 from each of the five CCs (see Sample size calculation).
The selection of practices was designed to reflect the sociodemographic mix of the catchment communities.
A range of strategies were used to identify and invite practices to participate. Practices from which an
expression of interest in trial participation was received were visited by the research team to assess their
eligibility before their inclusion was confirmed.
General strategy
The 11 practices that had participated in the FiCTION pilot trial,86 carried out in Scotland, Newcastle and
Leeds/Sheffield, were invited to participate in the main trial. A further 44 practices that indicated interest
in main trial participation when surveyed as part of the FiCTION feasibility study and in which at least one
GDP had expressed willingness to randomise patients in that survey exercise were re-contacted and
formally invited to participate by letters sent to the senior partner as well as to the GDPs working in
these practices.
Practices that formed the overall sampling frame for the feasibility study but that had not been contacted
as part of that study were also invited to express an interest in the FiCTION trial (total: 632 practices across
the five CCs).
RANDOMISED CONTROLLED TRIAL METHODS
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Any practice responding to general advertising in the national and local dental press and expressing an
interest in participating in the trial was considered in accordance with practice eligibility criteria and
proximity to the CCs [Scotland (Dundee), Newcastle, Leeds/Sheffield, Wales (Cardiff) and London].
Local strategy
In addition to the general practice recruitment strategy described above, a local recruitment strategy was
developed by the clinical leads at each CC in liaison with the research networks in England and Wales
and the Scottish Primary Care Research Network in Scotland. This comprised e-mail and postal mailing of
FiCTION trial flyers to practices and practitioners by PCRNs in England and their equivalents in Wales and
Scotland. Practices wanting to express an interest in the trial were asked to contact the Dundee FiCTION
trial office. Expressions of interest were followed up locally by the clinical leads with the support of their
local PCRNs. Local practice recruitment meetings were held in the CCs to inform interested GDPs about
the FiCTION trial and to answer any questions they may have had.
By July 2013, 56 practices had been recruited and it was recognised that additional practices would be
needed to reach the target number of participants. Following consultation with the Trial Steering
Committee (TSC), Independent Data Monitoring Committee (IDMC) and HTA, the target number of
practices was increased to 70 and catchment areas for two of the CCs (Leeds/Sheffield and Newcastle)
expanded geographically into Derbyshire/Manchester/Liverpool and Cumbria, respectively.
Practice retention
The trial manager, clinical leads and their secretaries, and the clinical researcher actively maintained
regular contact with all participating practices throughout the trial. They identified practice retention or
associated problems early, using the formally established communication strategy and informally through
their ongoing engagement with the practice, working closely with the practitioners to troubleshoot any
problems. Regular e-mail and telephone updates from clinical leads’ secretaries and the trial manager,
plus quarterly newsletters from the trial core team, were issued during the trial. Active support was
sought from the PCRNs, research networks and local research champions for recruitment and retention
of practices.
Continuing professional development (CPD) credit for all members of each FiCTION trial practice dental
team was made available for attendance at any trial training events.
The practices were remunerated with service support costs for participant screening and recruitment
activities, as well as with research costs based on the additional time spent on trial-related data collection.
Dental treatment was remunerated in the normal way, depending on the nation where the practice
was located.
Trial participants
Child participant inclusion criteria
Children (aged 3–7 years) who:
l were willing to be dentally examined
l had at least one primary molar tooth with decay into dentine (i.e. carious lesion) on clinical
examination
l were known regular attendees or, if new to the practice, considered likely to return for
follow-up.
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Child participant exclusion criteria
l Children aged < 3 or > 7 years.
l Children aged 3–7 years who:
¢ at the recruitment appointment, were accompanied by an adult who lacked the legal or mental
capacity to give informed consent
¢ at the recruitment appointment presented with either dental pain and/or dental sepsis due to caries
(as diagnosed by the GDP from patient history, examination, radiographs). These participants were
not enrolled into the trial at that point, but, after treatment, could be reassessed for eligibility.
Discomfort or pain associated with erupting or exfoliating teeth or an incident of trauma or oral
ulceration was not an exclusion criterion
¢ had a medical condition requiring special considerations with their dental management, for example
cardiac defects or blood dyscrasias
¢ were currently involved in any other research that might have affected this trial
¢ were part of a family that knew they would be moving out of the area during the 3 years
following recruitment.
Interventions
Three multicomponent treatment strategies for managing carious lesions in the primary dentition were
tested. Each patient was randomly allocated to one strategy, with the expectation that they would be
managed in that arm of the trial for up to 3 years. These strategies were documented in detail in the
clinical protocols used in the training of practices and were available to practices for reference thereafter.
Conventional management of carious lesions, with best-practice prevention
[This intervention will hereafter be referred to as conventional with prevention (C+P).] (See Chapter 1,
Evidence from conventional/traditional approaches to managing carious lesions.) Conventional
management is commonly known as the ‘drill-and-fill’ method and is the traditional approach to managing
dental caries that has been taught and practised for many years. It is based on active management of
carious lesions by complete removal of the carious tissue. The teeth are numbed with local anaesthesia
(a dental injection), carious tissue is mechanically removed using rotary instruments (drill) or by hand
excavation (using hand tools), and a restoration (filling) is placed in the tooth to fill the cavity. If the dental
pulp (nerve) is exposed during carious tissue removal or there are symptoms of pulpitis, a pulpotomy
(removal of some of the nerve) may be carried out, followed by provision of a metal crown (usually) or a
filling. Retained roots, and teeth for which the crowns are unrestorable or the pulp chamber is open,
are managed by extraction (removal) of the tooth following local anaesthesia.
Best-practice prevention was carried out in line with current guidelines and as per the prevention alone
(PA) arm.
Biological management of carious lesions, with best-practice prevention
[This intervention will hereafter be referred to as biological with prevention (B+P).] (See Chapter 1,
Evidence from non-destructive/minimally invasive approaches to managing carious lesions.) This minimally
invasive approach to managing carious lesions involves sealing decay into the tooth and separating it from
the oral cavity; this is achieved by application of an adhesive filling material over the caries or by covering
with a metal crown. It may be clinically necessary, on occasion, to partially remove superficial carious tissue
prior to the tooth being sealed. Local anaesthetic injections are rarely needed. Retained roots and teeth
for which the crowns are unrestorable, or dental pulp is exposed, are managed on a tooth-by-tooth basis.
In situations when a tooth has active carious lesions (decay still progressing) or when the clinician decides
that the tooth is likely to give the patient pain or sepsis before it exfoliates (falls out), the caries is managed
by extraction following local anaesthesia.
RANDOMISED CONTROLLED TRIAL METHODS
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Best-practice prevention was carried out in line with current guidelines and as per the PA arm.
Best-practice prevention alone
[This intervention will hereafter be referred to as prevention alone (PA).] (See Chapter 1, Evidence from
Good Practice Prevention approaches to managing caries.) For the PA arm, no drilling, filling or sealing of
primary teeth occurred. Treatment plans for participants were based on best-practice preventative care for
teeth and oral health. This involved the four component pillars of prevention, carried out according to
current guidelines:25,87
l dietary investigation, analysis and intervention to reduce fermentable carbohydrates in the diet
l tooth-brushing twice daily with a fluoridated toothpaste, plus fluoride mouth-rinsing in children
> 7 years of age
l topical fluoride varnish applied to primary and permanent teeth by a dental professional
l fissure sealants for permanent teeth.
Training of dentists and practice staff
Between July and October 2012, each CC hosted a practice training day to deliver clinical and trial process
training (which included GCP and informed consent training) to all enrolled dentists. Whenever possible,
dental therapists/hygienists/nurses and practice receptionists/managers were also trained at the practice
training day. For dental team staff who could not attend a practice training day, training was delivered as
part of a site initiation visit by the trial manager and clinical researcher.
Training was provided for the individual clinical procedures with which dentists were unfamiliar and was
tailored as far as possible to each group of dentists. Topics included, but were not limited to, recording
dental caries using ICDAS, taking radiographs in children, the Hall Technique and conventional crown
provision. Additional training materials were developed for taking radiographs and for the Hall Technique;35
these materials were made available to participating dentists in their practice. Although the detection of
dental sepsis (infection) is a standard part of a dental clinical examination, given its importance as one of the
primary outcomes, specifically directed training was included.
Training was given during appropriate treatment planning and delivery to children according to the
randomised trial arm. This comprised a didactic teaching session from members of the core team
followed by practical treatment planning with cases and discussion with the local clinical lead and
co-chief investigators.
Outcomes
Primary outcomes
When the trial was originally designed it was powered only for a single primary outcome of incidence of
dental pain and/or dental sepsis. However, as the trial progressed, it became clear that the number of
episodes of dental pain and/or dental sepsis experienced by a child is a more clinically relevant outcome
and, statistically, a more sensitive measure (compared with dichotomising the number of episodes into
zero episodes vs. one or more episodes). Therefore, it was decided that the number of episodes of dental
pain and/or dental sepsis should be a co-primary outcome.
Originally, participants were planned to be followed up in the study for a fixed 3-year period.
However, the extension to the trial recruitment period resulted in the maximum potential follow-up
ranging from 23 to 36 months; hence, the co-primary outcomes were assessed across a variable
follow-up period.
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Definition of the clinical effectiveness outcomes
The co-primary outcomes for clinical effectiveness were the:
l proportion of children with at least one episode of dental pain or dental sepsis or both during the
follow-up period (incidence)
l number of episodes of dental pain or dental sepsis or both for each child during the follow-up period.
The primary outcome measure of incidence was a binary indicator of dental pain and/or dental sepsis at
each treatment visit during the follow-up period (minimum of 23 months to a maximum of 36 months).
Treatment visits included scheduled appointments and unscheduled/emergency appointments.
Dental pain was defined on the case report form (CRF) by a ‘yes’ response to question 7 and a ‘yes’
response to question 7a (dental caries).
Dental sepsis was defined as confirmed infection on the CRF by a ‘yes’ response to question 8.
Schedule of assessment of primary outcomes
Data for the primary outcomes of dental pain and/or dental sepsis due to caries were recorded on the CRF
during or following all visits to the GDP (Table 1) [see also the project web page: www.journalslibrary.nihr.ac.uk/
programmes/hta/074403/#/ (accessed 22 February 2019)].
Dental pain due to caries (toothache)
Assessments for dental pain were made at each visit (scheduled or emergency treatment) throughout a
child’s participation in the trial using the CRF completed by dentists. To differentiate between pain
originating from a decayed tooth and pain from other causes (e.g. erupting or exfoliating teeth, mouth
ulcers), the dentist formed a judgement based on the patient/parent history and the clinical evidence
available from examination, which was recorded on the CRF completed at each appointment.
Dental sepsis (dental infection)
Clinical visual examination for dental sepsis was specifically undertaken at every visit by the GDPs and
recorded on the CRF. The clinical detection criterion for the positive recording of dental sepsis was
the presence of a swelling, dental abscess or draining sinus. Clinical examination was expected to be
supplemented with examination of any radiographs taken [in line with Faculty of General Dental Practice
(FGDP) guidelines],70 to record radiographic signs of inter-radicular pathology. Our statistical analysis plan
(SAP) indicated that if it was found that < 80% of children had radiographs within 1 year of entry to the
trial, this source of data would be considered unrepresentative and would be disregarded in the definition
of dental sepsis.
Definition of an episode
Several treatment visits (i.e. a course of treatment) can be associated with the same ‘episode’ of dental
pain and/or dental sepsis. Therefore, we needed a definition of an ‘episode’ of dental pain and/or dental
sepsis due to caries; this definition was operationalised on a tooth-by-tooth basis using CRF data,
according to the following algorithm:
l Let Y (yes) = the presence of dental pain and/or dental sepsis at a single treatment visit (as defined
above); N (no) otherwise.
l Let YY = the presence of dental pain and/or dental sepsis at consecutive treatment visits (i.e. on
consecutive CRFs)
l Y on one or more teeth at a single treatment visit = an episode.
l Any number of consecutive ‘yeses’ on the same tooth, regardless of timeframe = a single episode
(e.g. YYYYY over 5 months).
l YY on different teeth (regardless of timeframe) = two separate episodes.
l YNY on the same tooth = two separate episodes (regardless of the timeframe).
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Although episodes were defined on a tooth-by-tooth basis, for a given child, if there were two (or more)
teeth with dental pain and/or dental sepsis at the same visit, this was recorded as one episode at that visit
for that child. For example, if a particular tooth had dental pain and/or dental sepsis at two consecutive
visits and at the second visit a different tooth also had dental pain and/or dental sepsis this would be
counted as one episode.
It was assumed that those who did not return for regular appointments during their follow-up did not
experience dental pain and/or dental sepsis.
Secondary outcomes
See the project web page [www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)] for the SAP and study documentation, patient information sheet and questionnaires,
for additional detail on the secondary outcome measures used.
Incidence of dental caries in primary and permanent teeth
A systematic review of clinical caries detection systems revealed a vast selection of scales with many
inconsistencies in how the caries process was measured.88 This review and the NIH consensus statement67
led to the development of an evidence-based and histologically validated system for staging dental caries,
known as the ICDAS system.89 This system is widely used in clinical research as a reference standard
for measuring caries prevalence and incidence that all clinicians can use ethically, without harm and
irrespective of the equipment they have. These features, along with the reported acceptable validity and
reliability of ICDAS in primary teeth90 and the permanent dentition,91 make it an appropriate tool for dental
caries measurement. Because, at a population level, nearly all caries experience in the permanent teeth of
children in this age group are accounted for in the FPM teeth, the analysis of caries in permanent teeth
focuses on these teeth alone.
Detailed measurements of caries experience were recorded at baseline and final assessment by the GDPs
using the CRF and ICDAS charting. The dentists measured both early and more advanced stages of dental
caries. The primary requirement for the examination was clean, dry teeth. All surfaces of all teeth were
examined and the status of each was recorded in terms of caries and restorations. In the event of enough
data (at least 80% of children with a radiograph taken within 1 year of entry to the trial) being available to
provide a valid measure in this population, it was planned that bitewing radiographs, taken in line with
FGDP guidelines (with blinded, independent assessment), would be used as an independent measure of
dental caries. However, as the guidance for frequency of bitewing radiographs is based on caries risk
assessment, and as some children may have moved out of the high-risk group during the course of the
trial, it was anticipated that the frequency of bitewing radiographs taken for some children might reduce
over the period of the trial. In addition, some children might have been unco-operative with this type of
assessment, in view of their young age.
As the SAP [see the project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/
(accessed 22 February 2019)] describes, an incident of caries was defined in terms of the observations
made on the ICDAS charts scored at baseline and at the final visit. As observations on surfaces of the same
tooth and between adjacent surfaces of different teeth were likely to be correlated, a single whole-mouth
Caries Assessment Score for each child was derived and a computer program written to define for each
child whether or not there had been disease development/progression from baseline to the final visit in
teeth that were ‘sound/reversible’ at baseline, that is caries-free or with non-cavitated enamel caries [see
appendix 1 in the SAP, as found on the project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/
074403/#/ (accessed 22 February 2019)]. Primary and permanent teeth were analysed separately.
Child- and parent-reported outcomes: participant oral health-related quality of life
Our chosen measure of OHRQoL was the Parental–Caregivers Perceptions Questionnaire (P-CPQ). The P-CPQ,
in its original 31-item version,92 was found to be reliable and valid for use in the UK.93 More recently,
a modified 16-item short form, Parental–Caregivers Perceptions Questionnaire-16 items (P-CPQ-16),
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has been developed and validated;94,95 to minimise respondent burden, this shortened version was selected
for use in the trial [see the project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/
(accessed 22 February 2019)]. The questionnaire includes four domains: oral symptoms, functional limitations,
emotional well-being and social well-being. Parents are asked to indicate, using a six-point Likert scale
(‘never’ = 0, ‘once or twice’ = 1, ‘sometimes’ = 2, ‘often’ = 3, ‘every day or almost every day’ = 4, and ‘do not
know’ = 7), the frequency with which the events affected their children in the previous 3 months. The P-CPQ-16
also includes two global ratings: the parent’s ratings of the child’s oral health and their rating of the extent
to which the oral/orofacial condition affects his/her life overall;96,97 these are rated on five-point response
scales ranging from ‘excellent’ to ‘poor’ for the former and from ‘not at all’ to ‘very much’ for the latter.
Parents were asked to complete the P-CPQ-16 at the baseline or the final visit; if the final visit was not
attended, parents were sent a non-attendance questionnaire [see Table 1 and the project web page:
www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019)]. A score for each
visit was calculated, ranging from 0 to 64 (a lower score represents better OHRQoL). The global ratings are
not included in the calculation of the scores.
Child- and parent-reported outcomes: participant dental anxiety, worry and discomfort
during dental treatment
In measuring participant dental anxiety, we distinguished between underlying trait anxiety and treatment-
related state anxiety. As with the assessment of OHRQoL, the challenges of child self-report and the need
for parental proxy report for some constructs was recognised. The choice of measures was informed by a
published systematic review of measures of child dental anxiety by Porritt et al.98
The chosen measure of trait anxiety was a six-item version of the Modified Child Dental Anxiety Scale
(faces) (MCDASf). As the last two questions of the standard MCDASf ask about conscious sedation and
dental general anaesthesia respectively, neither of which were relevant to FiCTION trial patients, these
were omitted, as recommended by SDCEP.99 The Modified Child Dental Anxiety Scale (MCDAS)100 aims to
assess dental anxiety in children and has been shown to be an acceptable measure of child dental anxiety
in children aged 8–15-years, exhibiting good internal consistency and validity.100,101 The MCDASf is a
modified version for younger children and has also been tested for criterion and construct validity and
test–retest assessment reliability.102 The response format for each of the six items is in the form of five
faces showing different expressions, from ‘relaxed/not worried’ to ‘very worried’. Howard and Freeman102
concluded that the MCDASf can be used with confidence to assess dental anxiety in children, although
they indicated that it has not been formally validated in those aged < 8 years. The MCDASf was completed
by the child before treatment at baseline and at every visit to provide information on his or her anxiety at
each dental encounter throughout the trial. The total score for each assessment was calculated, ranging
from 6 to 30, with lower scores indicating less dental trait anxiety.
The measurement of dental state anxiety, to assess how the child responded to the particular treatment
provided, was an important dimension of this trial. As with the MCDASf, it was necessary to choose an
instrument appropriate to the age and cognitive abilities of the child participants. Visual analogue and
pictorial scales are known to be useful in assessing single item constructs such as pre- and post operative
child dental anxiety (‘worry’). Although difficulties are noted with regard to the consistency of overall
test–retest reliability, the reliability is noted to improve in the middle and the extremes of the scale.103
Therefore, we judged that a pictorial scale using faces as the descriptors104 would be an appropriate
means of assessing child dental state anxiety. Accordingly, at the start of each treatment visit the child
completed a faces-based pictorial scale, scored 1 to 3, where 1 was ‘not at all worried’ and 3 was ‘very
worried’, to report on their level of worry prior to arriving at the dentist’s for their visit (anticipatory
anxiety). The child subsequently completed a second pictorial scale with the response options and scoring
system at the end of each treatment visit to report on treatment-related dental state anxiety.
Although accounts of the use and psychometric properties of parent-proxy measures of children’s state
anxiety are equivocal,103,105,106 such assessments have been shown to be valuable when assessing anxiety in
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younger children.103,107 Therefore, in parallel with the child self-reports of anticipatory and treatment-related
anxiety, parents were asked to make assessments of their child’s worry levels prior to arrival at the dentist’s
for their visit and following treatment; these assessments were recorded using a single categorical global
worry question for each time point, scored 1 to 5, where 1 was ‘not at all worried’ and 5 was ‘very worried’.
Discomfort during dental treatment was assessed by the child in relation to their treatment experience at
the end of each visit using a global question on hurt, with a face format pictorial scale, scored 1 to 3 where
1 was ‘not at all hurt’ and 3 was ‘hurt a lot’. In addition, parents were asked to report on their perceptions
of their child’s levels of pain regarding that particular visit to the dentist using a global question on pain due
to treatment, scored 1 to 5, where 1 was ‘not at all painful’ and 5 was ‘very painful’.
Dentists also estimated child discomfort at every visit using a global discomfort question scored 1 to 5,
where 1 was ‘no apparent discomfort’ and 5 was ‘significant and unacceptable’ discomfort, with these
ratings being reported via the CRF.
There was no specific validation of any of the above pictorial or global rating scales.
Cost-effectiveness of managing dental decay in primary teeth
(See Chapter 4.) The objective of the economics analysis in the FiCTION trial was to determine the relative
cost-effectiveness of alternative ways of managing dental decay in primary teeth. The primary (base-case)
analysis focused on estimating the cost of the three treatment strategies based on the resources (staff
time, consumable materials and reusable materials) used to provide care at each visit. The differences in
costs between different treatments were equated to the differences in effectiveness measured in terms
of dental pain and/or dental sepsis. Sensitivity analyses determined the effect on results when costs were
based on current charges to the NHS. Finally, a wider societal perspective was adopted to account for
parental costs. The inclusion of a thorough economic evaluation as part of the FiCTION trial was crucial
to help address uncertainties surrounding the effectiveness and efficiency of each treatment strategy.
Acceptability and associated experiences of treatment strategy for children and
parents/carers and dental professionals
(See Chapter 5.) Given the difficulty in measuring children’s attitudes towards treatment strategies,
identified in the pilot trial, the acceptability of the three treatment strategies was explored using a
child-centred approach with qualitative methods, and specifically, with child participatory activities,
to allow children rather than adults to shape the data collection process.108 Separate ethics approval was
sought for this study.
Dentist-reported child behaviour and compliance was measured at each appointment using a behaviour
score of 1 to 4, in which 1 was ‘The child refused the treatment: . . . It was very difficult to make any
progress’ and 4 was ‘Child was completely co-operative’, recorded on the CRF.
The dental professionals’ experiences of the three treatment strategies was explored qualitatively through
interviews and focus groups. Topic guides were derived from qualitative information collected during the
FiCTION pilot trial.
Safety (harms)
The three interventions tested in this trial are all in common use in general dental practice and were
considered to be of relatively low risk. Expected adverse events (AEs) are summarised in Appendix 3.
Because of the type of trial, non-serious AEs were not captured. However, all serious adverse events (SAEs)
were required to be reported, by the practice lead, to NCTU via a secure fax line within 24 hours of the
practice learning of an occurrence.
DOI: 10.3310/hta23XXX HEALTH TECHNOLOGY ASSESSMENT 2019 VOL. 23 NO. XX
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Maguire et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
UNCORRECTED PROOF DATE: 11/18/2019 FILE: 07-44-03-2P.pdf
19
A SAE is defined as any untoward and unexpected medical occurrence or effect that:
l results in death
l is life-threatening (refers to an event in which the subject was at risk of death at the time of the event;
it does not refer to an event that hypothetically might have caused death if it were more severe)
l requires hospitalisation (for > 24 hours), or prolongation of the participant’s existing hospitalisation
l results in persistent or significant disability or incapacity
l is a congenital anomaly or birth defect.
Dental practice staff were reminded that clinical judgement should be exercised in deciding whether or not
an AE was serious in other situations. Important AEs that were not immediately life-threatening or did not
result in death or hospitalisation but might jeopardise the subject or require intervention to prevent one
of the other outcomes listed in the definition above were also considered to be serious.
Hospitalisations for elective treatment of a pre-existing condition did not require reporting as SAEs.
Unrelated hospitalisations were to be elicited at the post-treatment follow-up appointment, scheduled
subsequent appointments and all unscheduled/emergency appointments.
All SAEs that, in the opinion of a co-chief investigator, were ‘related’ (i.e. resulted from the administration
of any of the research procedures) and ‘unexpected’ (see Appendix 3) were reported to the REC.
Sample size calculation
At the planning stage, the proposed primary outcome was the proportion of children reporting either dental
pain and/or dental sepsis during 3 years of follow-up. Based on evidence from previous studies on similar
populations receiving no fillings,6,7 conventional fillings and the Hall Technique,34 sepsis rates of 20%,
10% and 3% were expected in the PA, C+P and B+P arms, respectively. Using the ‘sampsi’ procedure
(a sample size calculation based on a two-sample test of proportions assuming a normal approximation
and incorporating a continuity correction) in Stata® version 9 (StataCorp LP, College Station, TX, USA),
and assuming a significance level of 2.5% (to allow for the multiple testing involved in a three-arm trial),
the required sample size was calculated as:
l two groups of 334 children to detect a difference in rates of between 20% and 10%, with 90%
power, for PA versus C+P
l two groups of 334 children to detect a difference in rates of between 3% and 10%, with 90% power,
for B+P versus C+P.
The sample size was then increased by an inflation factor of 1.09 (giving 365 children per arm at end of
follow-up) to allow for adjustment of estimates of effect size, taking into account variation between
randomisation strata (dental practices).
Based on previous experience (Jan E Clarkson, University of Dundee, 1 July 2010, personal communication)
of conducting RCTs in primary dental care, the sample size was further inflated to allow for a loss to
follow-up of 25% over 3 years, requiring 487 children to be consented and randomised to each intervention
arm (a target sample size of 1460 in total). In the pilot trial, participants were followed up for only
6 months, rather than the 3 years proposed for the main trial. Therefore, although follow-up in the pilot
was complete, no adjustment was made to the assumed rate of loss to follow-up (25%) for the full trial.
The original aim, therefore, was to invite 18,717 children to attend for screening, of whom 12,166 (65%)
were expected to actually attend and agree to be screened for the trial. Based on findings from the pilot
trial, it was initially assumed that 1825 (15%) of those screened would be eligible and 1460 (80%) of
those eligible would consent to be randomised.
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However, as the main trial progressed, the rates of participant identification, recruitment and consent
proved lower than anticipated from experience in the pilot trial, amounting to 994 accruals by the end of
June 2014. Therefore, a contract variation request was submitted to the HTA programme in August 2014
explaining that, based on the recruitment trajectory at the time, and with recruitment anticipated to continue
until 31 December 2014 and follow-up until 30 June 2016, the trial would recruit only 1113 children. This
would correspond to an effective sample size (after allowing for 25% loss to follow-up) of three groups of
278 children with a mean length of follow-up of 24.6 months. Assuming a linear incidence of dental pain
and/or dental sepsis over the follow-up period, this would result in only 61% power to detect a difference
between the arms for the primary outcome, dental pain and/or dental sepsis, assuming a type 1 error rate
of 2.5%. In August 2014, it was therefore agreed by the NIHR HTA programme that there should be a
12-month extension to the trial, with the end of recruitment, end of follow-up and end of trial set at
31 December 2014, 30 June 2017 and 31 December 2017, respectively. No new practices would be
recruited and those children recruited after June 2014 would not have the full 3 years of follow-up.
Allowing for 25% loss to follow-up, the effective sample size under this scenario would be three groups
of 278 children followed up for, on average, 35.5 months. Assuming a linear incidence of dental pain
and/or dental sepsis over the period of follow-up, this would result in 82.0% power (77.4% power if an
adjustment for strata was necessary) to detect the hypothesised effect sizes (19.72% vs. 9.86% for PA
vs. C+P and 2.96% vs. 9.86% for B+P vs. C+P), assuming a type 1 error rate of 2.5%.
It was subsequently (November 2014) agreed with the NIHR HTA programme that, owing to the already
variable follow-up and in order to maximise the chances of reaching the desired power, recruitment could
continue until 30 June 2015 (with follow-up still finishing on 30 June 2017) and that new sites could be
added to facilitate this recruitment on the understanding that any additional costs would be absorbed by
the existing budget.
Participant timeline: screening, recruitment, consent, retention,
withdrawal and visit schedule
The flow diagram of the FiCTION trial is shown in Figure 7. The participant identification and recruitment
strategy were informed by the experiences in the pilot trial.86
Identification and screening of participants
Potential trial participants were children aged 3–7 years who were identified from participating dental
practices, which invited the potential participants to participate through two routes:
1. Simple searches of practice databases to identify potentially eligible children, using a date of birth
query. Potentially eligible children due for a recall visit were invited to participate by letter of invitation
from the child’s GDP. This letter, together with information sheets for parents and the child (the child’s
version was pictorial and age-appropriate), was sent with their dental appointment card at least 1 week
ahead of the scheduled recall visit.
2. Parents of children presenting opportunistically, and identified as being potentially eligible for
participation, were invited to participate at the time of presentation. Unless they declined immediately
these parents were given the invitation letter and the parent and child information sheets, and time
(a minimum of 24 hours) was allowed to consider participation in the trial before consent was sought.
Potential participants identified through both routes had a routine screening examination (‘check-up’)
to confirm eligibility. This screening consisted of standard dental recall clinical investigations (including
medical and dental history taking, questioning regarding oral pain since last visit and current oral pain,
clinical examination of the soft tissues and teeth, and radiographs in line with national guidance). This
allowed the identification of children with dental caries and the exclusion of children with current dental
pain or dental sepsis due to caries, as well as medically compromised children.
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For those children without evidence of caries into dentine or where dental pain due to caries and/or
dental sepsis were present at the screening visit, the GDP explained why it was not possible to take part in
the FiCTION trial at that time and, if relevant, treated the carious lesion(s) and related pain and/or sepsis.
The family was informed that if the child re-presented with dental caries but without pain or sepsis, he or
she could then be considered for the FiCTION trial. If a child was caries-free at screening but subsequently
presented to the practice with caries during the recruitment phase of the trial, he or she could be invited
to join the trial.
Recruitment and consent
Post screening, if there was evidence of dental caries and absence of both dental pain due to caries and
dental sepsis, a FiCTION trial-trained dentist in the practice discussed the trial with the parent and child,
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FIGURE 1 Flow diagram of the FiCTION trial.
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supplementing the written trial information, and answered any questions they may have had. If the parent
and child were willing to participate, and once eligibility had been confirmed, parental written informed
consent, and oral or written assent from the child, was obtained by the FiCTION trial-trained dentist prior
to any trial-specific procedures being carried out.
The child was then given a subsequent treatment appointment. It was intended that randomisation to a
treatment arm should be carried out via the NCTU secure web-based randomisation service before the child
returned for the subsequent visit, at which time the child and parent would be informed of the treatment
arm to which the child had been allocated. A detailed ICDAS dental chart was completed at the initial
treatment visit. Treatment was commenced as per the child’s randomised arm and clinical protocol. Families
were also presented with a letter to give to their general medical practitioner to inform them of the child’s
involvement in the trial.
For those children for whom consent was not given for participation in the trial, the dentist carried out the
child’s normal dental care.
Participant management and visit schedule
The timing and frequency of subsequent visits was at the discretion of the GDP and the family. The original
trial design assumed a fixed follow-up period of 3 years, but, as indicated in Sample size calculation, an
extension to the trial recruitment period resulted in the maximum potential follow-up, post randomisation,
ranging from 23 to 36 months, with those recruited after May 2014 having a truncated follow-up.
Any recurrence of caries in the teeth that were originally treated and any subsequent incidence of caries in
other primary teeth were expected to be managed according to the randomly allocated arm and its
associated clinical protocol. At any visit during which there was deviation from the allocated clinical
protocol, either within or between arms, treatment deviation forms (TDFs) were completed by the GDP.
Data on all treatment provided over the trial period were collected at each FiCTION trial visit from the
dental team (usually the GDP), and parents and children completed outcome questionnaires at all visits
[see Table 1 and the project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/
(accessed 22 February 2019)].
A practice used its usual contact procedures to reschedule any missed visits until the child had not been seen
for > 540 days. After this point had been reached the practice sent a did-not-attend (DNA) questionnaire,
with a covering letter and pre-paid envelope, to the parent for them to complete and return to the NCTU.
All participants had a final trial visit date, with an associated defined final visit window, for collection of
‘final-visit’ data (see Table 1). A similar approach to that described above was used for children failing to
attend their final visit: in this case, a DNA final visit questionnaire was posted by the practice to the parent
for them to complete and return to the NCTU.
Participant retention
The concept of ‘marketing’ of clinical trials informed participant recruitment and retention strategies.109
A distinctive FiCTION trial logo and branding was developed and used on all trial-related materials.
On enrolment, parents and children were given FiCTION trial membership cards; this card carried details
of their dentists and who to contact should they change dentist/practice or require out-of-hours or
emergency dental care. The card also included FiCTION trial website details, which gave the children access
to colouring-in and other activities as well as providing trial updates and contact details of the trial team.
Leaflets and posters were distributed for display in practice waiting rooms to convey the research team’s
thanks to the FiCTION trial families for their participation, while enhancing the trial’s prominence in
practices. Children were sent FiCTION trial birthday cards via the practice and practice feedback was used
to guide the development of additional suitable FiCTION trial-branded merchandise promoting the trial.
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Participant withdrawal
Participants had the right to withdraw from the trial at any time without having to give a reason. Practices
were asked to try to ascertain the reason for withdrawal and document this on a Withdrawal Form [see
the project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019)].
Participants who failed to return for follow-up visits were not considered to have withdrawn, unless an explicit
request to withdraw was received or the practice confirmed that the child had moved to a practice that was
not participating in the FiCTION trial. When practices withdrew from the trial, all of their FiCTION trial
participants were considered to have been withdrawn at the time of the practice leaving.
Trial dates
The trial opened to recruitment on 1 October 2012. The first child was recruited on 12 October 2012 and
the last child was recruited on 18 June 2015. The end of the trial was defined as last patient, last visit;
follow-up of the last child was completed on 29 June 2017.
Randomisation
The unit of randomisation was the child, with randomisation into the three carious lesion treatment
strategies (C+P, B+P and PA) in a 1 : 1 : 1 ratio. Randomisation was stratified by site (dental practice).
Sequence generation
The allocation sequence was generated by a statistician not otherwise involved in the trial, using variable
length random permuted blocks of size 6 and 9 (based on the ‘ralloc’ function in Stata).
Allocation concealment
Allocation concealment was achieved by use of a centralised web-based randomisation facility hosted by
NCTU. Randomisation was intended to be carried out once the consent process was completed and the
child had left the dental practice. The variable length random-permuted blocking ensured concealment
of allocation.
Implementation
The intention was that participants were managed throughout their time in the trial according to the arm
to which they had been randomly allocated, that is any subsequent dental caries would be managed in the
same way (as per random allocation) as the initial occurrence. Any deviation from the allocated treatment
strategy (i.e. when treatment of carious lesions involved elements of a treatment strategy other than that
to which the child had been randomised, because of decisions or behaviours of the dental practitioner,
parent or child) was recorded on a TDF at each follow-up visit at which it occurred.
Blinding (masking)
This was an open randomised trial; the different treatment strategies being used meant that it was not
possible to blind the parents, children or dentists as to which arm the child was participating in. The
statisticians were not blind; however, there was no analysis conducted by arm until the final database lock.
Statistical methods
A complete SAP, which provides full details of all statistical analyses, variables and outcomes, was finalised and
signed before the final database lock and analysis [see the project web page: www.journalslibrary.nihr.ac.uk/
programmes/hta/074403/#/ (accessed 22 February 2019)].
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Primary analysis of the co-primary outcomes
At the start of the trial, the single proposed primary outcome was the proportion of children with at least
one episode of dental pain and/or dental sepsis during the planned 3-year follow-up period. However,
the extension to the trial recruitment period resulted in the maximum potential follow-up ranging from
23 to 36 months; hence, the analysis strategy was adjusted to incorporate variable follow-up. As indicated
in Primary outcomes, it was agreed that the incidence of dental pain and/or dental sepsis during the
follow-up period and the total number of episodes of dental pain and/or dental sepsis for each child
during the follow-up period would become co-primary outcomes. The original power calculation for the
trial was based on a comparison of proportions and, as such, was the only powered analysis; therefore,
an exploratory hypothesis test for the unpowered comparison of the mean number of episodes is reported.
The analyses of the co-primary outcomes were conducted on the basis of intention to treat (ITT), defined
as all randomised children with at least one CRF completed and in MACRO (Elsevier, Amsterdam, the
Netherlands), including protocol violators and ineligible randomised participants, retaining participants in
their randomised treatment groups. The results for the co-primary outcomes are reported as unadjusted
and adjusted models. Models were adjusted for age in years at randomisation and time in the trial in
years (defined as the time from randomisation to the date of last CRF in MACRO). Differences between
dental practices were included as a random intercept; therefore, all adjusted models were mixed-effects
models. Randomised treatment arm was included in the models as a factor with three levels, with the
C+P arm as the reference group. The adjusted analyses were defined as the primary analyses and,
therefore, the models to use for reporting purposes.
The primary analyses of the co-primary outcomes were:
1. The analysis of the incidence of dental pain and/or dental sepsis during the follow-up period, using
logistic regression.
The dependent variable was a binary indicator of whether or not there was a reported incidence of
dental pain and/or dental sepsis during the follow-up period. We generated 97.5% CIs for the
difference between treatment arms (PA vs. C+P and B+P vs. C+P), expressed as risk differences
[by integrating over the covariates in the model (time in study and age) and the random effects];
p-values were reported.
2. The number of episodes of dental pain and/or dental sepsis were analysed using negative
binomial regression.
The dependent variable was the total number of episodes reported by a child during the follow-up
period. Both negative binomial and zero-inflated negative binomial models were considered; the Vuong
test was used to determine the best-fitting model. We generated 97.5% CIs for the difference between
treatment arms (PA vs. C+P and B+P vs. C+P), expressed as incidence rate ratios (IRRs); exploratory
p-values were reported.
Sensitivity analysis specific to the primary analysis of co-primary outcomes
As a planned sensitivity analysis, the models were also re-fitted including only participants with at least
23 months follow-up, to assess the influence of shorter lengths of follow-up on the treatment effect estimates
(the rationale being that all participants had the opportunity to have at least 23 months of follow-up).
Secondary analysis of the co-primary outcomes
The time to the first episode of dental pain and/or dental sepsis has been identified as particularly
important in relation to the age of the child, as the impact of dental pain and/or dental sepsis is greater
on younger children and they have a reduced capacity to tolerate dental treatment.
Therefore, an analysis of time to first episode of dental pain and/or dental sepsis was undertaken using a
Cox proportional hazards model, including age in years at randomisation as a continuous covariate and
dental practices as a random effect. We generated 97.5% CIs for the difference between treatment arms
(PA vs. C+P and B+P vs. C+P), expressed as hazard ratios (HRs); exploratory p-values were reported.
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Analysis of the secondary outcomes
As described in Secondary outcomes, a number of secondary outcomes were measured during the period
of follow-up. The timing of measurements is described earlier (see Table 1), with further description of the
outcome measure index or scale given in the SAP [see the project web page: www.journalslibrary.nihr.ac.uk/
programmes/hta/074403/#/ (accessed 22 February 2019)].
Quantitative secondary outcome data (P-CPQ-16 and MCDASf) were analysed using the same approach
as for the co-primary outcomes. Models were adjusted for age in years at randomisation and time in the
trial in years. When a baseline measure was taken into consideration, the baseline measurement was
also included as a covariate. Differences between dental practices were included as a random effect. If
outcomes were measured at each visit (MCDASf), an additional random effect was added to account
for repeated measures nested within child. Randomised treatment arm was included in the models
as a factor with three levels, with the C+P arm as the reference group. Within this framework, the mean
difference between randomised treatment arms at final visit or across the whole of the follow-up period
was estimated.
Ordinal categorical outcomes (anticipatory and treatment-related anxiety and worry) measured at each visit
were modelled using multilevel mixed-effects ordinal logistic regression. The assumption of proportional
odds was assessed graphically and using the approximate likelihood ratio test. When this assumption
was not satisfied, multilevel mixed-effects multinomial regression was considered. The frequencies of
observations in each outcome category at each visit were also taken into consideration. When necessary,
outcome categories were collapsed to create a binary variable and multilevel mixed-effects logistic
regression was used.
Scoring of questionnaires and handling of missing data
For the parent questionnaire (P-CPQ-16) measuring perceived child OHRQoL, missing and ‘do not know’
responses were treated as ‘missing data’ and the same method of imputation applied to both, without
distinction or prioritisation. The method adopted was the imputation of the ‘subject–subscale mean’
[i.e. the respondent-specific mean across a minimum of two valid (i.e. 0–4) responses in the item’s own
P-CPQ-16 subscale] for missing and ‘do not know’ responses in the subscale [only if two or more of the
constituent subscale items had originally valid (0–4) responses]. There was no imputation for participants
with missing or ‘do not know’ responses for all 16 items of the P-CPQ-16.
A similar approach was used for MCDASf, although, as there are no subscales in this instrument,
this was effectively a ‘subject–overall mean’ imputation, if three or more of the six items had originally
valid (1 to 5) responses.
These methods assume that the data are missing completely at random.
Adherence to randomised treatment arm’s clinical treatment protocol
Deviations from the randomised treatment arm’s clinical treatment protocol were recorded on the
TDF. These forms were entered into an electronic clinical data management system, MACRO, and then
verified by the clinical researcher and classified as a ‘major’ deviation from the randomised treatment
arm clinical treatment protocol (if there had been a from-arm tooth treatment change) or otherwise.
For the purposes of assessing adherence to the clinical treatment protocol, only ‘major’ deviations
were considered.
Adherence to the clinical treatment protocol for each randomised treatment arm could not be evaluated
at an individual-tooth level because TDFs did not collect tooth numbers. Because multiple teeth could
have been treated at any particular visit, a TDF could not be linked to a specific tooth or number of teeth.
In addition, tooth numbers were not collected for prevention activities. Therefore, adherence to the clinical
treatment protocol was evaluated using child-level summaries.
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The prespecified per-protocol analysis set
The prespecified per-protocol (PP) analysis set excluded participants from the ITT analysis set who:
l were deemed likely to have had dental pain and/or dental sepsis at consent and/or
l were ‘non-compliant’ with the clinical treatment protocol corresponding to their randomised treatment
arm (i.e. defined as having a TDF involving a ‘major’ deviation from the randomised treatment arm’s
clinical treatment protocol at > 20% of their visits). A ‘major’ deviation was defined as a cross-arm
tooth treatment change.
Planned exploratory multivariable analyses
The variables listed below were included in prespecified exploratory multivariable regression models for
both the co-primary outcomes of incidence and the number of episodes of dental pain and/or dental
sepsis, regardless of their univariate association with the outcome:
l Age of participant, in years, at randomisation as a continuous covariate.
l Number of decayed teeth (level 5/6 cavitation) at baseline from ICDAS charting for each participant.
l Participant ethnicity. There were six ethnicities listed in the parent baseline questionnaire: (1) white,
(2) black, (3) Indian, Pakistani or Bangladeshi, (4) Chinese, (5) mixed race and (6) other. Ethnicity was
explored as far as possible within the limitations imposed as a result of the distribution of participants
across the categories and incomplete data.
l Fluoride concentration in tap drinking water. Tap-water fluoride concentration [in parts per million
(fluoride ion) (p.p.m.F-)] at the dental practice was used as a proxy for a child’s fluoridation status,
in terms of the tap water supply they received at home.
l Index of deprivation. The dental practice index of deprivation, based on the dental practice postcode,
was used as a proxy for a child’s index of deprivation. The index was extracted from census data
collected prior to the recruitment phase of the trial. Index of deprivation can change significantly
both spatially and temporally (dependent on the neighbourhood), and so was expected to be a very
approximate measure of the individual children’s level of household deprivation. In addition, each
country of the UK uses different domains, indicators and weighting of domains to calculate the index
of deprivation [England: see www.gov.uk/government/statistics/english-indices-of-deprivation-2015
(accessed 22 February 2019); Scotland: see www.gov.scot/Topics/Statistics/SIMD (accessed 22 February
2019); and Wales: see http://wimd.wales.gov.uk/ (accessed 22 February 2019)]. Methods have been
proposed110,111 for cross-country comparisons, but were not employed in this trial.
Data archiving
Original questionnaires, CRFs and consent forms have been securely archived at the University of Dundee
and are to be held for 7 years following publication of the last paper or report from the trial; patient
identifiers have been separated from clinical and outcome data. Archiving of trial data was carried out
according to the relevant standard operating procedure, as detailed below.
A full set of source data, including trial definition data and audit trail data were exported from the clinical
data management system database (MACRO) for archiving. Archived data were saved on a read-only
compact disc (CD) or digital versatile disc (DVD) for archiving in the trial master file, stored with the
sponsor. For future longevity, all data were saved to CD/DVD using a comma-separated values (CSV)
format, other files were saved in Portable Document Format (PDF) or Hypertext Markup Language (HTML).
The archived MACRO data set included the full audit trails of data changes, including who made the
change and when. Additional data such as questionnaires and ICDAS data were also included on the
archive CDs in CSV format, ensuring that all files/data could be linked by the participant trial identifier.
In addition to this, the statistics analysis folder with Stata data files and associated Stata analyses
programmes were archived.
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Patient and public involvement
Extensive consultation with all stakeholders – dental practitioners, parents and children – informed this trial
from the outset.
Prior to submission of the original funding application, GDPs attending a CPD-accredited meeting were
asked about their willingness to take part in a trial of traditional fillings versus no active treatment. They
fed back that they would not take part in any trial in which their child patients might be randomised to
no care at all, likening it to ‘supervised neglect’. Therefore, an alternative approach, with the ‘no active
treatment’ arm comprising prevention alone, was posed to them. With this qualification, they said they
would then be willing to take part in a trial. This caveat was pivotal to subsequent trial design, in which
best-practice prevention was put at the heart of all treatment, as it also formed a key component of
intervention in the C+P and B+P arms.
Prior to submission for REC approval for the pilot trial, informal discussions were held with parents and
children in Sheffield who had experience of receiving treatment of carious lesions. The feedback was to
review the format and content of the participant information sheets and consent/assent forms and to
make changes to these documents to improve their acceptability to participants and their families.
The focus on preparing materials that allowed children to be part of the consent/assent process112 was
commended by the REC. Two participant representatives were recruited and actively engaged in the TSC
throughout the project. These representatives were the mothers of young children who had experienced
premature loss of primary teeth as a result of dental decay.
Initial involvement of the participant representatives included working with the research team on the
development of parental and child questionnaires for use at each visit in the trial. The front cover of the
FiCTION trial child questionnaire was a drawing by one of the participant representative’s 6-year-old
daughter, illustrating a visit to the dentist.
Following the pilot trial, focus groups were held with child and parent participants in Sheffield to gain
insight into their pilot trial experiences. This information, although an element of planned qualitative data
collection rather than a patient and public involvement activity, also informed a number of changes to
reduce the burden on participants in the main trial. The participant representatives were also engaged in
the design and provision of material presented on the FiCTION trial website. An example of one of the
initiatives taken was the inclusion of two competitions: one for colouring and a subsequent one for
drawing, as the children in the trial became older.
The active engagement of children, their parents and the participant representatives, in the development
of, and feedback on, the trial, was very beneficial to its smooth running, particularly in ensuring continued
commitment of the child and parent participants throughout the 3 years of engagement for each family.
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Chapter 3 Trial results and clinical effectiveness
Introduction
This chapter presents the findings relating to clinical effectiveness. It starts by presenting the characteristics
of the practices recruited. Next, participant flow is described, followed by the baseline characteristics of the
participants in the three trial arms. This is followed by a description of the treatment provided, including
treatment deviations. Next we report trial findings for the co-primary outcomes of dental pain and/or
dental sepsis: the ITT analyses, the pre-planned sensitivity and exploratory analyses, and the PP analyses.
The chapter concludes with the ITT analyses of the secondary outcomes of caries incidence and child- and
parent-reported outcomes.
Dental practices
Dental practice recruitment
The original practice (site) recruitment target was 50 dental practices, comprising approximately 10 practices
from each of the five CCs (see Chapter 2, Practice recruitment): Scotland, Newcastle, Leeds/Sheffield,
Wales and London. However, the patient recruitment rate was lower than predicted within practices
and some practices, which originally initiated, withdrew. Following consultation with the TSC, the IDMC
and the NIHR HTA programme, the target number of practices was increased to 70. The CCs were also
expanded geographically, as described in Chapter 2, Practice recruitment.
Of the 93 practices that agreed to participate and received a site initiation visit, 21 did not randomise
any participants, leaving 72 sites across the five CCs that recruited at least one participant. Ten of these
72 practices subsequently withdrew.
Dental practice characteristics
Practice characteristics collected were size (number of registered patients), deprivation index in quintiles
(see Chapter 2, Planned exploratory multivariable analyses) and tap-water fluoridation status (p.p.m.F-).
These data are presented descriptively (Table 2) for the 72 practices that recruited at least one participant.
Participant journey
Screening at the sites
Patient/participant journey through invitation, screening, eligibility assessment, randomisation and
subsequent progress through the trial is shown in the Consolidated Standards of Reporting Trials (CONSORT)
flow diagram in Figure 2.
Recruitment rate
Recruitment opened on 1 October 2012; the first child was randomised on 12 October 2012.
The trial closed to recruitment on 30 June 2015; the last child to enter the trial was randomised on
18 June 2015.
Figure 3 shows the recruitment rates originally anticipated, the revised target (October 2013), the further
revised target (August 2014) and actual recruitment.
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Recruitment by arm
Seventy-two sites had randomised at least one child by the trial recruitment closure date. There was
variation across centres in the numbers of participants recruited and randomised: Scotland, 307;
Newcastle, 315; Leeds/Sheffield, 171; Wales, 125 and London, 226 participants. The number of
randomised participants per practice ranged from 1 to 55, with a median of 14 [interquartile range (IQR)
5–23.5] (see Appendix 4, Table 22).
Numbers analysed: intention-to-treat analysis (1058 participants)
The ITT analysis set was defined as all randomised children with at least one CRF completed and in
MACRO, including protocol violators and ineligible randomised participants, retaining participants in their
randomised treatment groups. Of the 1144 randomised individuals, 86 (7.5%) did not return for any
treatment and therefore had no CRF data collected: C+P, 34 out of 386 (8.8%); B+P, 29 out of 381
(7.6%); and PA, 23 out of 377 (6.1%). This left 1058 participants (from 68 of the 72 randomising
practices) who comprised the ITT analysis data set on which subsequent analyses were based.
TABLE 2 Practice size, practice deprivation index (by quintile) and practice tap-water fluoridation status (n = 72
practices that recruited at least one participant)
Characteristic Practices, n (%) (N= 72)
Region
Scotland 25 (35)
Newcastle 19 (26)
Leeds/Sheffield 13 (18)
Wales 4 (6)
London 11 (15)
Practice size (number of registered patients)
1–4999 19 (26)
5000–9999 15 (21)
10,000–14,999 1 (1)
≥ 15,000 1 (1)
No information 36 (50)
Deprivation index (quintile)
1 (most deprived) 23 (32)
2 21 (29)
3 10 (14)
4 12 (17)
5 (least deprived) 6 (8)
Tap water fluoridation status (p.p.m.F-)a
< 0.3 63 (88)
0.3–0.7 5 (7)
> 0.7 4 (6)
a A fluoride concentration of 0.7–0.9 p.p.m.F is generally considered to be optimal for tap water in temperate climates.113
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Ineligible participants
Ineligible participants in the ITT analysis set were classed as those randomised but subsequently found to
not meet the eligibility criteria of the trial (see Chapter 2, Trial participants). For the 22 participants who
were considered thus ineligible, five were outside the age range of 3–7 years at consent date and 17 had
dental pain and/or dental sepsis associated with carious teeth at the consent date. The 22 ineligible
participants were distributed across the three arms (C+P, n = 6; B+P, n = 5; and PA, n = 11). As the
proportion of ineligible participants was small [22 of 1058 in the ITT analysis set (2.1%)], a sensitivity
analysis without them was not conducted.
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(ITT analysis set)
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• Ineligible at screening, n = 5872
   (76% of total screened)c
• Declined but eligibility unknown, n = 71
   (1% of total screened)
• Eligible but declined, n = 331
   (19% of screened eligible)d
• Eligible but not randomised, n = 281
   (16% of screened eligible)
• Withdrawn, n = 40
   • Practice withdrawal, n = 10
   • Moving away, n = 12
   • Trial fatigue, n = 1
   • Dental reason, n = 3
   • Personal reason, n = 2
   • Other, n = 6
   • No reason given, n = 6
• Lost to follow up, n = 68
• Withdrawn, n = 35
   • Practice withdrawal, n = 12
   • Moving away, n = 11
   • Trial fatigue, n = 0
   • Dental reason, n = 2
   • Personal reason, n = 1
   • Other, n = 6
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• Lost to follow up, n = 80
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   • Dental reason, n = 3
   • Personal reason, n = 3
   • Other, n = 6
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• Lost to follow up, n = 81
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(n = 108)
Attended a final trial visit
(n = 244)
Did not attend a final visit
(n = 115)
Attended a final trial visit
(n = 237)
Did not attend a final visit
(n = 124)
Attended a final trial visit
(n = 230)
FIGURE 2 The CONSORT flow diagram of participant journey through the trial. a, Prior to the start of the study,
it was estimated that 18,717 children would be invited; b, prior to the start of the study, it was estimated that 65%
of children invited would attend a screening appointment; 64% attended; c, prior to the start of the study, it was
estimated that 85% of children screened would be ineligible – 76% were ineligible and 1% declined screening;
d, prior to the start of the study, it was estimated that 20% of children screened and found eligible would decline
to take part in the trial – 19% of those eligible declined; e, prior to the start of the study, it was estimated that
12% of children screened would be randomised – 15% of those screened were randomised.
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First trial visits for intention-to-treat analysis set (1058 participants)
For the ITT analysis set, time from randomisation to first trial visit was similar across arms, with most
participants (n = 736, 69.6%) having their first trial visit within 1 month of randomisation. For the remaining
participants, the timing of their first trial visit post-randomisation was as follows:
l more than 1 and up to and including 4 months, n = 241 (22.8%)
l more than 4 and up to and including 12 months, n = 63 (6.0%)
l more than 12 months, n = 18 (1.7%).
The distribution of time to first trial visit was balanced across arms.
Follow-up and final trial visits
Summary data for the time in trial and number of visits, by arm, are shown in Table 3. Participants spent
a median of just less than 34 months in the trial, with a median of 2.5 visits per year. These parameters
were well balanced across arms. A total of 711 participants attended a final trial visit (67% of the ITT
participants); this was well balanced across the three arms.
Withdrawals
There were 118 documented withdrawals from the ITT analysis set. All withdrawals were complete; that is,
there was consent to use participants’ data up to the point of withdrawal but with no further follow-up
or data collection after that point. Reasons for withdrawal were ascertained for 108 recruited participants.
TABLE 3 Follow-up and final trial visit summaries, by randomised treatment arm (ITT analysis set, n= 1058)
Time in trial and number of visits C+P (n= 352) B+P (n= 352) PA (n= 354) Total (n= 1058)
Time in trial (months)
Minimum 0.03 0.03 0.03 0.03
Median (IQR) 34.0 (24.7, 36.6) 33.6 (24.4, 36.8) 33.5 (22.2, 36.8) 33.8 (23.8, 36.7)
Maximum 51.4 53.7 46.7 53.7
Total number of trial visits
Minimum 1 1 1 1
Median (IQR) 7 (5–10) 7 (5–10) 6 (4–9) 7 (5–9)
Maximum 30a 22 20 30b
Median number of trial visits over median
time (years) in trial
2.5 2.5 2.1 2.5
Number (%) of the ITT participants who
attended a final trial visit
244 (69.3) 237 (67.3) 230 (65.0) 711 (67.2)
In or after their scheduled final visit
window
234 (66.5) 219 (62.2) 212 (59.9) 665 (62.9)
Before their scheduled final visit
window, but identified as a final visit
10 (2.8) 18 (5.1) 18 (5.1) 46 (4.3)
Number (%) of the ITT participants who
did not attend a final trial visit
108 (30.7) 115 (32.7) 124 (35.0) 347 (32.8)
Withdrawn 40 (11.4) 35 (9.9) 43 (12.1) 118 (11.2)
Lost to follow-up 68 (19.3) 80 (22.7) 81 (22.9) 229 (21.6)
a The next observation below 30 is 24.
b One participant had 30 visits over 39.4 months (aged 7.2 years at randomisation).
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Seven randomising practices withdrew (n = 38 participants). The median time from first randomisation to
date of practice withdrawal was 561 days (IQR 482–822 days).
Other reasons for withdrawal were the participant moved away (n = 34); trial fatigue (n = 4); dental reason,
for example a traumatic event (n = 8); and personal or another reason (n = 24). The numbers of participants
who withdrew were evenly distributed across the three trial arms with no differences in the length of
time in trial (time from randomisation to time of last known trial visit) or in the number of trial visits (see
Appendix 4, Table 23).
Baseline data
Baseline comparability
Demographic and clinical baseline characteristics were compared across treatment arms descriptively
(Table 4). No significance testing was carried out because of the randomised nature of the trial.
Characteristics were well balanced across arms.
As Table 4 and Appendix 4, Table 24, show, children’s caries experience at entry to the trial (baseline) was
balanced between the three trial arms for the number of primary teeth affected and the amount and
severity of the lesions. The mean number of primary teeth affected by caries (d3mft) was 2.72 [standard
deviation (SD) 2.66] [the national mean d3mft values for 5-year-olds who are not free of obvious carious
lesions (i.e. d3mft of > 0) are England (2015) 3.4, Scotland (2016) 3.93 and Wales (2015–16) 3.58].13,26,114
It should be noted, however, that the national surveys are of randomly selected children recruited in the
school setting and not from those attending general dental practices, whose oral health may be better
than non-attenders.
As the mean age of participants was 6 years, they had few FPMs present on entry to the trial; the mean
number of FPMs recorded as at least partially erupted was 1.74 (SD 1.88). The decay experience in these
teeth was very low, again, as might be expected for relatively newly erupting permanent teeth, with a
mean D3MFT for FPMs of 0.05 (SD 0.35), and this was balanced between the trial arms (see Appendix 4,
Table 25).
Baseline questionnaires were returned for almost all children [n = 1045 (99%)] and had a high level of
completeness.
Child OHRQoL at baseline also showed balance between arms, with an overall mean score of 8.4 (SD 6.4),
reflecting a group with an OHRQoL score similar to that found in other child populations.94 The results of
the MCDASf, with an overall mean score of 14.1 (SD 5.1), was also balanced across arms at baseline and
similar to scores reported in other UK children.102
Treatment provision and adherence to protocol
Treatment received (intention-to-treat analysis set, n = 1058)
A detailed breakdown of the treatments received is provided as part of the economic evaluation (see
Chapter 4). Appendix 5, Table 74, summarises the average total treatment provided at the first visit and
at follow-up visits by arm. This table provides insight into how the children were initially treated, how the
treatment progressed over the follow-up period and the differences in treatment by arm.
By visit
The interventions were multicomponent and were designed with preventative strategies (also consisting
of more than one component) being common to all three arms. Prevention (or at least one prevention
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component or ‘pillar’) was delivered, on average, at 81% (0.81) of all visits [B+P, mean 0.79 (SD 0.22);
C+P, mean 0.79 (SD 0.22); and PA, mean 0.85 (SD 0.19)]. All four prevention pillars were delivered in each
of the three arms, in line with the clinical protocols for each arm, but rates of delivery were higher in the PA
arm and similar between the C+P and B+P arms. The most commonly provided prevention component was
tooth-brushing/plaque control advice (at 75% of all visits) and diet investigation/advice (69%), followed by
fluoride varnish applications (57%) and fissure of permanent teeth (15%). The vast majority of preventative
care was provided by GDPs (71% of all visits) and the average length of time spent providing preventative
treatment was 7.5 minutes (B+P, mean 7.14 (SD 4.8); C+P, mean 7.0 (mean 4.5); and PA, mean 8.5
(SD 4.3) minutes].
Operative care occurred at 34% (0.34) of all visits [B+P, mean 0.42 (SD 0.26); C+P, mean 0.42 (SD 0.26);
and PA, mean 0.19 (SD 0.23)] and was also primarily undertaken by GDPs (91% of operative treatment
visits were undertaken by a GDP). The provision of operative care decreased as the trial progressed,
as highlighted in Appendix 5, Table 74. On average, those children who had operative treatment had
four primary teeth treated during their time in the trial.
The rate of restoration placement was estimated as the average of the total number of primary teeth treated
with a restoration, divided by the total number of primary teeth treated at each visit per child. The main
non-prevention-based care provided was placement of a restoration (at 28% of all visits) or extractions
(3% of teeth managed by non-prevention-based care at a visit were extracted). Extractions of primary teeth
were balanced across the three arms [B+P, mean 0.03 (SD 0.08); C+P, mean 0.04 (SD 0.07); and PA,
mean 0.03 (SD 0.09)]; this can be interpreted as, on average, each child randomised to B+P having 3% of
their operatively treated primary teeth extracted at each visit. However, this did not account for all tooth
extractions as, additionally, extractions were carried out following referral to secondary/tertiary care centres.
Referral rates differed slightly between arms (C+P, 9%; B+P, 10%; and PA, 11%), with the majority
(C+P, 69%; B+P, 61%; and PA, 69%) of those referrals being for day case dental extractions under
general anaesthetic (group B) or inhalational sedation for extractions and/or restorations (group D)
(see Appendix 5, Table 74). For explanations of groups B and D, see the project web page:
www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019).
In line with the intervention arms, and as specified in the clinical protocols, the provision of restorations
varied between the three arms; the percentage of visits with a restoration provided over the course of
the trial were as follows: C+P, 36%; B+P, 36%; and PA, 12%. In the C+P arm, the majority of routine
restorations performed were GIC restorations (on average, each child randomised to the C+P arm had
11% of their operatively treated primary teeth treated with a GIC restoration at each visit), followed
by RMGI restorations (8%) and composite restorations (7%). In the B+P arm, the majority of restorations
were GIC restorations (11%), followed by PMCs placed using the Hall Technique (9%) and RMGIs (7%).
As expected, the PA arm involved little operative care, being largely prevention- and extraction-based,
with 6% of operatively treated teeth receiving a GIC restoration.
By course of treatment
It was expected that, for every course of treatment [for a definition, see Chapter 4 and the project web page:
www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019)], a participant in
any arm would receive fluoride varnish plus at least one of the remaining three prevention components, when
relevant: (1) brushing/plaque control advice, (2) diet investigation/advice or (3) fissure sealing of permanent
teeth. There was slightly more fluoride varnish provided in the PA arm as part of a course of treatment (C+P,
62% of courses of treatment had fluoride varnish; in the B+P arm this was 64%, and in the PA arm, 73%).
Over the follow-up period, fluoride varnish was provided at 67% of all courses of treatment. Similarly for
the components of prevention by visit, the order in which they were provided per course of treatment
remained the same (brushing/plaque control advice, 84%; diet investigation/advice, 78%; and fissure sealants
for permanent teeth, 18%) (see Appendix 5, Table 75, for the course of treatment summaries by arm).
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Adherence to protocol
‘Major’ deviations (i.e. clinical treatment provided not according to the randomised arm) reflected
non-adherence to the clinical treatment protocol. At 6% (429/7713) of visits, we observed a ‘major’
deviation from the clinical protocol for a participant’s randomised treatment arm, that is a cross-arm
deviation. These major deviations occurred in 263 participants, with 46% among participants randomised
to the C+P arm, 15% in the B+P arm and 39% in the PA arm. The most frequently reported direction of
treatment deviation for the C+P arm was to B+P (69%); for the B+P arm it was to C+P (80%); and for the
PA arm it was to C+P (53%). The main reason for major deviations were parent factors (28%) and
dentists’ clinical judgements (29%). The participants with major deviations were not equally distributed
across trial arms: C+P, 99 out of 352 (28%); B+P, 51 out of 352 (14%) and PA, 113 out of 354 (32%).
Further details on the reason for and direction of all major deviations are shown in Appendix 4, Tables 26
and 27.
For 104 participants (10%), > 20% of their treatment visits involved a major treatment deviation from their
randomised treatment arm, and they accounted for 182 of the 429 major treatment deviations recorded
on TDFs. Across the trial arms, these participants were distributed as follows:
l C+P arm, 37 out of 352 participants (11%)
l B+P arm, 19 out of 352 (5%)
l PA arm, 48 out of 354 (14%).
These 104 participants remained in the ITT analyses but were removed from the PP analyses.
Use of radiographs
For the ITT analysis set, radiographs were taken at 11% (886/7713) of visits over the duration of the trial.
This was less than originally anticipated [see Chapter 2, Schedule of assessment of primary outcomes, and
the project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February
2019)]. The 886 radiographs were taken in 48% (511/1058) of children and distributed evenly across all
three treatment arms: C+P, 49% (174/352); B+P, 47% (165/352); and PA, 49% (172/354). Sixty per cent
(308/511) of children who had a radiograph taken had at least one taken during their first year in the trial;
this accounted for 39% (349/886) of all radiographs taken.
The reasons for not using radiographs were collected via the CRF at 94% of visits. The justifications given
were similar across treatment arms:
l not due to be taken, according to FGDP guidelines (42%)
l radiograph(s) not attempted (child compliance issues) (18%)
l already taken during this course of treatment (18%)
l other (12%)
l attempted but failed (5%)
l parental wish (4%).
When radiographs were taken, the presence or absence of periradicular infection was recorded
in 73% of cases. The rate of periradicular infection was 11% and was balanced across arms;
however, 17% of radiographs assessed for periradicular infection were considered to be of limited
diagnostic use.
Given that the percentage of children with radiographs taken was less than our pre-defined threshold of
80% [see the project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)], this source of data was excluded from contributing to the analysis of outcomes related
to dental sepsis.
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Co-primary outcomes: dental pain and/or dental sepsis
The primary outcome analysis was a comparison of children’s experience of dental pain and/or dental sepsis,
during the follow-up period, across the three treatment arms. This was analysed in two ways: (1) as the
proportion of children with at least one episode of dental pain and/or dental sepsis during the follow-up
period (incidence) and (2) as the total number of episodes of dental pain and/or dental sepsis for each child
during the follow-up period.
Proportion of children with at least one episode of dental pain and/or dental sepsis
during the follow-up period (incidence)
Descriptives: incidence of dental pain and/or dental sepsis
For the ITT analysis set, 42.5% of participants experienced at least one episode of dental pain and/or
dental sepsis during the follow-up period (Table 5). Although the absolute differences in the incidence of
dental pain and/or dental sepsis observed between the arms were smaller than anticipated at the design
stage, the rank order was as expected, with the lowest rate in the B+P arm and the highest in the PA arm.
When the descriptive analysis was restricted to participants with at least 23 months’ follow-up as a
planned sensitivity analysis, the overall incidence of dental pain and/or dental sepsis increased from 42.5%
to 47% (see Appendix 4, Table 28). For the PP analysis set, the overall incidence reduced to 40%
(see Appendix 4, Table 29).
Statistical modelling: incidence of dental pain and/or dental sepsis
The results of fitting logistic regression models to the incidence of dental pain and/or dental sepsis during
the follow-up period for the ITT analysis set (Table 6) are presented as unadjusted and adjusted risk
differences, comparing the B+P arm and the PA arm to the C+P arm. A negative risk difference indicates
TABLE 5 Incidence of dental pain and/or dental sepsis (ITT analysis set, n= 1058)
Outcome
Treatment arm, n (%)
Total (N= 1058), n (%)C+P (N= 352) B+P (N= 352) PA (N= 354)
Dental pain ever 126 (35.8) 113 (32.1) 140 (39.5) 379 (35.8)
Dental sepsis ever 90 (25.8) 87 (24.7) 91 (25.7) 268 (25.3)
Dental pain and/or dental sepsis ever 148 (42.0) 141 (40.1) 161 (45.5) 450 (42.5)
TABLE 6 Estimates of the risk difference over the follow-up period in dental pain and/or dental sepsis between
randomised treatment arms using logistic regression
Analysis set Model Arm Risk difference 97.5% CI p-value
ITT Unadjusted (n = 1058) C+P 0.00
B+P –0.02 –0.10 to 0.06 0.6
PA 0.04 –0.05 to 0.12 0.3
Adjusted (n = 1057) C+P 0.00
B+P –0.02 –0.10 to 0.06 0.6
PA 0.04 –0.04 to 0.12 0.2
Note
Unadjusted models include a random effect for practice and adjusted models include age in years, time in trial in years and
a random effect for practice.
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a reduced risk of dental pain and/or dental sepsis during the follow-up period, in comparison with the C+P
arm. The adjusted risk difference in the incidence of dental pain and/or dental sepsis over the follow-up
period in the B+P arm compared with the C+P arm was –0.02 (97.5% CI –0.10 to 0.06), which indicates,
on average, a 2% reduced risk of dental pain and/or dental sepsis in the B+P arm compared with the C+P
arm. For the PA arm compared with the C+P arm, the adjusted risk difference was 0.04 (97.5% CI –0.04
to 0.12), which indicates, on average, a 4% increased risk of dental pain and/or dental sepsis in the PA
arm compared with the C+P arm. There was no evidence of a statistically significant difference between
the arms when compared with the C+P arm. The comparative results remained almost unchanged when
the adjusted analysis was restricted to participants with at least 23 months follow-up and when the PP
analysis set was used (see Appendix 4, Table 30).
Total number of episodes of dental pain and/or dental sepsis during the
follow-up period
Descriptives: number of episodes of dental pain and/or dental sepsis
For the ITT analysis set, a total of 676 episodes of dental pain and/or dental sepsis were recorded over the
follow-up period, which is an average of 0.64 episodes per participant. The number of episodes ranged
from 0 to 7, but the majority of participants (86%) had 0 or 1 episodes (Table 7). The distribution of the
number of episodes was similar across the arms, although the unadjusted rate of episodes in the PA arm
was slightly higher, at 0.72 episodes per participant, than in the C+P arm (0.62 episodes per participant) or
the B+P arm (0.58 episodes per participant). The PA arm had more participants experiencing ≥ 2 episodes
of dental pain and/or dental sepsis than the C+P or B+P arm (17.5% vs. 12% vs. 12.5%, respectively)
(Figure 4).
When the descriptive analysis of episodes was restricted to participants with at least 23 months’ follow-up
(n = 797), the overall mean number of episodes per participant increased from 0.64 to 0.72 (see Appendix 4,
Table 31). For the PP analysis set (n = 940), the overall rate of episodes reduced to 0.59 (see Appendix 4,
Table 32).
TABLE 7 Number of episodes of dental pain and/or dental sepsis (ITT analysis set)
Episodes of dental pain and/or dental sepsis C+P (N= 352) B+P (N= 352) PA (N= 354) Total (N= 1058)
Minimum 0 0 0 0
Median (IQR) 0 (0–1) 0 (0–1) 0 (0–1) 0 (0–1)
Mean (SD) 0.62 (0.95) 0.58 (0.87) 0.72 (0.98) 0.64 (0.94)
Maximum 7 6 5 7
Number, n (%)
0 204 (58.0) 211 (59.9) 193 (54.5) 608 (57.5)
1 106 (30.1) 97 (27.6) 99 (28.0) 302 (28.5)
2 23 (6.5) 29 (8.2) 40 (11.3) 92 (8.7)
3 15 (4.3) 13 (3.7) 15 (4.2) 43 (4.1)
4 2 (0.6) 1 (0.3) 5 (1.4) 8 (0.76)
5 0 (0.0) 0 (0.0) 2 (0.6) 2 (0.2)
6 1 (0.3) 1 (0.3) 0 (0.0) 2 (0.2)
7 1 (0.3) 0 (0.0) 0 (0.0) 1 (0.1)
DOI: 10.3310/hta23XXX HEALTH TECHNOLOGY ASSESSMENT 2019 VOL. 23 NO. XX
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Maguire et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
UNCORRECTED PROOF DATE: 11/18/2019 FILE: 07-44-03-2P.pdf
39
Statistical modelling: number of episodes of dental pain and/or sepsis
The results of fitting negative binomial regression models to the number of episodes of dental pain and/or
dental sepsis during the follow-up period are presented in Table 8 as unadjusted and adjusted IRRs,
comparing the B+P arm and the PA arm to the C+P arm. An IRR of < 1 indicates a reduction in the rate of
episodes of dental pain and/or dental sepsis during the follow-up period in comparison with the C+P arm.
The adjusted IRR of 0.95 (97.5% CI 0.75 to 1.21) for the B+P arm relative to the C+P arm indicates that
there were 5% fewer episodes, on average, in the B+P arm than in the C+P arm; for the PA arm to relative
to the C+P arm, the adjusted IRR of 1.18 (0.94 to 1.48) indicates that, on average, there were 18% more
episodes in the PA arm than in the C+P arm. There was no evidence of a statistically significant difference
between the arms when comparing the B+P arm with the C+P arm or the PA arm with the C+P arm.
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FIGURE 4 Number of episodes of pain and/or sepsis by randomised treatment arm (ITT analysis set).
(a) C+P (n= 352); (b) B+P (n= 352); (c) PA (n= 354); and (d) total (n= 1058).
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The comparative results of the adjusted analysis remained almost unchanged when the PP analysis set was
used (see Appendix 4, Table 33). However, when the adjusted analysis was restricted to participants with at
least 23 months’ follow-up, the IRR for the comparison of the PA arm with the C+P arm increased from 1.18
to 1.26 (97.5% CI 0.98 to 1.63), indicating that there were 26% more episodes, on average, in participants
with at least 23 months’ follow-up in the PA arm when compared with the C+P arm, although this was not
statistically significant at the 2.5% level. This was because a higher proportion of children had more than
one episode of dental pain and/or dental sepsis (i.e. rather than just more children with one episode)
(see Appendix 4, Table 33).
Secondary analysis of the primary outcome: time to first episode of dental pain and/or
dental sepsis
Descriptives: time to first episode of dental pain and/or dental sepsis
The Kaplan–Meier survival curves for the time to first episode of dental pain and/or dental sepsis for the
ITT analysis set are shown in Figure 5. From these curves, the estimated probability of having no dental
pain and/or dental sepsis at 2 years post randomisation in the C+P arm is 0.64 (97.5% CI 0.58 to 0.69),
in the B+P arm it is 0.65 (97.5% CI 0.59 to 0.70) and in the PA arm it is 0.56 (97.5% CI 0.50 to 0.61).
Further Kaplan–Meier probabilities by length of time in the trial in years and treatment arm are given in
Appendix 4, Table 34. The median time to first episode and associated quartiles by treatment arm are
given in Appendix 4, Table 35.
TABLE 8 Estimates of the IRR over the follow-up period in episodes of dental pain and/or dental sepsis between
randomised treatment arms using negative binomial regression
Analysis set Model Arm IRR 97.5% CI p-value
ITT Unadjusted (n = 1058) C+P 1.00
B+P 0.94 0.74 to 1.21 0.6
PA 1.17 0.93 to 1.48 0.1
Adjusted (n = 1057) C+P 1.00
B+P 0.95 0.75 to 1.21 0.6
PA 1.18 0.94 to 1.48 0.1
Note
Unadjusted models include a random effect for practice and adjusted models include age in years, time in trial in years and
a random effect for practice.
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Statistical modelling: time to first episode of dental pain and/or dental sepsis
The results of fitting a Cox proportional hazards model to the time to first episode of dental pain and/or
dental sepsis data are presented in Table 9, as adjusted HRs comparing the B+P and PA arms with the
C+P arm. A HR of < 1 indicates a reduction in the risk of a first episode of dental pain and/or dental sepsis
in comparison with the C+P arm. The HR of 0.95 (97.5% CI 0.73 to 1.24) for the B+P arm relative to the
C+P arm indicates that there was a 5% reduced risk of a first episode of dental pain and/or dental sepsis
in the B+P arm when compared with the C+P arm. The HR of 1.19 (97.5% CI 0.92 to 1.53)
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FIGURE 5 Kaplan–Meier estimates of survivor functions by randomised treatment arm, generated using Stata
version 14 (StataCorp LP, College Station, TX, USA) (ITT analysis set, n= 1058). (a) Total; (b) C+P arm; (c) B+P arm;
and (d) PA arm.
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in the PA arm relative to the C+P arm indicates a 19% increased risk of a first episode of dental pain and/
or dental sepsis in the PA arm when compared with the C+P arm. There was no evidence of a statistically
significant difference between the arms in the risk of a first episode of dental pain and/or dental sepsis.
Pre-planned exploratory analyses: dental pain and/or dental sepsis ever
(ITT analysis set)
The relationship between the incidence of dental pain and/or dental sepsis during the follow-up period
and the explanatory variables of age, ethnicity, practice tap water fluoride level, index of deprivation and
number of decayed teeth at baseline from ICDAS charting (level 5/6 cavitation), which are described in
Chapter 2, Planned exploratory multivariable analyses, were explored descriptively (Table 10) and in
univariate and multivariable logistic regression models (see Appendix 4, Tables 36 and 37). From the
summary statistics presented in Table 10, those participants who had dental pain and/or dental sepsis had,
on average, more teeth with level 5/6 cavitation at baseline than those who did not. All other variables
had very similar distributions across the two groups. This is also shown in the exploratory univariate
TABLE 9 Time to first dental pain and/or dental sepsis modelled using a Cox proportional hazards model adjusted
for age (n= 1057)
Trial arm HR 97.5% CI p-value
C+P 1.00
B+P 0.95 0.73 to 1.24 0.7
PA 1.19 0.92 to 1.53 0.1
TABLE 10 Descriptive statistics by dental pain and/or sepsis ever (yes/no) (ITT analysis set)
Variable
Dental pain and/or sepsis ever
Non-missing
data points (n) Yes (N= 450)
Non-missing
data points (n) No (N= 608)
Age (years), mean (SD) 450 5.9 (1.2) 607 6.0 (1.3)
Ethnicity (white), n (%) 402 312 (77.6) 553 415 (75.1)
Fluoride level (p.p.m.)a 450 608
Minimum 0.003 0.003
Median (IQR) 0.093 (0.039–0.181) 0.096 (0.049–0.231)
Maximum 1.024 1.024
Index of deprivation (deciles)a 450 608
Minimum 1 1
Median (IQR) 3 (2–5) 3 (1–5)
Maximum 10 10
Decayed teeth at baseline from
ICDAS charting (level 5/6 cavitation)
433 0 573
Minimum 0 0
Median (IQR) 2 (1–3) 1 (0–2)
Mean (SD) 2.1 (2.1) 1.2 (1.6)
Maximum 14 9
a These variables were measured at the dental-practice level.
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analysis in which the only variable significantly associated with the incidence of dental pain and/or dental
sepsis was the number of teeth with level 5/6 cavitation (see Appendix 4, Table 36). The exploratory
multivariable model for incidence of dental pain and/or dental sepsis that was adjusted for all exploratory
variables did not provide evidence at the 2.5% level of a difference between the arms (see Appendix 4,
Table 37).
Secondary outcomes, part 1: incidence of carious lesions in primary and
permanent teeth
The results presented in this section are from the visual assessment of carious lesions, as recorded by each
dentist who had been trained to use the ICDAS method of recording carious lesions. Although radiographs
could have informed on some additional carious lesions not visible during a clinical visual examination,
markedly < 80% of the children had radiographs on entry to the trial (or within 1 year of entry); only 308
out of 1058 (29%) participants had at least one radiograph taken in the first year of the trial. Because the
threshold for use of radiographs described in Chapter 2, Schedule of assessment of primary outcomes,
was not met, ICDAS data alone are presented.
As previously described [see Chapter 2, Incidence of dental caries in primary and permanent teeth, and see
the project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019)],
an ICDAS examination was scheduled at baseline and at the final visit. A total of 1006 children had an ICDAS
examination completed at the baseline visit and 667 had an ICDAS examination completed at the final visit
[see Appendix 4, Tables 24 and 25 (baseline) and Tables 38 and 39 (final visit)]. The following measures
of incidence of new carious lesions were analysed for both the primary dentition and the FPMs for those
children (n = 653 of the ITT analysis data set) who had both a baseline and final visit ICDAS chart completed
(see Appendix 4, Table 40):
l incidence of carious lesions (i.e. has there been new lesion development in at least one tooth surface
for a given child, as a binary variable)
l severity of carious lesion development (i.e. number of teeth with new lesions).
New dental carious lesions
As children entered the trial with caries experience in some of their primary teeth, the assessment
of carious lesion incidence in the primary dentition over the trial period considered only teeth that
were neither filled nor had dentinal lesions at baseline. We have used the term ‘sound/reversible’ for
these teeth, that is those that were caries-free or for which there were non-cavitated enamel lesions
only. Tables 24 and 25 in Appendix 4 show that the numbers of such teeth were balanced at baseline
between the three trial arms. Teeth that were ‘sound/reversible’ at baseline but that experienced
dentinal decay during the trial were taken as having caries progression and included in the analysis
of caries incidence.
As children exhibited little decay experience in their FPM teeth on entry to the trial (mean age 6 years,
around the time when the FPMs are erupting), and both the number of FPMs and their limited caries
experience was balanced between the groups, caries incidence in the permanent teeth is based on only
the assessment of the FPMs at the end of the trial.
Carious lesion incidence was analysed in this way at both the child (progression in any primary tooth or
FPM) and the tooth level (number of primary teeth or FPMs that exhibited progression).
For all participants in the ITT data set with at least one ‘sound/reversible’ primary tooth or FPM at baseline
and ICDAS data at follow-up (n = 653), the baseline characteristics were balanced across the three arms
(see Appendix 4, Table 40).
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Overall, 399 out of 653 (61.1%) participants had caries development/progression in one or more ‘sound/
reversible’ primary teeth over the follow-up period [C+P, 57.9%; B+P, 61.6%; and PA, 64.1% (see Appendix 4,
Table 41)]. The adjusted risk difference in the incidence of caries development/progression in primary teeth over
the follow-up period (Table 11) in the B+P compared with the C+P arm was 0.03 (97.5% CI –0.06 to 0.11),
indicating, on average, a 3% increased risk of caries development/progression in the B+P arm compared
with the C+P arm. For the PA arm compared with the C+P arm, the adjusted risk difference was 0.05
(97.5% CI –0.03 to 0.14), indicating, on average, a 5% increased risk of lesion development/progression
in the PA arm compared with the C+P arm. However, it must be noted that this analysis is on a subset
(n = 653) of the ITT analysis set (61.7% of participants are included), and so must be treated with caution
(see Table 11).
On average, this subset (n = 653) had 1.3 progressed primary teeth that had been ‘sound/reversible’
(i.e. were sound or had non-cavitated enamel lesions at baseline) (see Appendix 4, Table 41). The range of
progressed primary teeth per participant was 0–6, but the majority of participants were at the lower end of
this range; 81.3% of the 653 participants had between 0 and 2 teeth that progressed (0 teeth progressed,
38.9%; 1 tooth progressed, 25.6%; 2 teeth progressed, 16.8%) and the distribution between arms
was similar (Figure 6). The unadjusted mean number of progressed primary teeth was 1.2 in the C+P arm,
1.2 in the B+P arm and 1.4 in the PA arm.
With regard to the number of primary teeth in which dental caries developed/progressed from ‘sound/
reversible’ at baseline, as Table 12 shows, the IRR for the B+P arm relative to the C+P arm, adjusted for
time in trial, age and including a random effect for practice, was 1.01 (97.5% CI 0.83 to 1.24) and for
the PA arm to relative to the C+P arm, it was 1.15 (97.5% CI 0.95 to 1.41). There was no evidence of a
statistically significant difference at the 2.5% level between the arms when comparing the B+P with the
C+P arm or the PA with the C+P arm.
There was no evidence of a difference in carious lesion development/progression in FPMs between the
three arms (see Tables 11 and 12, Figure 6 and Appendix 4, Table 41).
TABLE 11 Estimates of the risk difference over the follow-up period for caries development/progression (in primary
teeth and FPMs) between randomised treatment arms using logistic regression
Analysis set Model Trial arm Risk difference 97.5% CI p-value
Primary teeth: ITT Unadjusted (n = 653) C+P 0.00
B+P 0.03 –0.06 to 0.11 0.5
PA 0.06 –0.03 to 0.14 0.1
Adjusted (n = 652) C+P 0.00
B+P 0.03 –0.06 to 0.11 0.5
PA 0.05 –0.03 to 0.14 0.2
FPMs: ITT Unadjusted (n = 653) C+P 0.00
B+P 0.03 –0.04 to 0.09 0.4
PA 0.02 –0.04 to 0.09 0.5
Adjusted (n = 652) C+P 0.00
B+P 0.03 –0.04 to 0.09 0.3
PA 0.03 –0.04 to 0.09 0.4
Note
Unadjusted models include a random effect for practice and adjusted models include age in years, time in trial in years and
a random effect for practice.
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FIGURE 6 Number of progressed teeth (primary teeth and FPMs) by randomised treatment arm (n= 653). (a) C+P
arm, primary teeth; (b) C+P arm, FPMs; (c) B+P arm, primary teeth; (d) B+P arm, FPMs; (e) PA arm, primary teeth;
and (f) PA arm, FPMs.
TABLE 12 Estimates of the IRR over the follow-up period in the number of progressed teeth (primary teeth and
FPMs), from those that were ‘sound/reversible’ at baseline, among the randomised treatment arms, using negative
binomial regression
Analysis set Model Trial arm IRR 97.5% CI p-value
Primary teeth, ITT Unadjusted (n = 653) C+P 1.00
B+P 1.01 0.83 to 1.24 0.8
PA 1.16 0.95 to 1.41 0.09
Adjusted (n = 652) C+P 1.00
B+P 1.01 0.83 to 1.24 0.8
PA 1.15 0.95 to 1.41 0.1
FPMs, ITT Unadjusted (n = 653) C+P 1.00
B+P 1.29 0.59 to 2.82 0.5
PA 1.29 0.59 to 2.79 0.5
Adjusted (n = 652) C+P 1.00
B+P 1.12 0.52 to 2.42 0.7
PA 1.09 0.51 to 2.34 0.8
Note
Unadjusted models include a random effect for practice and adjusted models include age in years, time in trial in years and
a random effect for practice.
TRIAL RESULTS AND CLINICAL EFFECTIVENESS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
UNCORRECTED PROOF DATE: 11/18/2019 FILE: 07-44-03-2P.pdf
46
Secondary outcomes, part 2: child- and parent-reported outcomes
Children’s oral health-related quality of life
The P-CPQ-16 was administered at baseline and at the final visit. At baseline, 93% (984/1058) of parents
returned at least partially completed questionnaires. Baseline and final visit parent questionnaires were
received from 59% (627/1058) of parents. The P-CPQ-16 was well completed at both baseline and the
final visit, with P-CPQ-16 scores being calculable, following imputation, for 94% and 95% of respondents
at baseline and the final visit, respectively. Just over half of the children in the trial [560/1058 (53%)] had a
P-CPQ-16 score following imputation at both baseline and the final visit (see Appendix 4, Tables 42–46).
Box plots of the P-CPQ-16 scores at baseline and the final visit, and the change in score from baseline to
the final visit, are shown in Figure 7.
By the end of the trial scores had changed, on average, very little. In the analysis adjusted for baseline
P-CPQ-16 score, age at randomisation and time in trial, the estimated mean P-CPQ-16 at the final visit
was, on average, 0.27 points higher (97.5% CI –1.08 to 1.62) in the B+P arm than in the C+P arm,
and 0.17 points higher, on average, (97.5% CI –1.20 to 1.53) in the PA arm than in the C+P arm.
These estimated positive mean differences represent a very slightly poorer OHRQoL for children in the B+P
and PA arms than for children in the C+P arm, but the differences were very small, not statistically
significant and would not be considered clinically meaningful (see Appendix 4, Tables 42–46).
Children’s general anxiety and worry about dentistry (see Appendix 4, Tables 47–50)
The MCDASf was used to assess whether or not the way in which children’s teeth were managed
influenced how they felt about dentistry (trait dental anxiety); lower scores represent lower anxiety.
Child questionnaires were completed at every visit and were returned for 88% (6793/7713) of visits.
After adjusting for baseline MCDASf, age at randomisation and time in the trial, there was no evidence of
any statistically or clinically significant difference between arms in levels of trait dental anxiety, averaged
over all follow-up visits. The estimated post-baseline mean MCDASf score was 0.07 points lower for
children in the B+P arm than for those in the C+P arm (97.5% CI –0.74 to 0.59), and was 0.22 points
higher in the PA arm than in the C+P (97.5% CI –0.44 to 0.89 (see Appendix 4, Table 50).
Anticipatory and treatment-related anxiety and worry (state anxiety)
(see Appendix 4, Tables 51–59)
Using the child and adult questionnaires, anticipatory anxiety was recorded at baseline; at every subsequent
treatment visit, both anticipatory and treatment-related anxiety were recorded in the same way, with one
question posed before treatment and one after treatment. A small proportion of questionnaires had missing
data for these pre- and post-treatment questions (child questionnaires: < 5% missing; parent questionnaires:
6% missing). See Appendix 4, Table 51. The percentages of children and parents answering ‘not worried’
at baseline and over all subsequent visits were compared between trial groups.
Anticipatory anxiety and worry
At the baseline visit, 71% (1021/1045) of children who completed this question responded that they were
‘not worried’ before they saw the dentist. This was balanced across all three arms. During the follow-up
period (i.e. all visits excluding baseline), the proportion of visits for which a child indicated that they were
‘not worried’ before treatment decreased slightly to 67% (3729/5605) (see Appendix 4, Table 52). After
adjusting for baseline anticipatory anxiety, age at randomisation and time in trial, there was no evidence
of any statistically or clinically significant difference between arms in levels of anticipatory anxiety, averaged
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over all follow-up visits. The adjusted risk difference for the B+P arm compared with the C+P arm was
0.02 (97.5% CI –0.04 to 0.07), which indicates, on average, a 2% increased risk of anticipatory anxiety
in the B+P arm compared with the C+P arm post baseline. For the PA arm compared with the C+P arm,
the adjusted risk difference was –0.03 (97.5% CI –0.09 to 0.02), which indicates, on average, a 3%
reduced risk of anticipatory anxiety in the PA arm compared with the C+P arm post baseline (see Appendix 4,
Table 53).
At baseline, 67% (620/929) of parents thought that their child was ‘not worried’ before treatment. Prior
to treatment visits during the follow-up period, parents indicated that at 69% (3757/5459) of visits their
child was ‘not worried’ (see Appendix 4, Table 54). When considering the risk difference for anticipatory
anxiety between treatment arms, adjusted as noted in the previous paragraph, there was no evidence
of a statistically significant difference between the B+P and C+P arms (risk difference –0.04, 97.5% CI
–0.09 to 0.02). However, parental-reported child anticipatory anxiety was, on average, 6% lower (risk
difference –0.06, 97.5% CI –0.11 to –0.003) in the PA arm than in the C+P arm (see Appendix 4,
Table 55).
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FIGURE 7 Box plots of P-CPQ-16 scores for the participants with both baseline and final data (n= 560). (a) Baseline
scores; (b) final visit scores; and (c) change in score from baseline to final visit.
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Treatment-related anxiety and worry
The proportion of visits for which children reported not being worried after treatment was 70% (4553/6487).
Averaged over all visits, and after adjusting for time in the trial, age and including a random effect for
practice, there was no evidence of any statistically or clinically significant difference between arms in post-
treatment worry [risk difference for B+P arm vs. C+P arm –0.002 (97.5% CI –0.05 to 0.04); risk difference
for PA arm vs. C+P arm –0.04 (97.5% CI –0.08 to 0.01)]. See Appendix 4, Tables 56 and 57.
The proportion of visits for which parents reported that, after treatment, their child had not been worried
was 67% (4331/6498). See Appendix 4, Table 58.
When considering the risk difference between treatment arms, adjusted as noted earlier in this section,
there was no evidence of a statistically significant difference between the B+P and C+P arms (risk difference
–0.04, 97.5% CI –0.09 to 0.02) or between the PA and C+P arms (risk difference –0.04, 97.5% CI –0.10
to 0.01). See Appendix 4, Table 59.
Discomfort during treatment
Discomfort during treatment was recorded independently from the child’s, parent’s and dentist’s perspectives
at each treatment visit. Out of the 7713 visits, the question on treatment discomfort was answered 6468
(84%) times by children, 6498 (84%) times by parents and 7301 (95%) times by dentists. The data are
summarised in Appendix 4, Tables 60–63.
Children reported having experienced no discomfort at the majority of their appointments; 71% (4571/6468)
of the time they reported that their treatment did ‘not hurt at all’. The proportion of visits eliciting this
response was higher in the PA arm, 76% (1528/2018), than in either the C+P arm [68% (1551/2278)] or
B+P arm [69% (1492/2172)].
At 77% (4713/6093) of visits, parents thought that their child’s treatment was ‘not at all painful’. This was
reported more often in the PA arm, 83% (1596/1915), than in the C+P arm [73% (1536/2116)] or B+P arm
[77% (1581/2062)].
Dentists perceived ‘no apparent discomfort’ on behalf of the children in 68% (4990/7301) of treatment
visits. They reported this more often for the PA arm, 76% (1736/2292), than for the C+P arm
[63% (1614/2578)] or B+P arm [68% (1640/2431)].
Secondary outcomes, part 3: dentist-reported child behaviour
and co-operation
As another measure of the children’s experience in each of the treatment arms, the dentists were asked
to rate children’s behaviour during treatment and difficulties in providing treatment, as well as the reasons
for the difficulties. Appendix 4, Tables 64–67, give details of the findings relating to this aspect of the
children’s experience of treatment.
Dentists reported full co-operation without any reservations or caution being expressed by the children
at 61% (4426/7289) of all treatment visits. This was higher for PA arms, 66% (1508/2290), than for the
B+P arm [62% (1492/2425)] or C+P arm [55% (1426/2574)].
In terms of difficulties providing treatment, dentists reported having no difficulty in 80% (5808/7294)
of the visits. This varied little between arms. Concerning the visits for which difficulty was reported, the
most common reason given was the child’s behaviour [852/1486 (57%)] followed by moisture control
[327/1486 (22%)]. Inability to give local anaesthetic was reported as a difficulty in 9% (54/594) of C+P
arm visits for which a treatment difficulty was reported. However, this was also reported as a problem at a
small number of visits in the B+P [13/493 (3%)] and PA [13/399 (3%)] arms.
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When asked about the use of inhalation sedation, dentists reported using this infrequently, at < 1% of all
visits (see Appendix 4, Table 67 and Appendix 5, Table 74).
Secondary outcomes, part 4: other reported outcomes
Child dental discomfort (caused by toothache rather than treatment discomfort)
The Dental Discomfort Questionnaire (DDQ-8) was well completed, with few missing items (< 8%) (see
Appendix 4, Table 68). This descriptive additional analysis of parent-reported child dental discomfort
suggested that the scores between treatment arms were very similar and at the low end of the scale,
indicating that parents’ perception was of little child discomfort experienced from toothache (see
Appendix 4, Table 69).
Harms: safety analysis
Serious adverse events
No SAEs were reported.
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Chapter 4 Health economics
Introduction
This chapter reports the economic evaluation that was performed as part of the FiCTION trial to determine
whether or not any clinical benefit found from the three treatment strategies under evaluation was
worthwhile for the UK NHS. This economic evaluation included a within-trial cost-effectiveness analysis
and a number of sensitivity analyses that explored different reimbursement methods found in the UK NHS.
The primary aim of the economic evaluation was to determine the relative efficiency of the treatment
strategies in reducing the number of episodes of dental pain and/or dental sepsis in children with carious
primary teeth. In these analyses, the treatment strategies were ordered in terms of increasing average total
cost. Relative efficiency in the cost-effectiveness analyses was estimated by taking the difference in average
total costs between the trial arms and dividing this by the difference in effects. All analyses were based on
an ITT principle.
To allow a full understanding of cost-effectiveness and add value to the analysis, two ways of measuring
incremental costs were compared: (1) time/material-based costs (microcosting) and (2) the costs associated
with current charges to the NHS for treating children with dental decay in primary teeth in Scotland,
England and Wales. The second analysis is important because the payment systems differ for areas with
a fee-for-service (FFS) arrangement, which is used in Scotland, and the agreed UDA, which is used in
England and Wales. Both costing measures are explained in further detail in Costing methods. The primary
(base-case) analysis estimated costs using microcosting; costs based on FFS and UDA were used in the
sensitivity analyses.
The health economic evaluation took the perspective of the health service provider (NHS) and Personal
Social Services. The main costs collected related to health service utilisation, which, for the FiCTION trial,
was the average total cost to manage children with dental decay in primary teeth during the time in
trial of at least 23 months (maximum 36 months). A wider perspective was also taken by including
the costs borne by parents of these children. These included direct (e.g. out-of-pocket purchase of pain
relief medication) and indirect costs (e.g. time away from usual activities, such as work, to care for
a child).
The results of the economic analyses are reported as the following outcomes:
l health-care costs to manage dental decay in primary teeth over the child’s time in the trial of at least
23 months
l direct and indirect costs to parents of managing dental decay in their children’s primary teeth
l incidence of dental pain and/or dental sepsis
l average total number of episodes of dental pain and/or dental sepsis
l regression models estimating the key predicators of costs and effects (e.g. age, time in trial).
Methods
This analysis was designed and conducted in accordance with best practice, conforming to the
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist.
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Cost data collection
NHS costs and frequency of use of health-care services
The costs for treating dental decay in primary teeth depended on the quantity of dental care resources
used for each child during their time in the trial, for up to 3 years post randomisation. The use of dental
services was recorded in the CRFs for visits to a GDP and for patient referrals. The frequency of use of
health-care resources was calculated for each child and combined with the cost of each resource to generate
the average total cost to manage dental decay in primary teeth in each arm over at least 23 months.
Treatment costs
The cost of each treatment was based on information provided in the CRF and was estimated on an individual
child level (microcosting) and, in sensitivity analyses, on an aggregate level using FFS and UDA data.
The CRF captured any information on treatments that occurred during the first and subsequent visits to a
practice. The CRF collected detailed information on prevention and operative treatments and who
performed such treatments.
Information on the visit start time and end time on the CRF allowed us to estimate the duration of each
visit for every child. The length of time for each visit was used to estimate the cost of dental personnel
providing treatment, taking into account that the same personnel may not provide prevention and
operative treatment. We assumed that a dental nurse would be present for the full duration of each visit.
Information on the total length of visit and the time providing prevention was used to estimate length of
time providing operative treatment.
Operative treatment Operative treatment refers to conventional management and biological
management of decay, and includes (when indicated) carious tissue removal, restorations, anaesthesia,
extractions and opening-up lesions. GDPs or dental therapists were the dental personnel options provided
on the CRF for operative treatment. Additional information on the number of surfaces treated per tooth
was also collected, because if more than one surface of a tooth was treated this could incur additional
costs, such as the use of additional restorative material or a matrix band [see the project web page:
www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019)].
Prevention Best-practice preventative care was expected to have been provided at every visit regardless of
randomised allocation. Information on prevention collected by the CRF included what prevention activities
were performed, how much time was spent on those activities and which personnel performed them.
We categorised the prevention activities into the four generally recognised components (or pillars): (1) diet,
(2) oral hygiene, (3) fissure sealing of FPMs and (4) fluoride applications.87,115
Patient referral costs
A patient referral was classified as a child referred to a dental hospital/clinic for a consultation and/or
operative treatment. The team were notified of patient referrals through the CRF and further data
collection on referrals was made through contact with the referring clinician [see the project web page:
www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019)]. Additional data
collected included the modality of adjunctive behavioural management used (behaviour management
alone and type of sedation), specific information relating to the tooth or teeth requiring treatment,
and the outcome of the referral (treatment complete, referral ongoing or failure to attend).
To estimate costs associated with referrals, ‘packages of care’, categorised A to F [see the project web page:
www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019)], were generated that
defined where the treatment took place, who provided the treatment and how many visits were involved. The
‘packages of care’ were then costed using routine sources and the total cost of each treatment package was
estimated based on advice from staff at Newcastle Dental Hospital (Ben Cole, July 2017, personal
communication). It was originally anticipated that we would source this information from one site in both
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Newcastle and Scotland; however, after preliminary research, it was agreed that no additional information
would be provided from the Scottish site because both countries use the same NHS reference costs for
secondary/tertiary care.
Parent costs
These costs were included in a sensitivity analysis to explore the impact of widening the cost perspective.
The parent questionnaire containing questions on parent costs was completed at all scheduled and
unscheduled visits, excluding the baseline visit. Parents were asked whether or not their child had
experienced any toothache since their previous visit. If they had, they were asked to complete the parent
cost questions; however, if the child had not experienced toothache, they could skip this section. The
parent questionnaire provided information on any absence from school owing to toothache, parental/carer
time off paid work to care for a child with toothache, any additional paid child care arising as a result of
toothache, non-prescribed (over-the-counter) medication and any time spent away from usual activities
because of toothache (for the child and parent).
In a further sensitivity analysis, children’s time away from school and usual activities because of toothache
were incorporated. Children are not economically active; however, children’s time has an opportunity cost,
so we costed their time as leisure time116 and determined the effect, if any, that this had on overall results.
To summarise, data collection on resource use and cost can be split into three areas (see Appendix 5,
Tables 70 and 74):
l Treatment costs (first and all subsequent visits, including scheduled and unscheduled visits) were
collected via the CRF.
l Patient referrals were collected via the patient referral form, completed once a referral for a FiCTION
trial child was identified. Each referral was categorised into a prespecified ‘care package’ (see NHS costs
and frequency of use of health-care services).
l Parent costs were collected via the ‘about your child’s teeth’ questionnaire completed at scheduled and
unscheduled visits.
Costing methods
As previously mentioned, two costing techniques were undertaken as part of the FiCTION trial economic
evaluation: microcosting and the current charges to the NHS. A sensitivity analysis explored FFS and UDAs
individually and the impact the two different fee structures had on the overall cost-effectiveness of the
treatment strategies being explored.
Microcosting
A time/materials-based costing was used to estimate the treatment costs for each child at every visit.
Capital costs were not included in our analysis. A spreadsheet was developed using information collected
in the CRF and clinical advice obtained to determine what consumable and reusable resources were used
to perform each dental treatment. These resources were collated to design an itemised data collection tool
and unit costs were assigned to each resource.
We used existing data sources, when possible, to estimate the unit costs.117–120 The unit costs used in the
microcosting analysis are detailed in Appendix 5, Table 70. Further information on how these costs were derived
is provided in the health economic analysis plan [see the project web page: www.journalslibrary.nihr.ac.uk/
programmes/hta/074403/#/ (accessed 22 February 2019)]. In brief, staff costs were inflated to account
for national insurance and pension contributions to estimate the total gross annual salary. From this, we
were able to estimate the cost per minute for each member of dental personnel who could have provided
treatment.
Consumable resources were inflated by 20%, when appropriate, to account for value-added tax (VAT) and
costs of individual items were estimated by dividing a total ‘pack’ cost by the number of items used.
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Reusable resources were also inflated to account for VAT, and the total cost of a pack (e.g. of mirror heads)
was divided by the total number of items in that pack. The total cost per item was then converted to
the equivalent annual cost, using a 3.5% discount rate. Based on clinical advice, we assumed that all
dental equipment would have a 3-year lifespan. In addition, we applied an autoclave cost to every use of
a reusable item, when applicable. All assumptions (e.g. 3-year lifespan for reusables) were explored in
sensitivity analyses. The costs estimated using microcosting were used in the base-case analysis.
Charges to the NHS
Fee for service
In Scotland, GDPs are reimbursed for every unit of activity they perform. As it has been suggested that this
fee-per-item system may create an incentive to overtreat participants,121 this was explored in a sensitivity
analysis. Unit costs were collected from the Information Services Division Scotland.122 The cost of treating
each child for every visit was used to estimate the average total cost in Scotland for treating dental decay
in primary teeth over the time in the trial of at least 23 months. The unit costs used in the FFS analysis are
detailed in Appendix 5, Table 71.
Units of dental activity
In England and Wales, a reimbursement similar to the current Scottish FFS-based system was in play until
2006, when UDAs were introduced.123 UDAs are a fixed reimbursement that GDPs receive for dental work
and vary between practices (between £16 and £40 per UDA).118 Under the UDA system, dental procedures
can be classified into three bands:123
1. Band 1 (1 UDA) – diagnosis, treatment planning and maintenance. It includes examination,
radiography, scale and polish and preventative care.
2. Band 2 (3 UDAs) – simple treatments such as fillings, extractions and periodontal treatment.
3. Band 3 (12 UDAs) – complex treatment that includes a laboratory element. Examples include bridges,
crowns and dentures.
In addition, GDPs can receive 1.2 UDAs for a band 1 urgent treatment. To incorporate urgent treatment
into the UDA analysis, we defined urgent treatment as an unscheduled visit that occurred at the start of a
course of treatment. We assumed that needing urgent treatment would begin a new course of treatment,
as it was improbable that a child would require urgent care during an existing course of treatment. This
assumption underestimated UDA reimbursement by 0.2 UDAs if an unscheduled visit occurred during a
course of treatment. However, the number of visits affected by this assumption were minimal [n = 15
(< 1%)] and, in these incidences, the number of days between the unscheduled visit and the previous visit
was < 28 days (mean 18.8 days); hence, it was assumed that the unscheduled visit was related to the
previous visit.
It is important to note that UDA(s) are reimbursed for only one course of treatment. A course of
treatment definition is provided in the health economic analysis plan [see the project web page:
www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019)] and Figure 8
is an illustrative presentation of the course of treatment pathway.
We collected UDA values for FiCTION trial practices in England (n = 43) from the NHS Business Services
Authority website,118 which has information on dental processing and payments. The UDA value was
estimated to be the value of the total contractual payments divided by the number of contracted UDAs
based on the value of GDS contracts only. The average health board UDA value was adopted for the
Welsh practices (n = 4). This information was obtained through personal communication (Research and
Development Division, Welsh Government, October 2016, personal communication). Practice-level UDA
values used in the UDA analysis are summarised in Appendix 5, Table 72. UDAs were discounted based
on when a course of treatment started.
HEALTH ECONOMICS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
UNCORRECTED PROOF DATE: 11/18/2019 FILE: 07-44-03-2P.pdf
54
The UDAs incurred for each course of treatment were combined into a total number of UDAs received for
each child over their time in the trial (see Appendix 5, Table 75). These UDAs were combined with practice
UDA values to produce a total cost per child and, hence, the average total costs in England and Wales for
treating dental decay in primary teeth.
Parent costs
Information on child and parent costs were collected via the parent questionnaire, excluding baseline visits.
The unit costs for time were based on data obtained from the Department for Transport116 and the Office
for National Statistics.124 All medication costs were estimated based on the over-the-counter costs of
medications from high-street pharmacies.125 Child-care costs were sourced from recent UK online reports
of current child-care costs.126 Parent and children costs are detailed in Appendix 5, Table 70.
Effectiveness measure
Health outcomes were measured in natural units; incidence of dental pain and/or dental sepsis and
episodes of dental pain and/or dental sepsis. The methods for deriving these outcomes measured are
described in detail in Chapter 2. It was assumed that those who did not return for regular appointments
during their follow-up did not experience dental pain and/or dental sepsis.
Cost-effectiveness analysis
Adjusted analyses were performed to estimate cost-effectiveness. All results were presented as point
estimates of the mean incremental differences in costs and effects, the incremental cost per incidence of
dental pain and/or sepsis avoided, and the incremental cost per episode of dental pain and/or dental
sepsis avoided.
Child presents
to GDP
New course of
treatment
Is this the first
presentation
for 60 days?
Same course
of treatment
New course
of treatment
Did the child
have an
emergency visit?
Did the child
have pain and
receive operative
treatment?
What were the
number of days
between this
visit and the
last visit?
New course
of treatment
Same course
of treatment
YES NO
YES NO
YES NO
1 – 28
days
29 – 60
days
FIGURE 8 Course of treatment pathway [see HEAP at project web page: www.journalslibrary.nihr.ac.uk/
programmes/hta/074403/#/ (accessed 22 February 2019)].
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Adjusted analysis
Costs
Using the data on total costs per child (estimated using microcosting, FFS and UDAs), regression techniques
were applied to identify whether or not there was a difference between the treatment strategies when
compared with C+P, in the first instance, while controlling for potentially modifying factors, such as age
and length of follow-up. An ordinary least squares regression technique was applied:
f(NHS costs) = β0 + β1i.R + β2T + β3A + β4P + e^. (1)
In Equation 1, a dummy variable for the randomised arm estimates the difference in costs between the arms
when compared with C+P, controlling for all other factors in the model. Estimated beta values describe the
direction and magnitude of the relationship between each variable and the dependent variable. For
example, if the beta estimate of B+P is +50 and the beta estimate of PA is –50, this indicates that B+P is
more costly on average, and PA is less costly on average, than C+P, controlling for all other factors.
Benefits
As with costs, regression techniques were carried out to derive the drivers of the difference in effects
between the three treatment strategies after controlling the key predictors of dental pain and/or dental
sepsis. Equation 2 is the equation applied to estimate effects:
f(dental pain
and
or
sepsis) = β0 + β1i.R + β2T + β3A + β4P + e^. (2)
The two equations differed in terms of their dependent variables, but the same independent variables
were adopted and used in the statistical analysis.
The variables considered were:
l Dependent variable(s) –
¢ Costs: estimated using microcosting, FFS and UDAs. This equation was replicated to incorporate
parent costs with total treatment costs.
¢ Dental pain and/or dental sepsis – estimated as the average incidence of dental pain and/or sepsis
and replicated for the average total number of episodes of dental pain and/or dental sepsis.
l Independent variables –
¢ Randomised arm (i.R): this is an indicator variable that allows us to compare two of the treatment
strategies with our comparison strategy (C+P) independently.
¢ Time in trial (T) in months (minimum 23 months, maximum 36 months).
¢ Age (A) of the child in years.
¢ Individual practice variations (P).
Seemingly unrelated regression
The cost and outcome regressions (see Equations 1 and 2) were run simultaneously using seemingly
unrelated regression (SUR).127 SUR permits the simultaneous estimation of costs and effects, calculated at
the individual level, while accounting for unobserved individual characteristics that could affect both costs
and effects and lead to potential correlation between these two dependent variables.128 In addition, the
SUR allowed us to control for additional covariates that may affect costs, effects or both. This analysis was
conducted in Stata using the SUR command ‘sureg’.
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Sensitivity analyses
Sensitivity analyses were conducted to assess the robustness of the results to realistic variations in the levels
of underlying data. Deterministic sensitivity analyses were used to address any uncertainty in the assumptions
used in our analysis. A stochastic sensitivity analysis using the bootstrapping technique129 explored the impact of
the statistical imprecision surrounding estimates of costs, effects and cost-effectiveness. The bootstrapped results
from the three-arm comparison were presented as a cost-effectiveness frontier. The cost-effectiveness frontier130
allowed us to determine the treatment strategy that maximised net benefits at each willingness-to-pay
(WTP) value for an additional unit of health effect (i.e. dental pain and/or dental sepsis avoided).
The base-case analysis was replicated to include children who were treated according to the clinical
protocol for at least 80% of visits (see Chapter 2, The prespecified per-protocol analysis set, and Chapter 3,
Adherence to protocol) to determine what effect, if any, this had on the overall results. The results of the PP
analysis are presented in Appendix 5, Table 79.
All costs and effects were discounted at the recommended rate of 3.5%.131 Discounting for incidence
was based on when the child incurred the dental pain and/or dental sepsis during their follow-up period.
Discounting for episodes was based on when the episode began. Similar to the co-primary outcome analysis,
97.5% CIs were generated for point estimates of costs and effects and for the differences between the
management strategies.
Complete-case analysis
A complete-case analysis was performed on all children who attended their final visit, regardless of the
number of visits they had over their period of follow-up. The inclusion of only these children allowed us to
estimate the cost-effectiveness of the three treatment strategies with at least 23 months’ follow-up data
and overcome some of the issues relating to unscheduled visits. It is important to note that this analysis
was underpowered (as the sample size was based on the primary outcomes) and so was less likely to detect
a difference should one exist. The results of the complete-case analysis are presented in Appendix 5, Table 80.
Results
A total of 1114 children were randomised to the FiCTION trial. Children included in the economic analysis
were those who were deemed eligible to be included in the primary ITT analysis [see Chapter 2, Statistical
methods, and Chapter 3, Numbers analysed: intention to treat analysis (1058 participants)]. Data on these
1058 children were used in the health economics base-case analysis and data on 1057 children were used
in the adjusted analyses, as one child had missing information on age (age was one of the independent
variables in the regression analysis described in Cost-effectiveness analysis, Adjusted analysis).
The children included in the health economic analyses were evenly distributed across the three treatment
arms; 352 were randomised to B+P, 352 to C+P and 354 to PA. On average, children had seven visits
during their time in the trial.
Data validity and completeness
This section reports on the completeness of the data used to estimate costs and effects.
Case report form
The percentage of missing data was relatively low (< 5%) for all of the questions used in the economic
analysis collected via the CRF. A detailed description of missing CRF data, data validity checks and any
assumptions made in the base-case analysis (n = 1058) is provided in Appendix 5, Table 73. All decisions
made were verified with clinical advice. For operative treatment, we made no assumptions for missing
treatments as there was no way to identify whether this was just a check-up visit or, if operative treatment
was provided, what potential treatment could have been provided. This assumption therefore slightly
underestimates the average total cost in each of the three treatment strategies, but the numbers of
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missing data are similar across the three treatment strategies (missing data on whether or not restoration
materials were used was 36% in the B+P arm, 33% in the C+P arm and 31% in the PA arm).
Information on prescribed medications (painkillers and antibiotics) was missing for 2% of all visits. We
assumed that no medications were prescribed in these visits. Again, this assumption leads to a slight
underestimate of the average total cost. It also affects the B+P arm more than the other two treatment
strategies, as there were more missing medications data in this group than in the other two groups
(40% vs. 30% vs. 30% of the missing data for the B+P, C+P and PA arms, respectively). When an analgesic
[n = 2 (< 1%)] or antibiotic [n = 2 (< 1%)] was prescribed but no information on the name, dose or frequency
was provided, we did not assume a cost for this prescription.
Unit of dental activity values
Information on UDAs was available for 41 out of 43 English practices in the FiCTION trial. The average
UDA value for practices in the local area, based on the first half of their postcode, was used to estimate a
UDA value for practices with no information on the Business Services Authority website (n = 2).118 There
was information from a minimum of three practices in the same area for this imputation. The following
assumptions were adopted for duplicate practices (n = 12): a duplicate may exist if more than one GDP
at that practice had a GDS contract, duplicates were removed if there was no UDA information available
(n = 2) or the UDA information was the same (n = 5). For the remaining duplicates (n = 5), we estimated
the weighted average UDA based on the baseline contract size.
Parent questionnaire
Data on 968 children from 5632 visits were used to inform parental costs, as outlined in Parent costs.
Questionnaire data on 145 visits were excluded from the economics analysis (108 visits had no dates and,
hence, could not be discounted; 32 visits had a date of questionnaire that was before the first CRF; five
were duplicates). We analysed the responses to the parent questionnaire at an aggregate level and used
this to assign ‘unit costs’ at a participant level. We estimated the average total time parents had to take
off work and the total out-of-pocket expenses associated with the child’s dental treatment. The response
rates of the parent questionnaire for the health economic questions were high (≈95%). On average,
parents reported experiencing few direct and indirect costs associated with their child’s toothache over
their follow-up (< 10% responded ‘yes’ to any single question). As a result, any missing data (< 5%) were
assumed to be ‘no’.
On average, nearly all parents who completed the parent questionnaire reported that their child had
experienced toothache once during their follow-up [mean 0.98 (SD 1.46)]. All summary statistics on
estimating the parent costs are provided in Appendix 5, Tables 70 and 74.
Resource use and costs
The average total resource use based on staff, time spent providing treatment and type of treatment was
estimated for all three treatment strategies and is presented in Appendix 5, Table 74. A summary of types
of treatment provided according to arm is also included [see Chapter 3, Treatment received (intention-to-treat
analysis set, n = 1058)]. On average, all three treatment strategies were similar in terms of average total
frequency and duration of visits. The three strategies differed in terms of operative treatment, with < 20% of
all PA visits receiving operative treatment compared with > 40% of B+P and C+P visits. The type of operative
treatment also differed across the arms, which is reflective of the different treatment strategies (e.g. complete
carious tissue removal was more routinely performed during C+P visits, whereas B+P visits with operative
treatment were expected to have partial or no carious tissue removal). GDPs provided the majority of
prevention and operative treatment.
Costs were estimated for the first visit and for all follow-up visits during the time in the trial. The average
total cost per randomised arm was estimated based on the three costing strategies.
Table 13 illustrates the difference in the total cost per child of treating dental decay in primary teeth, based
on costs estimated using microcosting over a minimum of 23 months (maximum 36 months) in the trial.
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As would be expected, the total cost is lower for PA than for the other two treatment strategies, as children
being managed by the PA arm had less operative treatment and shorter appointment times.
If we assumed a cost for the missing medications, mentioned in Data validity and completeness, it would
have a trivial effect on the overall average total cost estimates for each treatment strategy and, given
that B+P had the lowest average prescription costs, it would not affect the order of the three treatment
strategies in terms of mean (or median) total cost.
The mean costs have a direct relationship to the total cost of adopting a given strategy. However, the
median costs presented in Table 13 are arguably more representative of the typical total cost associated
with managing dental decay in primary teeth over a minimum of 23 months and up to a maximum of
36 months. Typically, PA had more referrals and more referrals involving a general anaesthetic, which has
inflated the average total cost of this treatment strategy. The assumptions we made previously to exclude
costs when information was missing do not affect our results and would only strengthen the difference in
costs between PA and the other treatment strategies if they were included.
Fee for service
The unit costs used in the FFS analysis are detailed in Appendix 5, Table 71. Costs were taken to be the
fees provided under ‘treatment under capitation’ and specific to minors when possible. For every child,
a basic fee for their care and treatment was adopted and multiplied by the number of months they were
in the trial. This fee includes examinations, oral hygiene advice, tooth-brushing advice, dietary advice,
radiographs and all clinical prevention. Additional costs incorporated were reimbursed based on the
number of teeth treated, number of visits or course of treatment. A new course of treatment for the FFS
analysis was defined as a visit at least five calendar months after the previous visit, as outlined in the
Statement of Dental Remuneration Amendment No. 135.122
Unit of dental activity
The median number of courses of treatment per child during their time in trial was six, with the average
number of UDAs reimbursed per course of treatment being 1.75 UDAs [C+P arm, mean 1.88 (SD 0.55);
B+P arm, mean 1.92 (SD 0.53); and PA arm, mean 1.45 (SD 0.53)]. The unit costs used in the UDA analysis
are detailed in Appendix 5, Table 72.
Table 14 illustrates the difference in the total cost per child to treat dental decay in primary teeth based on
the different reimbursement strategies over a minimum of 23 months (maximum 36 months). Costs based
on UDAs were generally lower than those based on FSS. There is very little difference in the total costs
between C+P and B+P in the UDA analysis, which is expected given that both treatment strategies are in
the same band category (3 UDAs). In the FFS analysis, B+P is the most costly treatment strategy. Again,
this is not surprising as fillings are reimbursed at a lower rate than preformed crowns under the FFS
reimbursement system. In all three costing methods, the PA arm is the least costly treatment strategy.
Effectiveness
Summaries of incidence of dental pain and/or dental sepsis and episodes of dental pain and/or dental
sepsis are provided in Table 15. The effectiveness outcomes were discounted at 3.5%, as per the National
Institute for Health and Care Excellence guidelines.131 The effectiveness point estimates used in the
economic analysis are presented in Table 16, alongside the comparative results, which are described in
the following section.
Cost-effectiveness results
Biological arm versus conventional arm and prevention alone arm versus conventional arm
In the first instance, we compared both B+P and PA with C+P as if they were two independent
comparisons. In this analysis, we assumed that C+P was equivalent to usual care. We replicated these
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analyses for both of our primary outcome measures: incidence of dental pain and/or dental sepsis and
number of episodes of dental pain and/or dental sepsis.
Table 16 illustrates the incremental difference in average total costs and average total effects between the
treatment strategies. On average, B+P dominates C+P in both analyses, as it is, on average, less costly and
more effective. The comparison between PA and C+P is less clear. On average, PA is less costly than C+P,
but it is also less effective in terms of both incidence of dental pain and/or dental sepsis and episodes of
dental pain and/or dental sepsis. In this circumstance, an incremental cost-effectiveness ratio (ICER) was
estimated to judge whether or not the extra costs of the more effective C+P are worthwhile. If society
were willing to pay up to £310 per episode of dental pain and/or dental sepsis avoided, then we would
choose C+P. If society were not willing to pay this amount, then we would choose PA. Considering
incidence of dental pain and/or dental sepsis as our measure of effect, the threshold for choosing C+P for
this decision increases to approximately £800.
The deterministic results alone are not sufficient to support decision-making. For this, we need to consider
the imprecision surrounding estimates of costs, effects and cost-effectiveness; for this, stochastic sensitivity
analysis was used. The probabilities of each treatment strategy being considered cost-effective at different
threshold values for society’s WTP to avoid dental pain and/or dental sepsis are based on the bootstrapped
results of the cost-effectiveness analysis. We can clearly see in Table 16 that B+P always has a higher
probability of being considered cost-effective than C+P at all presented WTP values for both measures
of effectiveness. A similar pattern can be seen for PA compared with C+P, with PA having the higher
probability of being considered cost-effective at most WTP thresholds presented. However, PA’s probability
of being considered cost-effective decreases as our WTP value increases because we progressively put
more value on avoiding dental pain and/or dental sepsis, which C+P is more likely to avoid. The more we
value avoiding dental pain and/or dental sepsis, the more probable it is that the higher costs of C+P will
be offset.
Incremental analysis
Arguably, an incremental analysis is more appropriate from an economics perspective as it allows us to
compare the three treatment strategies simultaneously. In this analysis, we first ordered the treatment
strategies in terms of increasing average total cost and then compared a more costly strategy with a less
costly strategy in terms of incremental cost-effectiveness. As PA is the least costly option,6 we compared
this to B+P, the next least costly option, and estimated an ICER as B+P is, on average, more costly
but more effective than PA. We then incorporated the most costly treatment strategy, C+P, into the
analysis and compared this with B+P. As B+P was, on average, less costly and more effective than C+P,
it dominated the comparison; hence, we would not consider C+P to be cost-effective compared with the
other two treatment strategies. The ICER for B+P is approximately £300 to avoid one case of incidence
and £130 to avoid one episode of dental pain and/or dental sepsis, compared with PA.
Again, the bootstrapped results present the uncertainty surrounding our results; Table 17 shows the
probabilities of the three treatment strategies, compared with each other, being considered cost-effective
at the different WTP thresholds. Figures 9 and 10 illustrate which treatment strategy has the highest
probability of being considered cost-effective at each WTP threshold when the measure of effectiveness is,
respectively, incidence of dental pain and/or sepsis avoided or episode of dental pain and/or sepsis avoided.
The stochastic analysis shows that PA would be the most cost-effective treatment if a decision were to
be based on cost alone. As society’s WTP for avoidance of dental pain and/or dental sepsis increases, it becomes
more probable that B+P would be considered cost-effective (see Figures 9 and 10, respectively). C+P would
not be considered cost-effective compared with PA and B+P; hence, it is not presented in Figures 9 and 10.
The complete-case analysis, as described in Complete-case analysis, has similar results, in that B+P would
be considered cost-effective at reducing the number of episodes of dental pain and/or dental sepsis at a
WTP threshold of £130 per episode avoided (see Appendix 5, Table 80).
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Sensitivity analysis
Fee for service analysis
Data on 287 children treated in Scotland were used in the FFS analyses (C+P = 90, B+P = 100 and PA = 97).
The average total cost per treatment arm was higher in the FFS analysis than the average total cost per
treatment arm in the analysis in which costs were based on microcosting (see Table 16). Estimates of mean
effect remain similar to the microcosting-based estimates, except that now PA has fewer incidences of
dental pain and/or dental sepsis than C+P (see Appendix 5, Table 76). This change in direction of effects
can be explained by the smaller number of children included in the FFS analysis than in the base-case
analysis (257 vs. 1058) and suggests that children in the PA arm based in Scotland are less likely to experience
dental pain and/or dental sepsis.
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FIGURE 9 Probability of being cost-effective at different WTP thresholds to avoid an incidence of dental pain
and/or dental sepsis: PA vs. B+P vs. C+P. C+P does not appear in the figure because C+P did not have the highest
probability of being considered cost-effective at the WTP values presented.
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FIGURE 10 Probability of being cost-effective at different WTP thresholds to avoid an episode of dental pain
and/or dental sepsis: PA vs. B+P vs. C+P. C+P does not appear in the figure because C+P did not have the highest
probability of being considered cost-effective at the WTP values presented.
DOI: 10.3310/hta23XXX HEALTH TECHNOLOGY ASSESSMENT 2019 VOL. 23 NO. XX
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Maguire et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
UNCORRECTED PROOF DATE: 11/18/2019 FILE: 07-44-03-2P.pdf
65
When comparing the full incremental analysis based on FFS costs (Table 18) with those based on the
microcosting (see Table 17), the conclusions drawn are similar. C+P is unlikely to be considered cost-
effective regardless of the basis of costs. Regarding incremental cost per episode of dental pain and/or
dental sepsis avoided, C+P was extendedly dominated by B+P. Extended dominance occurs when the ICER
for the management strategy is higher than that of the next, more effective, alternative.133 B+P would
probably not be considered cost-effective at reducing incidence of dental pain and/or dental sepsis
compared with PA with an ICER of > £1000. However, the incremental cost to avoid an episode of dental
pain and/or dental sepsis was £235.
Unit of dental activity analysis
Data on 771 children treated in England and Wales were used in the UDA analyses (C+P = 262, B+P = 252
and PA = 257). When the total average UDA-based costs of each treatment strategy are compared with
the microcosting-based data (see Table 16), B+P is more costly than C+P but remains more effective
on average (see Appendix 5, Table 77).
In terms of the incremental cost per episode of dental pain and/or dental sepsis avoided, the UDA-based
results (Table 19) are substantially different from those based on microcosting (see Table 17) and suggest
that PA would be most likely to be considered cost-effective over the range of WTP values presented
(in Table 17, B+P was most likely to be considered cost-effective when society was willing to pay £130 per
episode of dental pain and/or dental sepsis avoided). A broadly similar pattern was found for incremental
cost per incidence of dental pain and/or dental sepsis avoided.
Sensitivity analysis on course of treatment definition
The duration of 60 days, used as an assumption to define a course of treatment in the primary UDA analysis,
was explored in a further sensitivity analysis. When an alternative duration of 90 days was incorporated,
the average number of courses of treatment per child per treatment strategy was similar to the original
UDA analysis [C+P, mean 5.13 (SD 1.9); B+P, mean 5.00 (SD 2.04); and PA, mean 5.08 (2.04)].
Looking at the UDA-based analysis, and when 90 days represented a course of treatment, there was a
negligible difference in costs. The difference in average total cost between B+P and C+P was £8.80 and
between PA and C+P was £49.97 (results not shown). The difference in effects was, as would be
expected, the same as the previous analyses. As a result, the ICER between C+P and PA decreased to
£471 to avoid an episode of dental pain and/or dental sepsis, and PA would be considered the most
cost-effective treatment strategy owing to the associated cost savings (data not shown). As there was very
little difference in our conclusions regardless of whether a course of treatment was defined as 60 days or
90 days, we did not consider the 90-day assumption when looking at the combined FFS and UDA analysis,
presented in Fee for service and unit of dental activity analysis.
Fee for service and unit of dental activity analysis
Given the comparatively greater number of children in the England and Wales practices than in the Scotland
practices (771 vs. 287), the combined analysis reflects UDA costs more than FFS costs. As a consequence, the
average total costs reported are higher than for the microcosting (see Table 16), although the effectiveness
data remain the same, as all practices contributed to the analysis. The comparison between PA and C+P is
similar to the microcosting-based analysis (see Table 16 and Appendix 5, Table 78).
For the full incremental analysis (Table 20), B+P is the most costly management strategy and it no longer
dominates C+P (as it did for the analysis based on microcosting; see Table 17). However, a combination of
PA and B+P have extended dominance over C+P, meaning that the most appropriate incremental analysis
is for B+P against PA. As Table 20 shows, PA is considerably more likely to be considered cost-effective for
both measures of effectiveness owing to the cost savings associated with PA.
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Parent costs
Table 21 is a summary of the direct and indirect costs incurred by parents because of their child’s
toothache over their follow-up. On average, parents incurred direct and indirect costs of £14 because of
their child’s toothache over the trial follow-up period [mean £13.71 (SD £50.00)]. This average total cost
increased by £10 when we incorporated the opportunity cost of children’s time away from usual activities
owing to toothache in a sensitivity analysis [mean £24.13 (SD £77.85)].
On average, the inclusion of parental costs is negligible and would not change our overall conclusions.
TABLE 21 Parent costsa
Resource
Total cost per child (£)
C+P (n= 323) B+P (n= 322) PA (n= 323)
Mean (SD) Median (IQR) Mean (SD) Median (IQR) Mean (SD) Median (IQR)
Parent questionnaire (excluding baseline)
Missed paid work
costs
4.65 (28.53) 0.00
(0.00–0.00)
6.22 (37.00) 0.00
(0.00–0.00)
3.19 (14.14) 0.00
(0.00–0.00)
Missed usual activities
costs
6.23 (26.73) 0.00
(0.00–0.00)
7.94 (28.60) 0.00
(0.00–0.00)
5.40 (17.71) 0.00
(0.00–0.00)
Additional paid
child-care costs
0.92 (5.45) 0.00
(0.00–0.00)
1.48 (7.82) 0.00
(0.00–0.00)
1.05 (5.20) 0.00
(0.00–0.00)
Painkiller costs 1.32 (2.65) 0.00
(0.00–2.89)
1.27 (2.60) 0.00
(0.00–2.79)
1.48 (2.89) 0.00
(0.00–2.89)
Child usual activities
cost
10.25 (40.90) 0.00
(0.00–0.00)
12.81 (40.86) 0.00
(0.00–0.00)
8.21 (25.79) 0.00
(0.00–0.00)
Total parent costs
(excluding child costs)
13.12 (49.96) 0.00
(0.00–2.99)
16.90 (63.66) 0.00
(0.00–2.99)
11.13 (30.92) 0.00
(0.00–2.99)
Total parent costs
(including child costs)
23.37 (80.15) 0.00
(0.00–2.99)
29.71 (96.34) 0.00
(0.00–6.14)
19.34 (49.86) 0.00
(0.00–5.78)
a Costs and effects are discounted at 3.5%.
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Chapter 5 Acceptability and associated
experiences of the FiCTION trial arms for children,
parents/guardians and dental professionals: a
qualitative evaluation
Introduction
Qualitative research can add value to RCTs by exploring deliverers’ and recipients’ responses to an
intervention, and provide insight into how the intervention was delivered in practice.134–136
The purpose of the qualitative component of the FiCTION trial was to address two of the secondary
objectives of the trial: (1) to compare the three treatment strategies with respect to acceptability and
associated experiences for child participants and parents/guardians and (2) to compare the three treatment
strategies (C+P, B+P and PA) with respect to dentists’ and dental practice team members’ experiences.
In this chapter, the acceptability for children and parents/guardians and the experiences of dental
professionals will be described separately.
Child participants and their parents/guardians
Aims and objectives
To explore the acceptability of the three treatment strategies to manage carious lesions from the
perspective of the child participants and their parents/guardians.
The objectives were to:
l explore child participants’ and parents’/guardians’ experiences of the three treatment strategies and
compare and contrast the impact of the treatment strategies on their daily lives
l identify factors of importance when considering the acceptability of the three treatment strategies.
Methods
Participants and sampling
Participants were children participating in the FiCTION trial and their parents/guardians. The children were
selected from all FiCTION trial participants who had not explicitly withdrawn, and whose dental practice
had not explicitly withdrawn from the FiCTION trial in two of the five FiCTION trial clinical centres: Scotland
and Yorkshire. Parents/guardians of the children selected were also invited to participate. Children were
identified from FiCTION trial records by means of purposive maximum variation sampling using the
variables of sex, age, regional location and the setting (general practice or community dental service)
where the treatment had been delivered. The sample included children from each of the three treatment
arms, including some whose treatment deviated from the clinical protocol for the arm to which they had
been randomised as these were cases of particular interest.
Recruitment and consent
Potential child/parent participants were initially contacted by dental practices. Prior to this, the research
team had identified potential child participants by their participant identification numbers and passed this
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information to their dental practice. The practices then sent a letter of invitation along with information
sheets about the study to the identified child–parent/guardian dyads, which invited them to take part in this
component of the FiCTION trial [see the project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/
074403/#/ (accessed 22 February 2019)]. Each potential dyad was also given an expression of interest form
[see the project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22
February 2019)]) with a stamped addressed envelope to be returned to the research team if they wanted to
take part in the study, or if they wanted more information before making a decision. If they expressed an
interest in being interviewed, they were contacted by telephone by the researcher to arrange a suitable time
and location for interview. Before the start of each interview, the researcher obtained written informed
consent from the parent/guardian for their child and themselves to be interviewed; oral or written assent
was also obtained from the child [see the project web page: www.journalslibrary.nihr.ac.uk/programmes/
hta/074403/#/ (accessed 22 February 2019)].
Procedure
Each child–parent/guardian dyad took part in one interview together. The interviews were conducted in
person and took place at each participant’s home or another convenient location. The interviews were
audio-recorded. To facilitate communication, the interactions with the children during the interviews
adopted participatory approaches [e.g. drawings, playing with Play-Doh dentist (Hasbro, Inc., Pawtucket,
RI, USA), Dentist Barbie (Mattel, Inc., Segundo, CA, USA) or other dental toys].108 A topic guide [see the
project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019)]
was developed from literature on the concept of acceptability and its operationalisation137 and through
discussions with the trial management group. The specific wording of questions was tailored to the
participants and the guides were deliberately kept flexible, allowing for the discussion of unanticipated issues.
Each participating child and each parent/guardian received a £10 Love2Shop gift voucher to thank them
for taking part. Children received an additional FiCTION trial-branded gift.
Data analysis
Audio-recordings of the interviews were transcribed verbatim by an external company. The data were
anonymised by the use of participant identifiers. The participant identifiers related to their geographical
location, the nature of the participant (C = child, P = parent) and their study numbers.
Framework analysis138 was employed, which is a matrix-based method for the analysis of cross-sectional
qualitative data. The analysis involved the following stages:
l identifying initial themes
l labelling the data
l sorting the data by theme
l synthesising the data.
To ensure the coherence of the analysis and interpretation of the data, several members of the research
team from different disciplines (paediatric dentistry, dental public health, trial methodology, psychology
and sociology) were involved in the analysis process.
Results
Data saturation was reached after 13 interviews had been conducted across Scotland and Yorkshire
between January 2017 and November 2017. The 13 child participants were aged from 5 to 11 years
and comprised eight girls and five boys; four of the participants were being managed in the C+P arm,
five in the B+P arm and four in the PA arm. These children had been treated by six dental teams and
treatment deviation forms had been completed for four of them. Three of the 13 parents were male
(see Appendix 6, Table 81).
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Summary
The two key themes of the acceptability of carious lesion management in primary teeth for children and
parents were, first, their experiences of specific procedures and, second, associated factors such as
anticipatory anxiety, perceptions of effectiveness (particularly whether or not the child was in pain) and
the impact on home or work life from attending dental appointments. These themes were underpinned by
the notion of trust in the dental professionals; this notion was pervasive, regardless of which treatment
approach was experienced.
Experiences of specific procedures
Overall, although there was some variation between dyads and between specific dental procedures
delivered by different dentists, the procedures delivered within all three arms were generally acceptable
to both children and parents.
Conventional arm
Children reported their dislike for specific dental procedures: a local anaesthetic injection, the placement
of PMCs and extractions. Parents echoed their children’s concern and raised an additional concern about
PMCs in a child’s mouth being a visible sign of inadequacies in their parenting practices. However,
overall, children found the procedures to be tolerable and they would be willing to undergo them again.
Their apparent acceptability appeared to stem from children’s underlying trust in the dentist.
For example, a 6-year-old boy reported his experiences of having an injection and compared the current
with the previously seen dentist (see Appendix 6, Table 81, for participant codes):
Not nice . . . Well, it was kind of nice . . . Because it was my third time coming. And then, I kept really,
really still. It didn’t hurt. It feels like I . . . my tooth, when I was brushing my tooth.
LC03: child, Yorkshire
It’s a bit painful when they do that, injection. That’s why he was a little bit scared. But he was fine.
I was very happy with everything.
LP03, parent, Yorkshire
She was, like doing it really roughly. Yeah, the first one. But this one, like, does it carefully.
LP03, parent, Yorkshire
She didn’t say anything about brushing my teeth.
LC03: child, Yorkshire
She didn’t have time. She’s only got, like, about 10, 15 minutes, just quick . . . more time here.
LP03, parent, Yorkshire
And she said, ‘Bye.’ She does that.
LC03: child, Yorkshire
The conventional treatment was described by some parents as the ‘traditional’ or ‘expected’ treatment
based on their own experience; they were not aware of other options:
I think it was the filling, the traditional filling . . . I didn’t realise there were other treatment options,
to be fair. I had to get a filling, it was a needle . . . and I expected it before I was told about any
other options.
SP05: parent, Scotland
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Parents had concerns regarding the aesthetic aspect of PMCs but felt that, if it was the best option,
it was justified:
Obviously, I’m to blame as the mum for the overall hygiene of his teeth. But you just felt like OK,
everyone would see how bad mum I am . . . But then I thought, you know, what– whatever is best
for you. That’s what I was going to do.
LP02: parent, Yorkshire
On the other hand, children were not concerned with the aesthetics of PMCs and were excited to show
them to others:
Like the whole class. And my next-door neighbour. And she’s got three . . . They said, ‘Oh, he’s got a
silver tooth. Did they pull it out and put it in?’ . . . I like it.
LC03: child, Yorkshire
Children also disliked having injections:
. . . OK until I found out I had to get a needle.
SC05: child, Scotland
Definitely when he numbs your teeth . . . Because it feels like your lips are about three-and-a-half
miles long.
LC08: child, Yorkshire
The more invasive nature of the conventional approach for managing carious primary teeth was viewed
negatively by some parents:
I wondered why they were gonna put her through that when this thing was going to fall out anyway
. . . why are you filling a tooth that’s gonna just fall out?
SP05: parent, Scotland
Parents’ past experiences affected their preferences and expectations of fillings and injections:
. . . when I was little, I was petrified because I had a bad experience. And obviously because my dentist
weren’t as good as what they got now, I ended up losing my teeth on bottom . . . once you have a
bad experience, it puts you off it a little bit.
LP08: parent, Yorkshire
Biological arm
Children and parents found the B+P arm acceptable and expressed the value they placed on avoiding
fillings and injections. As in the C+P arm, children reported their dislike of specific procedures, such as the
actual fitting of a PMC and removal of carious tissue, because of their potential for pain or discomfort.
Parents were concerned with the ‘unnatural’ aesthetics of a PMC and felt that they may make the child
feel self-conscious, although children were not concerned. The apparent acceptability of procedures was
linked with their trust in the dental professional.
For example, when an 8-year-old boy was asked if he was worried about having treatment in the future,
he replied:
No, because she doesn’t really hurt your teeth. She uses the tools pretty gently.
SC02: child, Scotland
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A dentist’s gentle manner towards the child resulted in the child trusting the dentist and limited any
concerns regarding future visits. Parents also spoke of the welcoming manner of the dental team:
She’s not frightened of the dentist at all. You go in and they’re lovely . . . They make you feel like
you’re at home.
LP06: parent, Yorkshire
Parents found the B+P arm acceptable particularly because it did not involve any drilling or injections:
Well, I felt good with this one.
LP04: parent, Yorkshire
I’m very glad she got this one . . . if someone came near her mouth with the drill, she wouldn’t be
happy at all. And I think we’d have had a lot more problems in getting her to sit down and keep
coming back.
LP05: parent, Yorkshire
It’s better that than a filling and drilling and injections.
SP01: parent, Scotland
Some children disliked the process of fitting the PMC because of the pressure applied when placing it or
its discomfort if it was the wrong size:
SC01: child, Scotland: Quite sore . . . He made sure it fit your tooth and then he put it on . . . It’s just
stinging when he tries to fit it on.
SP01: parent, Scotland: The first one, as I say, he did say this was the wrong size. She wouldn’t cry in
front him . . . she cried when she got out . . . She said it was sore.
SC01: child, Scotland: But I didn’t cry the second time.
SP01: parent, Scotland: No, the second time was fine.
Conversely, for other children, the removal of carious tissue was described as uncomfortable:
They’re, like, trying to clean it out . . . It hurt a bit and I also felt a bit weird . . .
LC06: child, Yorkshire
. . . she weren’t too keen on when they were cleaning her teeth, you know, the little metal thing that
they’re putting in. I think it was just the tugging and the noises she could hear and feel that put her
off a bit. But other than that, no she, we, were fine with everything.
LP06: parent, Yorkshire
The aesthetics of PMCs were a concern for some parents, whereas for others it was not:
It seemed sensible . . . don’t really care what the look of it is.
SP01: parent, Scotland
Slightly worried that with . . . all of her back teeth capped now . . . that, like, she’d notice, that other
children didn’t . . . But she’s been absolutely fine. She’s not bothered by it.
LP05: parent, Yorkshire
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A parent explained their preference for a more restorative approach over prevention alone, but had
reservations about the ‘unnatural’ appearance of PMCs:
I’d have been a bit iffy about probably leaving it and waiting and seeing, but I’m not quite sure [how]
I feel about the stainless steel thing, to be quite honest with you. I think I’d have preferred them to try
and fill it rather than . . . you say it looks more natural.
LP06: parent, Yorkshire
Prevention alone arm
The PA approach was viewed as preferable to having restorations and injections and some parents also
preferred it to having PMCs for the previously mentioned aesthetic reasons. Parents, however, voiced
concerns about the potential for further deterioration, resulting in pain and/or affecting the permanent
successor tooth. Trusting the dentist to make the right decision was apparently an important factor in
parents’ acceptability of this arm:
I’m all for that, provided it doesn’t cause any more damage . . . My two concerns were (a) . . . the
decay was going to cause more damage and, therefore, she’s going to get some pain from it. And the
second thing is whether it’s going to damage the adult teeth underneath . . . the fact I trust . . . She’s
very clear, she explains things very . . . and really takes the time both with [name] and me . . . And that
helps, I think, to make a decision.
LP01: parent, Yorkshire
Parents preferred avoiding fillings and found other aspects of this arm a positive experience:
Obviously, if he doesn’t have to get treatment then, we would rather it wasn’t . . . if he doesn’t need,
then I don’t want them doing it.
SP02: parent, Scotland
I’d say a lot of positive things has come out of it. There’s nothing negative, definitely something
positive. And it makes the children aware . . . what they’re eating and what they’re doing . . . I think
it’s been really helpful.
SP04: parent, Scotland
Parent’s preferences also appeared to be affected by their experiences:
I prefer the preventative, because I’ve had fillings and I didn’t like getting them at all. And that kind of
puts the fear in. So, if we can stop getting fillings, then we can stop the fear.
SP03: parent, Scotland
Parents in the PA arm preferred this approach as they wanted to avoid PMCs for aesthetic reasons,
although some children wanted one:
LP01: parent, Yorkshire: A silver cap on that tooth but we’ve, at the moment, decided not to.
LC01: child, Yorkshire: I want one.
LP01: parent, Yorkshire: She wants one, I’m not sure. I think it’s me that’s saying no. I just . . . well,
partly the aesthetics. I think having a piece of lump of silver in her mouth is not ideal at this age.
LC01: child, Yorkshire: It is.
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A PA route was acceptable as long as the carious teeth were pain-free; PA was seen as the less ‘radical’
or ‘significant’ method of treatment:
But none of the three are causing her any pain. I think that’s the key thing for me. So we’re trying
to do this thing with diet and brushing, with full-strength toothpaste and all that kind of things . . .
I think that it’s all down to pain. So that would obviously influence that decision.
LP01: parent, Yorkshire
If she’d have been having a lot of pain, I’d have thought differently and I think that have been more
something more radical to either get rid of it, take the tooth out or to have a filling or whatever,
so do something more significant rather than just the painting.
LP01: parent, Yorkshire
Parents also reported that, in addition to their child’s experience, they found the PA approach to be
beneficial to them as a parent in terms of ways to reduce sugar consumption and improve tooth-brushing.
In summary, all three of the trial arms were generally acceptable to children and parents and their views
about some of the arm-specific procedures involved were captured. A procedure that was common to the
three arms was radiographs (X-rays) and the following section describes the acceptability of radiographs.
Radiographs
Having radiographs (X-rays) taken was found to be acceptable to most children and parents; however,
some children and parents described it as uncomfortable:
. . . he seems nice and still and she finds no problem when taking them. It’s like one, count one and
that’s it.
LP02: parent, Yorkshire
Cool and I really liked it.
LC04: child, Yorkshire
It did not fit.
LC05: child, Yorkshire
Well, it’s . . . there’s this plastic bit that they put in and it kind of makes me gag a little and then I feel
like I won’t breath. The first time I gagged. The second time . . . and then the third time I was crying.
SC04: child, Scotland
A mother explained that the radiograph procedure was what made her daughter anxious about attending
the dentist:
She’s petrified because she went for that . . . an X-ray and they couldn’t get it because she was just
gagging on the thing. So now every time we go she’s petrified they’re going to ask for these X-rays
again and she’s . . . gets herself in a bit of a state . . .
SP04: parent, Scotland
Factors of importance when considering acceptability of treatment options
Anticipatory anxiety
Children and parents reported being anxious at the thought of certain procedures, such as drilling,
injections and extractions. Even in children with positive experiences, the thought of certain procedures
made them dislike attending.
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One 6-year-old girl had mixed feelings about attending the dentist:
LC05: child, Yorkshire: I don’t know. Sometimes I’m a bit grumpy and sometimes I’m really happy.
Interviewer: What makes you grumpy? What is it about coming to the dentist that makes
you grumpy?
LC05: child, Yorkshire: I don’t know.
Interviewer: No? Is there something that the dentist does that makes you a bit grumpy?
LC05: child, Yorkshire: Pulls my teeth out.
LP05: parent, Yorkshire: She’s never pulled your teeth out.
The reason for being ‘grumpy’ about visiting the dentist was the thought of the dentist extracting her
teeth, not any actual prior extraction experience. In general, however, children who had experienced tooth
extraction reported being worried about it.
Parents also reported anxiousness at the thought of certain procedures because of potential pain and
concern that the child would not co-operate:
I think I were more nervous at first then she were . . . It was just the thought of her having an injection
I thought ‘oh no it’s going to hurt’ . . . She’s not going to let them do it. But no, she were fine.
LP06: parent, Yorkshire
Despite anticipating their child’s non-co-operation, parents found that the dental team was able to
facilitate the child’s acceptance of the procedure. Parents also reported being concerned about their child’s
willingness to return for certain procedures:
And she’s playing with the drill but, like, if someone came near her mouth with the drill, she wouldn’t
be happy at all. And I think we’d have had a lot more problems in getting her to sit down and keep
coming back.
LP05: parent, Yorkshire
Impact on schooling, home life and work life
Attending regular appointments generally appeared to be manageable and did not significantly interfere
with a family’s routine:
Not really. We choose the earliest, quarter to nine. He’s only maybe half an hour late for school or so.
And work, I take half an hour off as well.
LP03: parent, Yorkshire
No, we’re trying to make it, like, on times where she’s off school so she won’t miss any school terms.
But she likes to miss it, but we’re trying to keep it . . .
LP04: parent, Yorkshire
Parents also mentioned the efforts of the dental practice in being flexible:
We were fine. They were ever so flexible. They sort of put on . . . so she never had to have no time off
school, it were always after school and that.
LP06: parent, Yorkshire
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Perceptions of effectiveness
Children and parents across all arms reported a positive impact on their children in terms of less pain and
improved oral health. Parents felt that it was important that, when their child was in pain, it was quickly
relieved and efforts were made to prevent repeat episodes:
Yes, it seems fine. And we have no complaints, no problems, no toothaches with it . . . she doesn’t
complain when she’s eating or anything anymore.
LP05: parent, Yorkshire
She was about 3 [years of age] when we came first to the dentist; I was very worried because, like, up
to 6 or 5 or 7 [years of age], they won’t fall out as well and I didn’t want her to be ill with these holes.
But nothing worries me now because it did improve and like it’s been repaired.
LP04: parent, Yorkshire
Parents reported an overall improvement in their children’s oral health, with changes in their oral health
behaviours including improved tooth-brushing and sugar reduction:
There’s a massive change in his teeth.
LP02: parent, Yorkshire
When the dentist says to her that she has to let us brush . . . she was saying ‘OK, you’re allowed to do
it’, just because of the dentist.
LP04: parent, Yorkshire
And about fizzy drinks, they’re all quite conscious about, they’ll go ‘Oh, [name] says but only as a
treat’. So they’re all . . . [name] does it in a nicest possible way, but in a way that they remember so.
And it’s good for them, especially as they’re getting older.
SP04: parent, Scotland
Some children also reported changes in their oral health behaviour and gaining oral health knowledge:
He’s taught me how to brush my teeth . . . I didn’t know.
LC07: child, Yorkshire
Less unhealthy food . . . fat . . . sugar . . . and fizzy juice . . . I’ve started to cut down on it.
SC05: child, Scotland
Trust
Trust was a significant factor in the acceptability of all treatment options. Continuity of care with the
same dentist appeared to be particularly important to allow trust to be built up. Child participants were
co-operative and less anxious when they trusted the dentist and child–parent dyads spoke about the
importance of their relationship with the dentist and how being able to trust the dentist resulted in a more
acceptable experience. Both children and parents spoke of listening, explaining procedures and being
gentle, caring and patient as being important characteristics in a dentist and described their positive
experience with the dentist:
LP08: parent, Yorkshire: Yeah, and he’s fantastic with him.
LC08: child, Yorkshire: He’s pretty good. He’s just good at giving advice and everything like that.
LP08: parent, Yorkshire: He’s caring isn’t he, as well?
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Parents appeared to go beyond viewing the acceptability of the treatment just in terms of effectiveness but
also in terms of the empathy the dentist had when caring for their child. The following parent described a
‘good’ dentist and a disliked previous dentist:
Shows concern . . . it helps if you’ve got a bit of time, ask them what they’re doing at school. It’s just
that he was a bit short with them . . . and they hadn’t a ton of patience.
LP07: parent, Yorkshire
Parents reported their child’s co-operation when receiving treatment as a result of the dentist’s approach;
the dentists’ ability to make children feel comfortable and less anxious was important for parents:
We’re very lucky because she really, really likes ‘the dentist’, don’t you? . . . She’s made you feel really,
really comfortable. Sometimes, even if when you’re feeling a bit nervous, she’ll still get in the chair
and at least let her look and things.
LP05: parent, Yorkshire
She’s very patient with [name], particularly with the children in helping her to understand. When she
first came she was very reluctant to even open her mouth.
LP01: parent, Yorkshire
Parents also appreciated a dentist’s engagement with them, allowing them the opportunity to support
their child while undergoing treatment:
[Name] explains everything really well. And, like, she’s very big on pull a chair up, hold her hand, have
a look at what we’re doing.
LP05: parent, Yorkshire
Continuity of care with the same dentist and regular visits was an important factor in allowing the dentist
to gain the trust of the child participant and parent:
It kind of made me feel a bit braver going there, because I used to be terrified going there and now
I feel a bit, like, more braver.
SC03: child, Scotland
It has made it a lot easier. He was quite well and happy going to the dentist before. But now he sort
of gets quite excited.
SP02: parent, Scotland
Parents who trusted the dentist were confident that their child was being well cared for and spoke of
their trust of their own personal dentists and related this to acceptability and trust of a child’s FiCTION
trial dentist:
Basically, I left everything to the dentist. He knows what he’s doing and he’s brilliant; he’d do
whatever he could and do his best in his power. So I trusted his decision and choices.
LP06: parent, Yorkshire
She knows what she’s doing and she takes care of my teeth . . . I mean, my teeth were a disgrace
when I went to her. And she’s fixed them all up and I’ll just go and say, ‘What do you think?’
And, kind of, whatever she says, I’ll go with it.
SP02: parent, Scotland
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Dental professionals
Aim and objectives
The aim was to explore the three treatment strategies with respect to the experiences of dentists and
dental practice team members (hereafter collectively referred to as ‘dental professionals’).
The objectives were to explore:
l the experiences of dental professionals providing the three treatment strategies and whether or not
their past use had an impact
l dental professionals’ perspectives on children’s and parent/guardians’ preferences between the three
treatment strategies
l how dental professionals’ experiences of the trial might shape future management of children with
carious lesions in primary teeth and identify any associated training needs.
Methods
Participants and sampling
Participants were dental professionals (comprising dentists, dental hygienists and therapists, practice managers
and dental nurses) selected from the list of all practices participating in the trial. A purposive sample was
drawn from across the trial sites, including Scotland, north-east England, Yorkshire and London. Participants
were identified by means of purposive maximum variation sampling using the variables of sex, the dental
professional’s role in the dental team, time since qualifying, the number of FiCTION trial child participants in
their practice, research experience, dental setting (community/public dental service or general dental practices)
and regional location. The sample included those who had recorded instances of having deviated from the
FiCTION trial clinical protocol for a variety of reasons, as these were cases of particular interest.
Recruitment and consent
Lead dentists in practices participating in the FiCTION trial were sent a letter inviting them to take part in
the qualitative component, which also included a detailed information sheet [see the project web page:
www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019)]. If they expressed
an interest in being interviewed, they were asked whether or not other practice team members might also
be willing to take part. A suitable time and location to hold the interview or focus group was organised,
prior to which written informed consent was obtained from all participants [see the project web page:
www.journalslibrary.nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019)]. Each participant
received a £30 Love2Shop gift voucher to thank him/her for taking part.
Interviews and focus groups
Participants were offered a choice of an individual interview or a focus group with other practice team
members. Participants completed a brief demographic questionnaire, which recorded time since qualifying
and research experience. Individual interviews were carried out either in person or by telephone whereas
focus group interviewing took place in dental practices. Interviews and focus groups were audio-recorded,
transcribed verbatim by an external company and the transcripts checked. Data were anonymised by the
use of study numbers.
The interviews and focus groups followed a topic guide [see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed 22 February 2019)], derived from the literature on
behaviour change,139 process evaluation,140,141 the implementation of research findings in clinical practice142,143
and discussions with the Trial Management Group. This enabled thorough exploration of the dentists’ and
dental team members’ perspectives on carrying out the three treatment strategies, their delivery in practice
and the contextual factors that influenced this. Finally, it aided identification of the barriers to and facilitators
of implementing the findings of the trial in clinical practice, as well as appropriate strategies for disseminating
and encouraging adoption of the findings. Specific wording of questions was tailored to participants and the
guide was flexible, allowing for the discussion of unanticipated issues.
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Data analysis
Interview transcripts were imported into the qualitative data analysis software NVivo (QSR International,
Warrington, UK) for coding and management. The data were analysed, using thematic framework
analysis138 guided by the theoretical framework described in the following section, by two members of
the research team, then discussed with the Trial Management Group as the analysis progressed.
Theoretical framework
To understand how dental professionals engaged with the treatment arms used in the FiCTION trial,
the theoretical framework of practice theory was used. Individual behaviour is routinely shaped by our
understanding of ‘knowing how to do’ a particular activity or ‘practice’. Practice theory144–146 seeks to
explain how human activities are organised across individuals, how the standards of such activities are
set and recognised and how these activities develop and change over time.
This report draws on the ‘deliberately slim-line version of practice theory’.147 This model consolidates what
are seen as the key aspects of social practices. A social practice is composed of three elements: (1) materials,
(2) competences and (3) meanings. These elements are described as:
l materials – including things, technologies, tangible physical entities and the stuff of which objects
are made
l competences – which encompasses skill, know-how and technique
l meanings – in which we include symbolic meanings, ideas and aspirations.147
The focus of practice theory is not on the individual but on changes over time in (1) how particular activities
are done, (2) the meanings that these activities have and (3) the non-human agents (such as technologies
and policies) that shape those activities. Practice theory has value to the FiCTION trial as it can engage with
the real-world ‘messiness of the clinical encounter’.148 Rather than focusing on individual choice, practice
theory pays attention to the ‘larger socio-cultural, economic and technical transitions that re-define
“normal” social patterns of activity’.149
Results
The FiCTION trial dental practice staff from the Scotland, Newcastle, Leeds/Sheffield and London CCs were
interviewed, either face-to-face or by telephone. Overall, 31 dental professionals were interviewed between
August 2016 and March 2017: 22 dentists (4 community-based and 18 GDPs), 2 dental therapists, 4 nurses
and 3 practice managers (see Appendix 6, Table 82).
Exploring experiences and their impact
Differences between trial arms are outlined by illustrating the themes that emerged from the interviews
and their comprising elements of materials, competences and meanings.
Managing carious lesions
As well as the activities involved in each treatment arm (removing carious tissue and filling teeth, sealing-in
decay and offering preventative treatment), participants also referred to an overarching activity of managing
carious lesions, referred to throughout this chapter. Applying the definition of an activity as ‘a recognisable
entity of interacting elements that can be spoken about’,147 this activity was referred to across interviews
and focus groups. The activity of managing carious lesions involved determining what was best for a
particular patient and selecting a suitable treatment option (see Appendix 6, Table 82, for participant codes):
The child dictates what you do. You are going to . . . there’s no point in having a fancy plan about
what you’re going to do with a child who can’t keep their mouth open or a child who’s frightened
of local [anaesthetic]. So . . . or child with ADHD [attention deficit hyperactivity disorder]. So, very
much the child will dictate what your treatment plan is.
D01: dentist, Scotland
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To perform the activity of managing carious lesions, dental professionals were willing to deviate from the
FiCTION trial clinical protocol at times:
It was the best . . . it was in the best interests of the child, needed a change. And I changed the plan
and that reverted back to being more of a prevention at that stage.
N09: dental therapist, North East
This often involved referring to interpersonal knowledge about the individual child, developed through
the dental professional–patient relationship over time, in particular regarding their ability to cope with the
treatment provided. On reflection, other dental professionals demonstrated some discomfort that they
were not able to do what they felt was ‘best’ for a patient:
It wasn’t so much about doing the treatment, but I’m just wondering whether or not we’re definitely
doing the right thing for that child.
D03: dentist, Scotland
As performing the activity of managing carious lesions involved competence in selecting the best treatment
option, being told what to do in each case could result in a dental professional feeling ‘guilty’ or finding it
‘difficult’ not to intervene, as a particular treatment option might not be the ‘right thing’ for an individual
child. For example, the C+P arm might not be the ‘right thing’ for a child who may have a problem
accepting local anaesthetic.
However, as this dentist acknowledges, the lack of definitive evidence on the best way to treat carious
lesions can also make it difficult to engage in the activity of selecting the ‘best’ approach for an individual
patient:
Well, you don’t know what’s best. And I think dentists are scared of saying that because then they
think that ‘Well, I’m looking as though I’m a bit thick and I don’t know what the treatment is,’
you know? Or, ‘I’ve been providing you with this, and now I’m telling you I don’t know’, you know,
‘I don’t know what’s best’.
S07: dentist, Yorkshire
Competence in selecting the ‘best’ treatment for each patient requires practical knowledgeability in the
sense of which activity is best under which circumstances for particular children. Conflicting evidence in
this area can make it difficult for dental professionals to confidently engage in this activity.
Conventional arm
Participants provided little detail about what was involved in delivering the C+P treatment, although it was
described as what they had ‘always’ or ‘generally’ done, or what they were doing ‘before’:
That conventional arm, that’s how we generally treat people anyway. So that’s no different to us.
S02: dental nurse, Yorkshire
They felt that this approach had a meaning in terms of what they were ‘supposed to do’ (i.e. was an
‘element’ referred to in practice theory), as opposed to the other arms:
So, that is a little bit of a difference to get your head around when you maybe see a cavity and you’re
not doing anything per se, you’re not picking up a drill, which kind of goes against all of the teaching
that you’ve had before.
N08: dental associate, North East
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The actions of delivering local anaesthetic, removing carious tissue and filling the tooth cavity are labelled
as ‘conventional’ in the trial, but are also regarded as ‘conventional’ by dental professionals (i.e. they have
a meaning of being ‘routine’). However, there were examples of participants questioning the effectiveness
of this approach:
Because I think parents already know, and perhaps dentists already know as well, it’s very, very
difficult to predict what’s going to happen to these baby teeth. And whether actually putting an
amalgam filling makes any difference whatsoever.
D02: dentist, Scotland
Removing carious tooth tissue and filling teeth are competences involved in this particular activity.
This dentist highlights that, as she is confident in this approach, it has the meaning to her of being
‘effective’:
I think, for me, because I’m accustomed to doing conventional fillings and I’m good at them,
they’re . . . to me it often still feels like a cop-out putting on a crown.
D01: dentist, Scotland
This is an example of the importance of considering the performance of a particular activity (e.g. the
activity of filling teeth). When a dental professional does not demonstrate the competences required, this
affects the meaning of the activity to patients and parents, and, thus, its perceived effectiveness.
Using local anaesthetic was another competence involved in this treatment arm (although some dental
professionals reported removing carious tooth tissue without using local anaesthetic):
I mean, if you can get away with doing local without the kids realising, which you can, if you got a
good parent. But if they [the parents] are saying, ‘Oh, they don’t want the needle. You’re not going to
give them the needle’. That’s when you get a problem.
S06: dentist, Yorkshire
The competence here is not just physically delivering local anaesthetic, but also persuading a child’s parent
that this is an appropriate treatment and gaining their co-operation.
Biological arm
Whereas removing decay and filling teeth was labelled and understood as ‘conventional’ (albeit seen as
‘ineffective’ in some cases), sealing decay into teeth had different meanings. First, the PMCs or Hall crowns
were viewed as a particularly effective option by some dental professionals:
So, the biological arm, you’ve done something. And you feel as well that you’ve probably treated it
the best way, so you have that at the back of your mind, you know.
N03: dentist, North East
In terms of the Hall crowns that we have placed in practice, they have lasted surprisingly well. And the
patients have been symptom-free.
N01: dentist, North East
The use of ‘surprisingly’ here indicates that the meaning of sealing decay into the tooth could be
contentious; importantly, there is scope for the meaning to change as activities evolve through repeated
performance. When participants had prior or routine experience of using B+P arm techniques, they were
generally positive about this minimally invasive approach. They understood that it required particular
competences that could be developed through training and that it was effective.
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Participants identified the importance of finding the right size of crown; this could be difficult and
time-consuming if they were not used to using PMCs and were unfamiliar with the PMC kit:
You have to get the right size. That’s the most important one, to get the right size. It’s hard because
children’s teeth, they are different shapes and they’re sometimes very strange shaped. So, it’s difficult
to find the right one. But once you got the right one, it’s easy.
LDN01: dentist, London
You’ve got to get the right crown for the right tooth and the box is set up quite awkwardly actually,
because it’s not right and left.
D04: dentist, Scotland
The materials involved here could be understood as ‘strange’ or ‘awkwardly’ set up, reinforcing the view
that this activity is not necessarily familiar to all the participants and supports ‘conventional’ activity as a
more established approach:
Historically, there weren’t that many people doing Hall crowns regularly in this area.
N06: dentist, North East
Nevertheless, the dental professionals demonstrated that increasing knowledge of different treatment
options affected their understanding, particularly in terms of effectiveness, and illustrated a potential for
their meanings to change over time. Ease of performance is central to the adoption of an activity.
Prevention alone arm
The dental professionals spoke about prevention activities as part of what they ‘normally’ did:
If they had a carious lesion, then we would apply fluoride varnish. We’d stress more and more about
the oral hygiene and about diet. We would get them in and out more often to see if they were
following our advice about fluoride and helping to arrest the caries early before it leads to any more
complicated treatment. So nothing really new.
D01: dentist, Scotland
As with performing the activity of removing carious tissue and filling teeth, preventative treatment also has
a meaning of being ‘conventional’, in the sense of being routine. However, being in the FiCTION trial
involved giving more preventative advice than usual:
I do find that outside of FiCTION, we try to deliver some of that advice. But there’s a lot of advice to
deliver there . . . Certainly, at the moment, I feel that, sort of, I can give that time to my FiCTION
patients. But outside of FiCTION, they get some of that advice, but perhaps not as much as I’d like.
N01: dentist, North East
This may indicate that, outside the FiCTION trial, providing preventative advice is affected by the financial
context of NHS remuneration. Alternatively, the additional element of specifically recording the prevention
given, required in the FiCTION trial processes, may have impacted the performance of this activity.
Nevertheless, although prevention is something ‘we do all the time’ (D04: dentist, Scotland), several
participants suggested that the PA arm was insufficient:
I think the prevention alone has been quite difficult. Especially when you know there’s a cavity and the
parent knows there’s a cavity and they’ve sometimes found it quite difficult leaving that cavity and so
have I. On several occasions that there’s been a few where I’ve had to just say, ‘This is getting worse,
we need to intervene.’
D05: dentist, Scotland
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I think we’d get accused of leaving cavities to progress if we went on the prevention arm.
S06: dentist, Yorkshire
As this second quotation shows, this idea of using prevention on its own as ‘doing nothing’ was a shared
meaning, and dental professionals explained that parents could be unsatisfied and that other health
professionals, such as hospital doctors, could accuse them of ‘supervised neglect’ (S05: dentist, Yorkshire).
Participants questioned the effectiveness of not intervening, as preventative treatments, such as applying
fluoride varnish or fissure sealant, were not seen as ‘interventions’.
Not having a preference
Dental professionals did not necessarily express ‘preferences’ for certain treatments, although some favoured
treatments that they were familiar with prior to the FiCTION trial. Participants also referred explicitly to not
having a ‘favourite’ treatment option or explained how all three options were useful in different circumstances.
This may be because the dental professionals knew the importance of maintaining clinical equipoise, and
therefore recognised that the language of ‘preferences’ would be inappropriate in a clinical trial context.
Returning to the activity of ‘managing carious lesions’, the data showed that dental professionals would
appreciate having a choice, with the options seen as part of a toolbox at their disposal depending on a
patient’s needs:
I would prefer to have the range . . . the whole range at my fingertips.
D01: dentist, Scotland
Dental professionals’ perspectives on children’s and parents’/guardians’ preferences
Conventional arm
Some dental professionals reported that parents and children expected fillings; as well as being ‘conventional’
for the dental professional, this approach was ‘conventional’ or ‘normal’ for patients:
The parents that I’m thinking of are expecting, on a whole, that they’re going to come in and they are
going to have a filling if there was a problem.
N07: former practice owner, north-east
In relation to this, dental professionals reported that some parents were concerned about the PA arm
because it went against these expectations, whereas other parents did not want any interventions:
Well, the parents don’t really want their children to have any interventive [sic] treatment. They don’t
mind maybe a Hall crown being fitted and so on, they don’t like the look of them, but they don’t really
want the children to get a jag [sic] and get an amalgam filling. The parents are a bit against that.
D02: dentist, Scotland
This is similar to the meaning of offering only preventative treatment as ‘not intervening’. As with the
example of D02, a key issue here was with local anaesthetic:
I do remember deviating once from conventional to biological just because the mother didn’t want her
to be numbed up.
N02: dentist, North East
And a lot of parents have come in and said ‘can you take this tooth out or, you know, do a filling
but I don’t want my little boy getting freezed [sic] because I had it and I had a bad experience when
I was 15’.
D05: dentist, Scotland
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These negative associations linked to local anaesthetic reflect a meaning of ‘unpleasant experience for
the child’, also indicated by dental professionals who reported discomfort with performing this activity.
The appearance of fillings was also a consideration:
You know you’ll get . . . a mother that comes in with a child with a gaping hole in the lower sets.
And they don’t want you to put amalgam in it. ‘Can he not get a white filling?’, you know? And it’s
just that’s the way people are. I suppose function’s not necessarily their first option, you know, their
first priority.
G01: dentist, Scotland
As with the materials, local anaesthetic, needles and amalgam fillings had negative connotations, being
understood as a visible sign of previous decay that could also be associated with poor oral health in a family.
Biological arm
The B+P arm was seen by dental professionals as generally popular with parents:
I’d say 99% of the patients would normally . . . do choose a biological . . . with their choice and me
explaining the advantages and disadvantages.
N03: dentist, North East
However, the meaning of the B+P arm seemed to differ between dental professionals and they highlighted
parents’ objections to the PMCs on aesthetic grounds:
They didn’t want a metal tooth. And that was the only reason. It had nothing to do with it that it was
better for them or not or whatever, they didn’t want their child to have that.
S02: dental nurse, Yorkshire
In one case, a dental professional explicitly associated this with parents’ economic situation:
Actually, demographic side, the area that I work in is a more deprived area; there’s more children with
the crowns on and the parents are less concerned about it. I don’t know if you were to go to a more
affluent area of the city and say to a parent there, maybe where the children had one hole or two
holes, like ‘you’re going to need this’ . . . I think you may find a lot more resistance to their use.
D03: dentist, Scotland
In other situations, familiarity with crowns among a child’s peer group [where a crown is referred to as a
‘silver hat’, for example (N09: dental therapist, north-east)] could make them a more acceptable option:
They’re pretty acceptant of the crowns and they’re aware of them and could end up . . . that could be
. . . it doesn’t come as a big surprise.
N11: dental therapist, north-east
The meanings associated with the material involved (the PMCs itself) affected how sealing-in decay was
interpreted; nevertheless, parents were thought to recognise the benefits of the biological approach:
I think if you try and explain the benefits of the crown and . . . I guess it’s how you spin it a little bit,
how you sell it to them, how the uptake is going to be. And I guess if you try to sell it that this is
going to be the best for their child, most people have been fine in the end.
N01: dentist, north-east
Here, what is important is that the minimally invasive biological approach of sealing-in decay has the
meaning of being effective. The selection of the PMC as a treatment option involves the dental professional
determining an appropriate treatment for an individual child, and thus managing carious lesions.
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The language used here, around ‘explaining’ and ‘selling’ an option, points to the influence dental
professionals have in shaping how parents interpret a particular treatment through conveying meaning.
The use of GIC was also mentioned as a parental preference by dental professionals:
I’d say 90% of the people would choose just to place GIC in the cavity and see what happens and
review it. I think that, for them, they’re looking for the easiest option, and sort of most painless option
for the child to get a dental check, get some sort of treatment done. And then, feel that something’s
been done.
N03: dentist, north-east
He identifies that, to a parent, sealing-in decay means ‘lack of pain’ and ‘doing something’ (as opposed to
providing preventative treatment alone, which was understood by some parents and dental professionals
as ‘doing nothing’).
Although the B+P arm did not have the meaning of being ‘conventional’ in the sense of being ‘routine’
(apart from in a few dental practices), if this approach was understood as ‘effective’ then this meaning
could be conveyed to patients:
This is a misconception with patients who have metal crowns. We talk to the parent, say it’s OK and
this is recognised that it’s actually better for your child, we think they wouldn’t have any issues.
S07: dentist, Yorkshire
Parents were less familiar with the activity of sealing-in caries than other treatment options. Nevertheless,
when considering the interaction between elements discussed in practice theory, these interviews indicated
that the material of PMCs could become associated with the meaning of being ‘effective’ as familiarity
increases.
Prevention alone arm
Dental professionals found that parents questioned the effectiveness of using prevention on its own:
When they have this prevention only, they’re a bit, like, cautious and a bit, like, not sure whether it
would work.
LDN01: dentist, London
I think the ones that we’re saying that we won’t be filling the teeth, we’ll just be keeping them clean,
I think they do have a number of questions, saying, ‘Is this safe? Are they going to get worse?’
They ask those questions.
N06: dentist, north-east
This reflected an expectation that the dental professional should ‘do something’:
There’s probably an expectation on the parents that some sort of active treatment is provided for the
patient, some sort of restorative treatment.
N01: dentist, north-east
Furthermore, the prospect that a dental professional could ‘do nothing’ could put parents off participating
in the FiCTION trial:
I did have some parents decline going on the trial because they didn’t like the idea that I wasn’t doing
anything if they went on the prevention arm, even though we were doing something, they just
perceived it as I wasn’t doing anything.
D04: dentist, Scotland
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In these accounts, the materials involved in the C+P and B+P arms are recognised by parents as acceptable
restorative treatments, whereas ‘just keeping teeth clean’ is viewed as insufficient. Nevertheless, another
recognised meaning associated with the provision of prevention was positively framed as ‘not intervening’
and mentioned as particularly preferable for the children themselves:
The patients like it and the parents like it because basically the way you put it to them is, ‘You know
we’re really trying to hang on to these teeth for as long as possible without you having to get fillings
for teeth’. So, they love it.
G01: dentist, Scotland
A key issue here was that preventative treatment was seen as the preferred option ‘when it works’.
However, dental professionals questioned whether or not the PA arm was sufficient; therefore, it is
important to recognise that the perceived effectiveness of this activity was conditional.
Trusting the dental professionals
Participants highlighted the importance of parents trusting dental professionals to decide what was best
for their child:
But the parents tend to be . . . if they’re prepared to take part they tend to be pretty trusting and
they just . . . they just know we’ll do the best for their children and go with the flow.
D01: dentist, Scotland
Getting to know the staff at a particular practice location was also important to build up trust; participants
spoke about ‘familiarity’ and ‘continuity’. As already shown by the parents, the dental professionals
recognised the importance of being seen to be engaged in an activity of managing carious lesions, which
involved displaying the competence of being able to select an appropriate treatment, and which meant
that they were acting in the best interests of the patient. Nevertheless, as described earlier, parents were
prepared to question dental professionals’ decisions.
Dental professionals’ views on how experiences of the trial may shape
their future management of children with carious lesions and any associated
training needs
Conventional arm
Some dental professionals spoke about preferring to avoid conventional methods in the future and other
dental professionals described how they would be ‘surprised’ or ‘astounded’ if the FiCTION trial was to
recommend the C+P arm. Other dental professionals had a less extreme response, although they did
want to reduce local anaesthetic use in future. Nevertheless, conventional treatments were seen to have
their place, for example, for small lesions or to satisfy parents who dislike the appearance of stainless
steel crowns.
Although participants spoke about moving away from the ‘conventional’ activities of delivering local
anaesthetic, removing carious tissue and filling teeth, it was recognised that the meaning of this approach
as ‘conventional’ made this difficult:
I’m still filling children’s teeth. That’s what I was trained to do and it’s very hard to get out of a rut,
isn’t it?
D04: dentist, Scotland
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Biological arm
Participants seemed willing to move towards minimally invasive biological treatments, rather than
necessarily providing fillings and described how the meaning of sealing-in decay had changed:
It might be a bit more towards using a biological approach. Because it does take time when you have
to talk a patient through having LA [local anaesthetic] or, you know. I think probably it’s a lot quicker
to be able to manage things biologically.
S04: community dental officer, Yorkshire
I don’t feel I’m cheating now if I put on a PMC. You know, before I would have tended to think ‘well,
in most cases you should either be doing an extraction or you should be doing a conventional filling’.
So I think . . . I think I probably will feel less guilty about doing a PMC.
D01: dentist, Scotland
The idea that performing a particular activity is ‘cheating’ reflects the idea of not doing what one is
‘supposed to’. However, dental professionals were generally positive about non-conventional options if
they had been trained in these, understood them to be ‘effective’ and displayed the relevant competences.
Nevertheless, when dental professionals did not feel confident about the techniques involved, their
responses suggested that the ‘unfamiliarity’ of the activity of sealing decay into crowns could put them off
engaging in this carious lesion management option.
The following dentist had previously said that she would probably use crowns more often, being more
‘aware’ about available options, but the second comment shows that, although this was a choice she
wanted to make, the competence required made this less probable than continuing with a ‘conventional’
approach. Furthermore, the expense involved was also a relevant factor:
Because I’m still not confident so much in Hall crowns. I would like to think I would do them. But I
know that it just takes so much longer, and the expense of them. There’s a huge difference between
doing a filling on a child.
N02: dentist, north-east
In the B+P arm, it was recognised that knowing when to use a PMC and when to use GIC was also a
competence. Furthermore, it was important for practices to invest in the required materials and to seek
training.
Dental professionals suggested a need to display confidence in the competences required in the B+P arm.
Providing training to develop the selection and fitting skills for PMCs would allow more dental
professionals to engage in this activity.
Prevention alone arm
Planning to engage in the activity of providing prevention on its own in the future was highlighted:
I mean, I’m more swayed by the preventive arm. Personally, I think it’s all about prevention, oral
hygiene and dietary instruction.
N01: dentist, north-east
Nevertheless, prevention alone was still seen as being potentially ‘insufficient’, and some dental
professionals spoke about planning to combine prevention alone with B+P treatment options:
And I would’ve said that, in terms of cost efficiency, the preventive way is probably the best. [. . .] And
then if you have to do a glass ionomer to prevent food trapping or a Hall crown or something like that.
G01: dentist, Scotland
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Prevention alone was also seen as a last resort option when a patient rejected other treatments.
The trial had encouraged several dental professionals to reflect on their approach to managing carious
lesions. They commented that taking part in the FiCTION trial had resulted in increased knowledge and
altered the meanings associated with particular treatment options, referring to having to ‘think’ about
what they are doing, and avoiding acting in a routinised way.
When asked a hypothetical question about what the results of the trial might show, dental professionals
spoke about being willing to accept the results, but also recognised that changing one’s approach might
be a lengthy process. Participants spoke about the value of ‘evidence’, and their responses indicate that a
trial such as FiCTION can alter the meanings of particular activities and, thus, how these are performed.
Nevertheless, it is important to recognise that experiential knowledge, both one’s own and those of
colleagues, was also valued:
But that’s when people start to accept things, because it’s not just the . . . it is important to get evidence,
but it’s the word of mouth of people’s experiences.
N11: dental therapist, north-east
Several dental professionals emphasised their intention to carry on acting in the best interests of the
patient when managing carious lesions in routine dental practice (i.e. selecting a suitable treatment for the
individual patient):
The whole purpose of evidence-based, in my understanding, is that it’s not just based on scientific
research, it’s in consultation with the patient and clinical expertise as well. So, I think, you know,
combining more together, you’ll get an individual plan for the patient provided you can justify what
you’re doing.
S07: dentist, Yorkshire
Similarly, other dental professionals suggested that the results of the trial would not be definitive;
therefore, it would be important to continue to draw on experiential and interpersonal knowledge to
manage carious lesions and work in the best interests of the patient:
But I don’t think we’ll get anything as definitive as that so we will carry on, I would think, looking at
each child individually [. . .] And giving treatment that best works for them.
D01: dentist, Scotland
Financial context
When considering how they would treat carious lesions in the future, several dental professionals
commented on the financial context in which they operated and raised concerns about the UDA-based
contract that operates in England and Wales, with UDAs allocated per course of treatment rather than
per item of treatment provided. The value of a UDA varies between dental practices. The time involved in
fitting a PMC, particularly when this was unfamiliar, meant this was not the best choice financially:
I feel if stainless steel crowns were . . . if dentists were given more money, paid higher UDAs, I think
that would maybe change the decision, maybe. If dentists are struggling with something, trying to
put stainless steel crowns, and they will revert some of that in what they’re more comfortable doing.
And then, if you’re getting paid the same amount of money, then, I think the dentist . . . that will
sway the decision that you’re going to make.
N03: dentist, north-east
The requirement to purchase PMCs made this a more expensive option, and a problem if dental practices
were paid the same for sealing-in decay using crowns as for filling teeth in the ‘conventional’ approach.
Receiving a fee-per-item in Scotland made PMCs a better option financially for dental practices.
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It was also suggested that providing preventative treatment alone could look like ‘profiteering’ under the
UDA system, as parents might question a treatment option that involves applying a small amount of
fluoride every 3 months. However, other dental professionals suggested they were not paid sufficiently for
all preventative interventions when paid a fee per item:
I mean, I don’t think you make any, I can’t think of how you would make any money doing [prevention].
E01: dentist, Scotland
Nevertheless, some dental professionals emphasised that they would provide preventative treatments anyway:
. . . wanting to do the right thing for your patient.
D02: dentist, Scotland
The co-existence of different activities that may lead to conflict for individual dental professionals and
the dental practice was clear. Overall, these comments illustrate how material aspects of different
activities (including the objects used and the underlying infrastructure) can sometimes undermine dental
professionals’ ability to perform the activity of selecting the most appropriate treatment.
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Chapter 6 Discussion and conclusions
Summary of findings
Trial findings
The FiCTION RCT compared three treatment approaches to the management of carious lesions involving
dentine in the primary teeth of children aged 3–7 years and has shown that over a median follow-up
period of 33.8 (IQR 23.8–36.7) months, there was no evidence of a difference between the arms for the
co-primary outcomes of (1) the proportion of children with at least one episode (incidence) and (2) the
number of episodes of dental pain or dental sepsis or both.
Overall, 43% of the 1058 children in the ITT analysis set experienced at least one episode of dental pain
and/or dental sepsis over a 3-year period (dental pain ever, 36%; dental sepsis ever, 25%).
For incidence, there was no evidence of a difference between arms. Comparing B+P arm children with
those in the C+P arm, the risk difference was –0.02 (97.5% CI –0.10 to 0.06; 2% less pain/sepsis for
B+P arm); comparing PA arm children with those in the C+P arm, the risk difference was 0.04 (97.5% CI
–0.04 to 0.12; 4% less pain/sepsis for C+P arm).
For number of episodes, there was no evidence of a difference between arms. Comparing the B+P and
C+P arms, the IRR was 0.95 (97.5% CI 0.75 to 1.21) (slightly fewer for the B+P arm); comparing the PA
and C+P arms, the IRR was 1.18 (97.5% CI 0.94 to 1.48) (slightly more for the PA arm).
A similar pattern, but with less marked observed differences, was noted in the pre-planned PP analysis,
which excluded children with treatment deviations on > 20% of visits from the analysis.
Child oral health-related quality of life remained high (median P-CPQ-16 score was 5–7) throughout the
trial and MCDASf had a median score of 14–15, representing low to moderate dental anxiety. There was
no evidence of a difference in the child OHRQoL or dental anxiety measures between treatment arms at the
end of the trial and no evidence that they changed over the period of the trial. However, parent-reported
child anticipatory anxiety was, on average, 6% lower in the PA arm than in the C+P arm (risk difference
–0.06, 97.5% CI –0.11 to –0.003).
Caries development or progression throughout the trial was considered for teeth that were entirely sound
or had non-cavitated carious lesions restricted to enamel at baseline, hereafter referred to as ‘sound/reversible’.
This analysis was on a subset of the ITT analysis set (61.7% of the 1058 ITT participants included) and so
must be treated with caution. Overall, 399 out of 653 (61.1%) of the participants with complete ICDAS
data exhibited development or progression of a carious lesion in one or more primary teeth (C+P: 57.9%,
B+P: 61.6% and PA: 64.1%). There was no statistical evidence of a difference in carious lesion development/
progression in primary teeth. Comparing the B+P arm with the C+P arm, the risk difference was 0.03 (97.5% CI
–0.06 to 0.11). Comparing the PA arm with the C+P arm, the risk difference was, on average, 5% higher
in the PA arm: risk difference 0.05 (97.5% CI –0.03 to 0.14). Of the 399 participants with development/
progression of caries, 69% had one (42%) or two (28%) teeth that were ‘sound/reversible’ at baseline,
but in which dental caries developed or progressed [mean 1.3 (SD 1.4) teeth per child], and the distribution
between arms was similar. There was no statistical evidence of a difference in carious lesion development/
progression in FPMs between the three arms.
Findings from the economic evaluation
In terms of cost-effectiveness, the PA arm was, on average, the least costly treatment but the least
effective for both of the co-primary outcomes. This means that if society is not willing to pay to avoid
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dental pain and/or dental sepsis, then PA would have the highest probability of being considered cost-effective
compared with B+P and C+P for both of the co-primary outcomes. The other two treatment strategies would,
on average, provide more benefits, albeit at higher cost. A judgement is required as to what value the NHS
places on avoiding dental pain and/or dental sepsis, as B+P is, on average, more costly and more effective than
PA and dominates C+P. Should the WTP to avoid an episode of dental pain and/or dental sepsis be ≥ £130,
then B+P would have the highest probability (49%) of being considered cost-effective compared with PA
(45%) and C+P (6%). As this WTP threshold increases, so does the probability of B+P being considered
cost-effective. A WTP threshold of approximately £330 per incidence of dental pain and/or dental sepsis
avoided would be needed for B+P to be considered the most cost-effective treatment strategy to avoid an
incidence of dental pain and/or dental sepsis.
Fee-for-service and UDA analyses represent the current methods of reimbursement for NHS treatments in
Scotland, England and Wales. Three variants of the analysis were completed: one using FFS data only, one
using UDA data only and a combined analysis in which FFS and UDA data were both used (an individual
participant would have either a FFS cost or a UDA cost but not both).
For these analyses, the average total cost per arm was higher than the corresponding average total costs
that were estimated in the microcosting analysis. This was to be expected, as the FFS and UDA analyses
account for additional overheads and capital costs that were excluded from the microcosting analysis.
The impact of this is that the difference in average total costs between B+P and C+P was smaller in the FFS
and UDA analyses than in the base-case analysis (which was based on the microcosting). This was
expected for the UDA analysis, given that the operative treatments provided in both the B+P and the C+P
arms are reimbursed at a rate of 3 UDAs per treatment episode. In the FFS analyses C+P was, on average,
less costly than B+P because the reimbursement of a filling (used in C+P) is less than the reimbursement of
a crown (used in B+P). Overall, analyses based on FFS and UDAs result in similar conclusions being drawn:
PA has the highest probability of being considered cost-effective if we are not willing to pay to avoid an
episode or an incidence of dental pain and/or dental sepsis. However, unlike the base-case analyses (which
used the microcosting data), PA continues to have the highest probability of being considered cost-
effective compared with B+P and C+P at higher WTP thresholds to avoid an episode or incidence of dental
pain and/or dental sepsis. For example, at a WTP threshold of £130 to avoid an episode of dental pain
and/or dental sepsis, PA has the highest probability of being considered cost-effective compared with B+P
and C+P in the FFS (72% vs. 17% vs. 11%, respectively), UDA (99% vs. < 1% vs. < 1%, respectively) and
FFS and UDA (99% vs. < 1% vs. < 1%, respectively) analyses. At a WTP threshold of £330 to avoid an
incidence of dental pain and/or dental sepsis, PA has the highest probability of being considered cost-effective
compared with B+P and C+P in the FFS (84% vs. 6% vs. 10%, respectively), UDA (97% vs. 2% vs. 1%,
respectively) and FFS and UDA (99% vs. < 1% vs. < 1%, respectively) analyses. This could lead to incentive
incompatibility in that practices could be driven to provide a treatment (i.e. PA) that, when costs are considered
rather than fees, might be viewed as inefficient. Further work is needed to understand the implications of this
and how dental practices might change practice as reimbursement policies change.
Findings from the qualitative study
The qualitative interviews with child–parent dyads indicated that each treatment arm was felt to be
generally acceptable to children and parents, but trust in the dental professional played a significant role.
Certain procedures, including local anaesthetic and extractions, were more likely to be viewed negatively.
Other factors identified by children and parents were anticipatory anxiety, perceptions of effectiveness and
the impact on home or work life from attending dental appointments. Children and parents had similar
perspectives on most aspects of the management of carious tooth tissues, except with respect to PMCs:
some parents were concerned about the aesthetics of PMCs, but children did not share this view.
The qualitative interviews with dental professionals illustrated how managing carious lesions was a
recognised activity, involving the competence of selecting the most appropriate treatment option to act in
the best interests of the child patient. Being a dental professional involves drawing on experiential and
interpersonal knowledge, as well as research-based evidence. Participants indicated that parents/guardians
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shared this understanding, trusting dental professionals to treat each child in the ‘best’ way possible.
This understanding of dentistry and the activity of managing carious lesions meant that some dental
professionals deviated from the allocated trial arm to treat a particular patient in a way other than that
to which the child had been randomised. Such treatment deviations indicate the importance to dental
professionals of being able to select the most appropriate treatment option; when they continued with
a treatment that they felt was less than ideal, they described this as a ‘difficult’ and an ‘uncomfortable’
experience. The interviews with dental professionals also revealed that treatment options were assessed in
terms of perceived effectiveness. Although delivering local anaesthetic, removing carious tissue and filling
tooth cavities were understood as elements comprising the ‘conventional’ activity of treating carious
lesions, dental professionals familiar with minimally invasive biological methods of sealing-in decay spoke
about this as more effective, particularly in terms of the negative connotations of local anaesthetic with
the traditional ‘drill-and-fill’ approach. Nonetheless, it was recognised that, as an unfamiliar activity, the
materials involved in the biological method could be ‘strange’ and dental professionals needed to develop
the competencies of selecting the right crown and judging when to use a crown and when to use adhesive
restorative material. Providing preventative treatment was viewed positively (and was also ‘routine’) but
this was often seen as an activity that needed to be combined with other treatments, otherwise it could
be ‘insufficient’.
Dental professionals reflected on how parents and children viewed different treatment options: fillings were
‘expected’, but local anaesthetic could be problematic for many children; crowns were initially viewed
with suspicion but understood as beneficial when the process was fully explained; and providing only
preventative treatment was often questioned and seen as ‘doing nothing’. Nevertheless, dental professionals
reported that parents had other concerns, particularly around the aesthetic aspects of different treatment
options. Children were also seen to prefer no intervention if possible; therefore, providing preventative
treatment could have positive meanings if this involved avoiding unpleasant experiences. Participants also
commented on how they planned to engage in different activities of treating carious lesions in the future.
The data revealed some movement towards minimally invasive biological treatments and away from
conventional methods; this was also reflected in the numbers and directions of the reported treatment
deviations. Nevertheless, it was recognised that it might be difficult to change one’s habitual way of treating
carious lesions. It was also clear that dental professionals expected to continue to use a range of different
treatment options to manage carious lesions. Although some dental professionals spoke about accepting
the results of the trial (should one management strategy be proven to be the best), it was also suggested
that dental professionals should continue to have a choice in how they treat patients. The qualitative data
indicate that, although the results of the FiCTION trial will form part of their knowledge base, dental
professionals will also continue to draw on what they know about an individual patient and their own
clinical experience to manage carious lesions.
Strengths and limitations
Overview
The size of the FiCTION trial is a huge strength with 1144 children recruited across 72 general dental
practices in three countries; therefore, the trial is thoroughly embedded in the environment where this
research question is most pertinent. The trial has collected a vast number of important data from different
perspectives (dental professionals and their teams, children and parents) and using different methods
(quantitative and qualitative). To our knowledge, no other RCT of this size has been undertaken in this
area of dental care and no RCTs have taken the pragmatic approach adopted in the FiCTION trial, with a
child (as opposed to a tooth) forming the basis of the assessment level. Efforts were made to recruit a
random and representative sample of practices and to also recruit dentists in clinical equipoise in each of
our chosen areas.86
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The pragmatic approach taken, observing what dental professionals did for patients in each of the arms
when requested to follow carious lesion management protocols, is akin to establishing what might happen
if guidance or policy were put in place to direct clinical practice towards managing carious lesions in
primary teeth using one particular approach.
Strengths
The sample of children who participated in the RCT was balanced across groups. At baseline, there was
balance between arms in terms of age [mean age 5.96 (SD 1.3) years], sex (51% female), ethnicity
(76% white) and d3mft [2.72 (SD 2.66)], including the amount of untreated decay (d3) [2.04 (SD 2.15)].
There was also balance across the arms in respect of fluoridation status and index of multiple deprivation,
although these variables were captured only at dental practice level. Overall, 67% of the ITT participants
attended a final visit and the median follow-up period was 33.8 (IQR 23.8–36.7) months, also balanced
across the three arms, with no evidence of differential attrition across the arms. This balance confirms
our confidence in the randomisation process, and the baseline participant characteristics demonstrate the
representativeness of the participants as typical high-risk child dental patients attending dental practices
with untreated decay. This aspect of the trial is discussed further in Generalisability.
Although the rate of recruitment was relatively slow and a time-only extension was required, the FiCTION
trial exceeded its revised target sample size of 1113 participants, and 1058 out of 1144 (92%) children
randomised attended at least one trial visit and were included in the ITT analysis set. Allowing for 25%
attrition, the revised effective sample size was to retain 834 children who were followed up to their
maximum potential of between 23 and 36 months. The FiCTION trial was able to follow up 797 out of
1144 (70%) participants for over 23 months and maximised the utility of the data collected by including
in the analyses all data available for each of the 1058 children in the ITT analysis set, regardless of time in
the study. The trial was adequately powered to detect the clinically meaningful differences between the
arms in the incidence of dental pain and/or dental sepsis, hypothesised at the design stage. However,
the estimated level of dental pain and/or dental sepsis was higher than had been anticipated at the design
stage; the consequence of this was that the associated CIs were also wider.
A further strength of the trial was the simultaneous evaluation of clinical effectiveness and cost-effectiveness
of the three treatment approaches. The economic evaluation was based on extensive data collection
undertaken in the RCT. In particular, the different costing approaches adopted allowed us to estimate the
cost-effectiveness using both the ‘true’ cost and the NHS reimbursement rates for each of the treatments.
The economic results allow us to draw out the implications of the trial findings on policy and practice.
The inclusion of the qualitative study component also added much value to the trial, in addition to
providing data for two secondary objectives: first, an understanding of the acceptability and associated
experiences of the three treatment strategies for child participants and parents/guardians; and, second,
an understanding of dentists’ and dental practice team members’ preferences between the three treatment
strategies. The latter, combined with information from the CRFs and TDFs, provided a detailed insight into
GDPs’ ability and willingness to deliver the three treatment strategies. By explaining patients’ and health-care
professionals’ perceptions of the interventions, the qualitative study also helped the interpretation of findings150,
while also providing some insight into how the three treatment strategies were delivered in practice.
In the qualitative component, we aimed to follow best practice. In research with children, efforts are
required to minimise the power imbalance that exists between the researcher and the child. During the
interviews with children, efforts were made to reduce the power imbalance by ensuring that interviews
took place where children were comfortable, using participatory activities and emphasising that children
could stop the interview at any time.108 The study was designed with input from the multidisciplinary Trial
Management Group; the interviews were conducted by experienced qualitative interviewers, including two
research associates (non-dental) and one clinical academic. The interviewers were experienced at assessing
signs of distress or boredom in participants, but none was observed. Most of the interviews were
conducted in children’s own homes, with steps taken to ensure interviewer safety. The analysis was
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conducted by several members of the team from different disciplines, with two researchers (one dentally
qualified) independently identifying initial themes before discussing these with the wider team. The
qualitative work with dental professionals was designed by the Trial Management Group with further
support from a sociologist experienced in the use of practice theory. The decision to use practice theory to
guide the analysis was driven by the data themselves. The interviews were conducted by three experienced
qualitative researchers, two of whom were clinical dental academics, to enable the more technical aspects
of the dental treatment to be explored while also ensuring the broader sociocultural and economic aspects
were not ignored. The analysis was initially conducted independently by two members of the team (one
dentally qualified), with ongoing discussions with the Trial Management Group and undertaken before the
results of the primary and secondary outcomes were revealed to the lead for the qualitative component.
Limitations
The trial experienced challenges throughout its course, some of which were anticipated and others that could
not have been predicted. These resulted in some limitations, as discussed below and inMethodological
rigour.
Recruitment and retention of participants in RCTs is recognised as a significant challenge,151,152 especially
among young children and in a relatively research-naive environment such as NHS primary dental care
services. The slower than predicted recruitment rate affected the length of time a practice was involved
in the trial; some practices were involved for up to 5 years in the RCT if they were practices that had
recruited participants at the beginning of the recruitment period and had continued to recruit participants
throughout the whole duration of the trial. The trial length also had an impact on the FiCTION trial
practice training, which sometimes required repetition or supplementation, in view of staff turnover,
particularly in long-serving and vocational training practices. In addition, some secondary outcomes were
measured only at baseline and the scheduled final visit and, as 33% of ITT participants did not attend their
scheduled final visit, the opportunity to capture these data for those individuals was missed. From some
of the qualitative interviews, as well as anecdotally, it was also clear that increasing numbers of practices
and participants experienced study fatigue as the trial approached the final visits period, requiring greater
levels of motivational input from the research support staff and clinical leads.
As noted above, fluoridation status and deprivation were based on practice address, not patient address,
and may well have masked some intrapractice variation (especially in deprivation). Given that the study
was patient randomised, it would have been preferable, although more resource intensive, to have been
able to calculate these variables at the participant level.
There were several limitations in the economic evaluation. First, there were a number of challenges
associated with implementing the different costing methods. In particular, the FFS is a more complex
system with reimbursements based on different criteria; for example, an extraction rate was based on the
number of teeth extracted in one course of treatment and a per-visit extraction rate was also available.
However, the detailed costing undertaken allowed us to cope with the complexity of both reimbursement
systems and provided us with robust estimates of the current charges to the NHS to manage dental decay
in primary teeth.
Second, an inflated UDA value was incorporated for urgent band 1 visits, which may have led to an
overestimation of UDAs for that course of treatment. In the UDA analysis, 3% of courses of treatment
(n = 133) were classified as urgent visits, although such visits were evenly distributed across the three
treatment strategies. In addition, for UDAs, discounting was applied to costs that occurred after the first
year of follow-up based on when a course of treatment started, not when it ended. This assumption may
not be reflective of current practice, given that practices are reimbursed retrospectively; however, given
that resources used are incurred at the start of the course of treatment, we deemed this to be a sensible
assumption. Both of these assumptions potentially give an overinflation of costs that may not be true.
However, the effect is small overall and is balanced across the three treatment strategies.
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Third, the SUR model used in the adjusted analysis may not be an appropriate fit for the co-primary outcomes.
In the primary adjusted analyses, a logit model was adopted for incidence and a negative binomial model was
fitted for the number of episodes. Although these models are arguably more appropriate for estimating these
outcomes, there is a trade-off between fitting the most appropriate model and applying a model that allows
for the correlation of costs and outcomes, which is arguably more appropriate for the economic analysis.
Finally, capital costs were excluded from the analysis as all three management strategies are being
provided as part of current care; therefore, these costs would have been incurred regardless of which
strategy was considered. Excluding capital costs reduces the total cost of each arm equally, hence the
incremental costs and ICER would remain unchanged.
There were several limitations of the qualitative study. First, it was not possible to embed the qualitative
component throughout the main trial, with interviews conducted only once recruitment had been completed.
Second, only the perspectives of those parents and children who were retained in the trial were gained;
it was not possible to interview children or parents who had withdrawn from the trial. In addition, during the
interviews with children and parents, it was difficult to distinguish between procedures children had received
during the trial from those before or since, especially if the child had subsequent treatment to their
permanent teeth, although this is unlikely to alter the findings about acceptability. Finally, although a range
of dental professionals were interviewed, it was not possible to interview those who had withdrawn from
the study.
Methodological rigour
Generalisability
To our knowledge, the FiCTION trial is the first multicentre three-arm, parallel-group participant-RCT to
evaluate three clinical management approaches for carious primary teeth at high risk of decay, in young
children, in NHS primary dental care services, the environment where the vast majority of dental care for
children takes place. As a pragmatic trial in NHS primary dental care it reflects, as closely as possible, the
real clinical practice and issues encountered in the provision of dental care services for children in this
environment, including the fact that the inclusion criteria were broad, thereby minimising exclusion, to try
to ensure full representation of this group of children. However, the restrictions that were imposed for
inclusion meant that children did not join the trial from a very early stage before they had developed a
carious lesion. The age criterion for the trial was 3–7 years but the median age of the recruited children
was 6 years, at the older end of the planned age range, and, therefore, arguably more compliant with
treatment. However, the requirement for children to have at least one primary molar with dental caries
into dentine and knowing that most children were screened for carious lesions on a visual basis alone
meant that these FiCTION trial participants had advanced caries, which meant that they may or may not
have been amenable to avoiding dental pain and/or sepsis. In terms of generalisability of the trial to the
reality of general dental practice, management of carious lesions in a trial encourages continuity of care,
which is not always observed in primary dental care.
The demographic and clinical characteristics of the practices and participants demonstrate a wide
representation of the characteristics of UK primary care dentistry, including the different contractual and
funding systems currently operating. Hence, we believe that this study provides generalisable findings for
regularly attending child patients at high risk of decay and attending with decay in their primary teeth.
A total of 72 practices participated in the study, which were linked to five centres in Scotland, England
and Wales. The large number of practices and diversity of location, including urban and rural areas,
strengthened the trial not only in terms of being able to achieve the required sample size but also in terms
of its generalisability to UK dental practice.
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The selection of the area of north-east England around Newcastle upon Tyne as one of the five study
centres was made as the city sits in a water fluoridation area. Based on the fluoridation status of the
practice, the proportion of randomised participants [114/1144 (10%)] associated with a practice receiving
optimally fluoridated water across the trial was similar to the proportion of the UK population receiving a
fluoridated water supply (12%).153
The RCT was also designed to include regions of the UK where children from ethnic minority populations
could be recruited, as it was considered important to understand any cross-cultural differences between
treatment approaches. The potential for such differences was anticipated to relate to cultural, behavioural
and acceptability aspects of dental treatment, rather than to the actual clinical management of dental
decay, which would be expected to be similar for all children in a given practice. The non-white population
of the UK is 8.17 million (12.9% of the overall UK population),154 and 24% of the FiCTION trial children
were non-white. Major efforts were made to engage with and recruit from these populations as there is
evidence to suggest that families from ethnic minority groups in populations researched internationally are
less likely to express an interest in or be recruited to RCTs. This is an ongoing problem in terms of research
evidence, in view of the disparity in caries experience seen between the larger ethnic minorities and
majorities in the UK;13,155 further research is needed to ascertain the main reasons for the difficulties seen
in recruiting ethnic minority participants, including children, to RCTs. Achieving 24% of children in the
FiCTION trial who were identified as non-white was an additional strength of the trial.
The overall mean caries experience in the primary dentition for all FiCTION trial participants at baseline was
2.72 (SD 2.66) d3mft. This is lower than the caries experience found in 5-year-old children with experience
of dental decay (i.e. d3mft > 0) in Scotland, for whom the mean d3mft in 2016 was 3.93;155 in England,
for whom the mean d3mft in 2015 was 3.4;13 and in Wales, for whom the mean d3mft in 2015/16 was
3.58.114 It should be noted, however, that the national surveys are of randomly selected children recruited
in the school setting and not from those attending general dental practices and are therefore likely to
include those with the poorest oral health, who are not engaged with regular dental care.
In summary, we believe that the practices recruited to the FiCTION trial represented practices delivering
primary dental care services in the NHS in Scotland, England and Wales in terms of their size, location
(in terms of social deprivation), skill mix and patient mix and were therefore generalisable to the UK. With
regard to participants recruited to the FiCTION trial, we believe that they were representative of UK 3- to 7-
year-old regular attenders who are at high risk of dental caries, in terms of their age, caries experience,
water fluoridation status and ethnicity.
Choice of primary and secondary outcomes
Failure to prevent or treat dental decay ultimately results in dental pain and/or dental sepsis with a
substantial impact on individuals, families and NHS resources. Pain and sepsis are therefore appropriate
outcomes to measure when comparing the impact of decay management approaches, and were the two
primary outcome measures requested in the HTA commissioning brief. The use of co-primary outcomes of
the incidence of dental pain and/or dental sepsis in the child (yes/no) and the number of episodes of dental
pain and/or dental sepsis in the child (an interval measure) was the optimal way of measuring these most
important outcomes, although challenging in terms of the data collection and its analysis.
At the trial design stage, these child- or mouth-based measures were deliberately chosen to focus on the
primary mouth-based consequences arising from failure to prevent, arrest or manage decay. The addition
of the co-primary outcome of number of episodes of dental pain and/or dental sepsis to the originally
planned measure of incidence alone provided a refined combination of measures that strengthened the
analysis and also provided further insight into the child participant experiences. Although 43% of children
experienced dental pain and or dental sepsis, 67% of these children experienced it only once during the
FiCTION trial. We believe that the wording of the pain question may have contributed to the high levels of
‘dental pain ever’ recorded (an overall incidence of 36%, with no evidence of differences between arms),
as it asked about ‘a history of pain at this visit’ rather than pain since the last visit, leading to a probable
inflation of the instances of positive recordings.
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The use of dental sepsis as an outcome measure provided the necessary objectivity, which was less evident
with the measure of dental pain. It was the prevalence of dental sepsis seen in other studies that provided
the basis for the sample size and power calculation for the trial. However, although pain was a less
objective outcome measure, being participant/parent observed (and reported to the dentist), it was the
measure that is important to patients.
The secondary outcomes included in the trial were diverse, but all were important contributors to the
overall assessment of the clinical, economic, behavioural and psychological impact of dental management
approaches to managing decay in children’s primary teeth. At baseline and at the end of follow-up, the
use of the ICDAS caries index – an objective measure suitable for recording carious lesion prevalence and
incidence – allowed the derivation of a binary indicator variable at a child level (progression of disease in
one or more teeth: yes/no) and a measure of disease severity (number of teeth with caries development/
progression). From the behavioural and psychological perspective, the child- and parent-reported outcomes
measuring OHRQoL, anxiety/worry and dental discomfort were important to capture, particularly as the
three treatment approaches differ substantially from one another in that one (C+P) requires the routine
use of local anaesthetic when removing decay involving dentine. Parents tend not to recognise dental
anxiety in their children very well: they usually under-report it, which is why child self-reported measures
are preferred if possible;105 however, it was difficult to identify instruments appropriate and/or valid for the
target age group. For example, the use of anticipatory and treatment-related anxiety and worry questions
(MCDASf scales) at every visit aimed to distinguish between state and trait dental anxiety. However, in
2007, Howard and Freeman102 concluded that, although the MCDASf scale was a reliable measure of
dental anxiety, demonstrating good reliability and validity, this had been demonstrated only with children
aged 8–12 years. At baseline scoring, FiCTION trial participants were aged 3–7 years. Notwithstanding this,
the pilot study gave some reassurance that the tools used were valid.
With regard to parental and caregiver perceptions, the P-CPQ-16 scale was used. In 2014, Thomson et al.95
compared the responsiveness and functionality of the Early Childhood Oral Health Impact Scale (ECOHIS)
and P-CPQ scales and found them similar and of good quality for internal consistency, reliability, validity
and responsiveness. However, when used for health services research, when the child participants had
significant amounts of decay as in the FiCTION trial, the P-CPQ did not have the shortcomings that
ECOHIS156 demonstrated (it focuses minimally on any ‘oral symptoms’ domain), instead centring on general
function and social and emotional well-being.
Financial costs for managing decay in the primary teeth of children in the UK are a substantial call on NHS
resources.5 It was important, therefore, that the FiCTION trial included appropriate clinical effectiveness
and cost-effectiveness comparisons using valid, reliable measures. The costs of the interventions were
assessed in terms of incremental cost, using data collected at an individual participant level using microcosting,
as well as being based on charges to the NHS on an aggregate level using UDA and FFS values. These robust
estimates of cost-effectiveness can be used in conjunction with the clinical effectiveness results to help inform
policy decisions regarding the management of dental decay in primary teeth.
Blinding and other methodological issues
For ethics reasons, the trial design did not allow for an arm receiving no treatment; therefore, all three
arms included the same active prevention element.
Dental professionals, parents and children could not be blinded to the intervention, as major features of
the C+P and B+P arms were the use of local anaesthetic and the Hall Technique, respectively. However,
they were all responsible for recording a number of the outcome variables, leaving the study open to an
element of (detection) bias. The measurement of caries would have been less open to bias if undertaken
by independent examiners. However, this would have been another very large resource implication in terms
of time and cost given the number of participants, their locations and the 3-month final visit time period.
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Although blinding of treatment arm was not possible, we tried to minimise other forms of bias. Of the
12,078 people sent a screening invitation, 4379 (36%) never attended, and, of the 1756 screened and known
to be eligible, 612 (35%) did not participate. It is almost certain that biases were introduced at both of these
stages, especially in respect of the 331 children who were eligible but declined the trial, but the impact of this
cannot be assessed. Selection bias was minimised by using a central randomisation process operated by the
NCTU, while detection bias was limited by including a simple observable reporting outcome (dental sepsis) as
part of the composite primary outcome alongside the more subjective dentist- and participant-/parent-reported
pain measures. We also tried to validate the reported pain by recording the tooth involved.
Dentists were asked to recruit eligible children when they attended their routine dental check-up
appointments and, in view of the pragmatic nature of the trial, subsequent treatments and recall intervals
varied as they do in real life. As a result, the number of data collection points varied not only with length
of follow-up but also between participants and between arms. Overall, the median rate of visits was
2.5 per year in the trial, ranging from 2.1 for the PA arm to 2.5 for the other two arms. This is a lower rate
of attendance than would be anticipated as, on the basis of the inclusion criteria for the trial, all children
had at least one primary molar with dental caries involving dentine and were therefore all at high caries
risk. This further indicates that, in the trial, GDPs tended to stick to a 6-monthly ‘check-up’, rather than
providing more frequent preventative interventions (e.g. application of fluoride varnish 3 or 4 times per year).
The reason for this is unclear, but may relate to administrative or financial factors tending to dictate the
frequency of recall intervals for children, or may be parent determined (e.g. not attending or arranging visits).
In addition, primarily for ethics reasons, the radiographs taken were only those that would be taken during
normal clinical practice, that is those taken in line with FGDP guidelines;70 therefore, they were not a
mandatory requirement for data collection. We had originally planned to use any available radiographs
to assess the primary outcome of dental pain and/or dental sepsis as well as the caries incidence and
progression outcomes. However, the level of adherence to guidelines recommending clinical radiography
in children is known to be low.157 The children entering the trial fell into the ‘high-risk’ category for dental
caries because having a carious primary tooth was an inclusion criterion. Therefore, all children in the trial
should, in principle, have had a radiograph within 1 year of entry to the trial (as they may have had one
taken prior to entry) and then annually or more frequently until they moved out of the ‘high-risk’ category.
However, in practice, we found that only 308 (29%) of the children had received radiographs on entry to
the trial (or within 1 year of entry). We decided that this rate of radiograph receipt was too low (and not
representative enough of the children across the trial) to be able to use the radiograph data to supplement
the clinical data. We therefore relied on assessment of the clinical data for the primary outcome measure
of sepsis and/or pain due to caries. Approximately half of the carious lesions that exist in a child’s mouth,
especially affecting proximal surfaces, are not detected by clinical visual examination alone158 and rely on
the use of further investigation through the use of bitewing radiographs.
Adherence to protocol
As reported in Chapter 3, Treatment provision and adherence to protocol, and Appendix 5, Table 74,
we are confident that dentists and dental teams provided treatment for the children in line with the clinical
protocols. Prevention was common to all arms and at least one item of prevention was delivered, on average,
at 81% of all visits, and balanced across arms. According to the trial protocol, recording of treatment
deviations was required at every visit at which they occurred. Of the 7713 CRFs completed, a major treatment
deviation recorded on a TDF occurred at 429 (6%) visits affecting 263 children, which indicated good fidelity
with the protocol. The majority (46%) of deviations were away from the C+P arm and most of these were
because of issues associated with local anaesthetic. The reported major deviations from clinical protocol
resulted in 10% of the children from the ITT analysis set having > 20% of their treatment visits deviating from
the clinical protocol. There was some evidence from the data collected via the CRF that additional protocol
deviations had occurred around the failure to use local anaesthetic in the C+P arm, but as the CRF had not
been designed to specifically collect this information, the data around additional deviations lacked sufficient
clarity for any meaningful analysis.
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As discussed earlier, the clinical protocol for the FiCTION trial was developed in 2007 and was based on
evidence-based guidelines available at that time.25 These provided a degree of flexibility between adhesive
intracoronal restorations and Hall Technique use and it is clear that some dentists chose to avoid Hall
Technique use in many situations where the protocol provided a legitimate alternative (ie. intracoronal
adhesive restoration); in the B+P arm, the majority of restorations used GIC (11%) followed by PMCs
placed using the Hall Technique (9%), and RMGIs (7%).
Patient and public involvement and engagement
Children and parents were involved throughout the FiCTION trial from the outset, including during trial
design and the development of recruitment and communication strategies, as well as later during the
planning of the qualitative study.
An important aspect of the trial was the inclusion of a child-centred approach to collecting data. Informal
discussions were held in Sheffield with parents and children who had experience of the treatment of
carious lesions, prior to submission for REC approval for the pilot trial when the format and content of
written and web-based participant literature and data collection materials were reviewed, to optimise their
acceptability to participants and their families. These discussions informed a number of changes to reduce
the burden on participants during the main trial and maximise the enjoyment that children had
experienced by being able to participate by answering their own version of a questionnaire when their
parents completed the parental questionnaire. Some participating dentists noted that children particularly
enjoyed the experience of being part of a trial and being engaged in trial discussions, helped in part by
initiatives aimed at keeping them engaged, including provision of small gifts carrying the FiCTION trial
logo, personalised birthday and thank-you cards, FiCTION trial medals and a FiCTION trial passport to bring
to dental visits.
The high retention rates achieved for practices and participants, discussed earlier, and the positivity of many
of the practices that remained with the trial throughout its prolonged course (up to 7 years for some
practices also involved in the pilot trial) and was still evident at close-down of the trial is a strength and
also testament to the motivation and dedication of parents, practices and the research team.
Interpretation of results
The evidence for a minimally invasive biological approach for the management of primary teeth as well as
permanent teeth was increasing when the trial was set up, which is why, when the original call from the
HTA programme was for a two-arm trial comparing a restorative and non-restorative approach, a third
(biological) arm was justified. This evidence has strengthened over the past 10 years since the FiCTION trial
interventions were designed in 2008. Indeed, for increasing numbers of dentists across the UK, a biological
approach has become the ‘conventional’ with a small ‘c’ approach and is now taught widely across UK
dental schools. It is against this backdrop that the results of the FiCTION trial are now interpreted and compared.
Previous research findings, including RCTs and systematic reviews, have been reviewed in Chapter 1, and have
consistently shown that, at the individual-tooth level, when compared with a conventional approach, a
minimally invasive biological approach to managing dental carious lesions results in less dental pain and dental
sepsis. However, although at least some of the evidence for a biological approach (notably the Hall Technique)
has come from primary care and field settings,34,36,50 the evidence for the effectiveness of the conventional
approach has been limited to specialist centres. Favourable findings from meta-analyses must be interpreted
cautiously, given the variations across trials in patient selection, the actual treatments studied, the definitions of
outcomes and other differences in trial design and conduct.159 The FiCTION RCT’s findings cannot be directly
compared with published evidence on the most clinically effective approach to managing carious lesions in
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individual primary teeth. There are several fundamental differences between the FiCTION trial and the other
published evidence: FiCTION was a child-level intervention for the whole primary dentition, whereas the vast
majority of the literature around interventions for carious lesion management is based on individual tooth
management and outcomes. In addition, FiCTION trial was designed to be a pragmatic trial and to use the
most clinically appropriate outcome measure, the child’s experience of dental pain and/or dental sepsis, rather
than the traditional outcome measure used in dental research, that of restorative material performance.
Based on evidence that has emerged since the start of the trial,30,36,37,49,51,160 current guidelines for use of
PMCs and the Hall Technique in a biological treatment approach are now less stringent25 with a lower
threshold for use, that is they are indicated at an earlier stage. The Hall Technique is now recommended
as the treatment of choice for proximal and multisurface lesions on primary molar teeth (cavitated or
non-cavitated), whereas the FiCTION trial protocol allowed GDPs to choose between the Hall Technique
and an intracoronal adhesive restoration for such lesions, presenting them with a hierarchy in which the
Hall Technique was not necessarily the primary choice. Evidence from the qualitative component of the
study suggests that the reason for dentists tending to prefer using intracoronal restorations rather than
PMCs in the B+P arm may have been related to their past clinical experience. The B+P arm was new to
many of the dentists taking part; although they were provided with training in the technique and supplied
with additional learning support materials, they recognised a number of challenges to their use. These
included judging when to use a PMC, selecting the correct one and when to use adhesive restorative
materials, especially when the intracoronal approach was more familiar to them: this represented (only)
cautious acceptance of the Hall Technique.
The pre-planned PP analysis compared arms for those 89% of children in the ITT analysis set in whom < 20%
of visits had a reported between-arm treatment deviation or where the child was not deemed likely to have
had dental pain and/or dental sepsis at consent and still found no evidence of a difference between arms.
We are confident about the power of the trial to detect any true differences between arms, particularly
with regard to the incidence of sepsis events, as they formed the basis of the original power calculation.
A possible explanation for finding no evidence of clinical benefit is the combination of (1) the inevitability
of the co-primary outcomes being observed in these children as they already had dentinal carious lesions
and possibly asymptomatic but unhealthy pulps on entry to the trial; (2) not all carious lesions were detected
and diagnosed at baseline (especially the less clinically obvious approximal lesions) because bitewing
radiographs were used infrequently and not in line with the trial or national guidelines;70 (3) the co-primary
outcomes being measured at child- rather than tooth-level, and therefore including outcomes for teeth
treated prior to FiCTION; and (4) dentists using materials and techniques that were accessible and familiar
to them rather than newer materials and less familiar techniques meant that optimal clinical outcomes
were not possible.
A child’s experience of dental pain and/or dental sepsis in the FiCTION trial was a result of one or more of
the following scenarios: (1) a lesion treated using one of the three approaches described in the FiCTION trial
clinical protocol, (2) a pre-existing restoration, and/or (3) a lesion that was undetected and undiagnosed at
baseline. It would be important to try to interrogate the FiCTION trial database further to determine a
tooth’s journey through the FiCTION trial to distinguish between these three scenarios, as opposed to a
child’s journey, and this is an area for further research. However, it is important to note that the results from
this tooth analysis would not be comparable with studies that randomised a tooth instead of a child.
Experience of dental pain ever (overall 36%) during the follow-up period was higher than dental sepsis ever
(overall 25%) over the same period. As these ‘management strategy failure’ rates are at a mouth level, they
might be expected to be higher than those reported in previous studies that have compared different
treatment strategies at an individual primary tooth level. Previous tooth-level trials in children have shown that
median survival times for conventional adhesive restorations in primary molars range from 20–42 months,52
and a Cochrane systematic review by Innes et al.30 showed moderate-quality evidence that risk of major failure
in the long term (> 12 months) was lower in crowns than in fillings [risk ratio 0.18, 95% CI 0.06 to 0.56; 346
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teeth in three studies, one using conventional (tooth reduction) technique and two using Hall Technique].
The suspected underdetection of carious lesions through clinical examination alone, due to the low use
of radiographs, may have increased the potential for unmanaged carious lesions, as well as pre-existing
restorations, to contribute to the primary outcome of dental pain and/or dental sepsis. A B+P approach,
when treated with the Hall Technique, is less vulnerable to lower carious lesion detection rates as all surfaces
are sealed. In terms of ‘dental sepsis ever’ as an outcome, the incidence at a child level across all arms at 25%
for the FiCTION trial was slightly higher than the dental sepsis rates predicted for a tooth-level preventative
approach based on the work by Levine et al.7 and Tickle et al.6
The FiCTION trial found no evidence that one management approach performed better than another
when used by dental professionals (non-specialist) working in primary care. This differs from secondary
care where there is more resource with respect to time and expertise, leading to more favourable
outcomes.24,161 However, it was the delivery of care in general dental practice that was under test in the
FiCTION trial and not the secondary care environment.
The trial has shown that, in primary care, the B+P approach would have the highest probability of being
considered cost-effective in terms of avoidance of dental pain and/or dental sepsis if society is willing to
pay to avoid an episode (≥ £130) or an incidence (≥ £330) of dental pain and/or dental sepsis.
In a cost-effectiveness analysis, the ICER can be difficult to interpret, given that there is no threshold to
determine what society’s WTP for a unit of effect is, that is WTP to avoid an incidence of dental pain and/or
dental sepsis in a primary tooth. Recent (2015) research conducted by Lord et al.162 estimated the WTP to
avoid dental decay with pain in a primary tooth. If we adopted this WTP threshold of £153 (95% CI £93
to £213, inflated to 2017 prices),119 the PA arm would have a 68% probability of being considered
cost-effective compared with B+P (29%) and C+P (3%) in terms of an incidence of dental pain and/or
dental sepsis avoided. A WTP threshold to avoid an episode of dental pain and/or dental sepsis needs to
be determined but, based on the Lord et al.162 threshold, B+P would have the highest probability (53%)
of being considered cost-effective compared with PA (40%) and C+P (7%).
A further strength of the trial is that it gives a significant insight to how children with carious lesions are
managed in general practice; however, the results of the trial also raise the issue of where a child’s dental
care is best managed. The levels of sepsis experienced by participants in the FiCTION trial (re-) open the
debate about whether or not children should have their own paediatric dental service and be cared for by
specialist teams with an appropriate skill mix.
The C+P arm was designed to encompass the clinical procedures needed to achieve complete carious
tissue removal prior to provision of a direct intracoronal plastic restoration (filling) or a direct extracoronal
restoration, that is a preformed crown placed following endodontic treatment and some tooth reduction.
As a result, it was heavily reliant on the properties of materials used at the dentine: restorative interface
within a much reduced tooth structure. In contrast, the B+P arm was based around a minimally invasive
approach with no, or partial, carious tissue removal, in which both infected and affected dentinal carious
tissue remains. The clinical effectiveness of this approach, which is designed to retain tooth structure, relies
on the reduction in further decay potential in the remaining carious dentine and underlying pulp as a result
of the reduced viability of the bacteria, which is now sealed-in and starved of nutrients.
The finding that the clinical outcome was dependent on the level of dental experience at baseline, with
those children with more decay more likely to experience dental pain and/or dental sepsis, emphasises the
need to prevent this disease.
Conclusions
There was no evidence of an overall difference between the three treatment approaches for incidence,
or number of episodes, of dental pain and/or dental sepsis experienced by the children. It is important to
understand that ‘no evidence of a difference’ does not mean that there was no difference, or that the
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three treatment approaches were equivalent. Nor was there evidence of a difference in quality of life or
dental anxiety. All three strategies were acceptable to children, parents and dental professionals and did
not provoke anxiety or discomfort.
The PA arm was, on average, the least costly and least effective treatment with respect to co-primary
outcomes. A judgement is required as to what value the NHS places on avoiding dental pain and/or
dental sepsis. Over the WTP values considered, the probability of B+P being considered cost-effective was
approximately no higher than 60% to avoid an incidence and no higher than 70% to avoid an episode
of pain and/or sepsis.
The level of dental pain and/or dental sepsis observed emphasises the importance of early prevention for
young children. The outcomes of the FiCTION trial were for the individual child and we suspect the low
number of radiographs taken may have led to undetected and misdiagnosed dental caries. This, together
with dental professionals’ preferences for familiar materials and techniques, will have contributed to the
overall findings.
As there was no evidence of a difference between the three treatment arms in the dental pain or dental
sepsis experienced, the choice of treatment should continue to be based on shared decision-making with
a conversation between child, parent and clinician to agree the best option for the individual child.
Implications for health care
l The results of the FiCTION trial emphasise the importance of preventing disease before it occurs to
avoid dental pain and/or dental sepsis. Prevention must start early to avoid the need for operative
management of disease.
l The FiCTION trial results indicate that, for successful management of carious lesions in young children,
the health-care system may require adjustment to ensure effective detection and diagnosis of dental
caries and the use of effective materials and techniques.
l The FiCTION trial’s findings open the debate around (1) where dental care for children at high risk of
dental caries is best provided, (2) the most appropriate way of identifying children at high risk of dental
caries and (3) the optimal clinical and funding environment for children at high risk of dental caries.
Implications for parents and practice
l Parental and dental professional roles are key to ensure that prevention starts early at home, and early
attendance at a dental practice is an opportunity for reinforcement of prevention, monitoring of oral
health, provision of effective advice and early intervention, if necessary.
l The FiCTION trial findings indicate that treatment of carious lesions in young children can be tailored to
meet their behavioural and clinical needs and, therefore, the role of shared decision-making is important.
Although there is no evidence of a difference in clinical outcome between arms, the biological approach
may offer an advantage when taking into account the disease process, the child’s needs and the
technical requirements, and is the most likely strategy to provide value for money if preventing dental
pain/sepsis is valued.
Implications for dental education/teaching and training
l There appears to be a need for knowledge tools, key evidence-based guidance and additional clinical
training and support of dental professionals to address their clinical skills with regard to use of
radiographs and choice of restorative materials and techniques.
l The FiCTION trial has evidence of facilitators of and barriers to the investigation, detection, diagnosis
and management of carious lesions, learnt through the qualitative study, which could inform
implementation strategies for Public Health England and SDCEP guidance. Messages and techniques
need to be clear, evidence-based and tailored for delivery and uptake in the primary care environment.
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The undergraduate and postgraduate curricula in all dental schools may need to be reviewed to ensure
that all caries management strategies evidenced as suitable for use in young children are included,
along with competencies in managing the dental care of young children and shared decision-making.
Recommendations for research
l Explore barriers to use of conventional techniques for the detection and diagnosis of carious lesions
(e.g. radiographs) and develop and evaluate suitable tools for use in young children in primary
dental care.
l Explore individual tooth outcomes descriptively by treatment provided, including dental materials and
techniques, through further analysis of the FiCTION trial data set.
l Identify the appropriate service structure necessary to provide cost-effective and acceptable prevention
for young children in a primary care setting.
l Explore clinicians’ decision-making around the use of minimally invasive techniques for caries
management in young children treated in primary care.
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Appendix 1 Recommendations from the
pilot phase
l The structures and processes for trial management deployed in the pilot trial were effective and will be
mirrored in the main trial.
l Practices with previous experience of participating in research will be considered for the FiCTION
main trial.
l Vocational dental practitioners working in FiCTION trial practices will be invited to participate by one
of the FiCTION trial dentists in their practice, to participate in the screening of patients for recruitment.
l The practice training material is being developed to include role-play scenarios and video footage
explaining the trial process, including consent, randomisation and participant responsibilities. Clinical
protocol documents are being enhanced to explain the treatment planning options and treatment
variation between arms more clearly. Tools are being developed to help practice staff explain these to
parents and child participants. These will form a part of the study set-up, initiation and training session
for the FiCTION main trial.
l Training of the GDPs and other members of the team for the FiCTION main trial will be carried out as
close to the start of patient recruitment as possible. ‘Top-up’ training will be provided for the dentists
and other members of the practice team when necessary during the 12-month recruitment phase.
l Feedback from the service providers emphasised the need for involvement of the whole dental team.
Receptionists were viewed as key members of staff to deal with patient queries and administration.
Dentists preferred to have other colleagues in their practice involved to share the workload. Approval
from the practice principal, as the business owner, was felt to be required. Practice recruitment for the
main trial will focus on larger practices and/or those with an interest in research.
l Clinical leads should be supported by a dedicated secretary to be the main point of contact and to
ensure that paperwork is accurately completed and returned from practices to the trial office.
l The responsibility for printing information packs for patients will rest with the clinical leads’ offices and
not the participating practice, although individual practice letter-heads will need to be used. Ensuring the
appropriate trial documentation and printing will form part of the remit for the clinical lead’s secretaries.
l Effective communication strategies that were developed and adopted in the pilot trial will be replicated
for the main trial.
l Flexibility will be offered over the process of patient identification and invitation to participate, allowing
the approaches to be tailored for individual practices. This will include the option of opportunistic
recruitment of children who present to the practice with caries into dentine.
l The timing of written information will be changed, and a case made to the REC to simplify the
information packs and reduce the amount of initial written information sent to patients/parents.
l Feedback from the GDPs indicated that the approach taken to screening patients for recruitment in
the pilot trial was convenient as they did not have to discuss the trial with those who were ineligible,
and there was little difference from their regular recall appointment. This approach will be adopted in
the main trial.
l Regularly attending patients will continue to be the main source of patients for screening as they are
more likely to re-attend for treatment and future follow-up. However, to keep the patient sample
representative, opportunistic identification of patients should continue.
l Despite differences between the expected and observed rates of eligibility in the pilot trial, the
recruitment period in the main trial of 12 months (compared with 6 months in the pilot trial) will not
require adjustment. There will be sufficient time for the dentists to invite (234), screen (152) and recruit
(18) the required number of children.
l The trial team is exploring the possibility of using the Community Dental Service to help with increasing
the number of patients with decay who are screened and, thus, the rate of eligibility. An options
appraisal will be carried out for this method of recruitment.
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l To generate interest and encourage retention, the trial materials will be made more appealing and
child-friendly. In addition, newsletters will be sent to the parents and children updating them on the
progress of the trial.
l For the FiCTION main trial, the importance of the explanations and reassurances provided by the
dentists to parents and children will be given more prominence and the projected time for this part of
the process will be increased.
l Training on dental charting using the ICDAS will be strengthened, with both dentists and their dental
nurses trained in the completion of the dental chart correctly. The supplementary training resources
[an annotated Microsoft PowerPoint® (Microsoft Corporation, Redmond, WA, USA) presentation and
laminated summary sheet for the dental surgery, identifying how the dental charts should be completed]
will be adopted as part of the FiCTION main trial training.
l Because caries incidence in the primary and permanent dentition is one of the secondary outcome
measures for the FiCTION main trial, consideration will be given to utilising the clinical researcher to
complete dental chartings on a random sample of patients at the end of the trial period if the quality
of baseline dental charts is poor despite improved training.
l Given the generally small numbers of missing data, the CRF tool appears to be a feasible and
acceptable method of collecting economic data relating to resource use and it will be used in the main
trial. However, some refinement is required to allow accurate detail on the treatments and any reasons
for diverging from the clinical protocol.
l The instructions and format of the child questionnaire will be amended. In addition, the child measure
of OHRQoL will be removed to simplify the questionnaire. In the absence of a more appropriate child
measure, data from parents will be used as a proxy, and more child-centred approaches will be
incorporated to explore the impact of dental caries and its treatment on the young children participating.
l Changes to the parental questionnaire will include clarifying the wording of the instructions and
re-ordering questions. The measure of parental OHRQoL will be changed to the short-form P-CPQ.
The section on dental discomfort will remain the same.
l As well as shortening the child questionnaires by removing the QoL elements, the burden on both the
dental staff in administering and the participants in completing questionnaires will be reduced
by decreasing the frequency of measuring OHRQoL. It is proposed that this measure be recorded at
baseline and annually, rather than at each appointment.
l It is proposed that improvements could be made in the explanation of the three treatment strategies
by including reassurance that have all been shown to be effective; this should be conveyed through
face-to-face discussions with dentists.
l Dentists who have expressed an interest in participating in the main trial will be considered for recruitment.
l The processes for the reimbursement of expenses for the pilot trial dentists were acceptable and will be
followed in the main trial.
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
UNCORRECTED PROOF DATE: 11/18/2019 FILE: 07-44-03-2P.pdf
122
Appendix 2 List of trial protocol amendments
Amendment
number
Protocol
version
number
Date of REC
favourable
opinion Details of changes made
AM06 2.0 6 November 2014 Updated to allow appropriate time point questionnaires,
accompanied by a covering letter and prepaid return envelope,
to be sent out to participants who have failed to attend a
scheduled or final appointment
AM12 3.0 8 May 2015 Updated to reflect new study sites. The total number UK sites
was increased from 50 to 70. The distribution of sites per region
was also changed:
l England – from 30 to 40
l Scotland – from 10 to 25
l Wales – from 10 to 5
l Study timescale updated to reflect HTA-approved extension
to study
l The recruitment window was extended by 6 months from
31 December 2014 to 30 June 2015, and the study end
date extended to 31 December 2017
l Target sample size updated to reflect altered sample size
data owing to HTA extension
l Sample size was reduced from 1460 to 1113 participants
l Length of follow-up updated
l Follow-up was changed from 3 years to up to 3 years
Section 4.1 primary outcomes and section 4.2 secondary
outcomes sections of the trial protocol: updated with more detail
regarding the statistical analysis and study-specific estimates of
unit costs added as a secondary outcome measure to Section 4.2
Development and distribution of promotional material to
improve participant retention: the protocol was updated to state
that FiCTION trial promotional material (posters and leaflets)
would be distributed to sites for display in practice waiting rooms.
Birthday cards were also sent to participating children via the
practice. Feedback would be actively sought from practices in
order to guide development of suitable FiCTION trial-branded
merchandise promoting the study
Minor administrative changes:
l Update of contact information in protocol contacts and
personnel
l Principal investigator protocol signature page removed
l Section 2.10 withdrawal criteria updated and two withdrawal
options removed to bring in line with the trial
l Identification and recruitment of participants (2.11) and
participant randomisation (2.12) sections updated to reflect
updated sample size and extended recruitment period specific
length removed
l Section 2.6 principal investigator changed to practice leads
l Figure 2: flow diagram of main trial updated to reflect updated
sample size and extended recruitment period
l Serious adverse events (5.5) – removal of reference to AE
recording and SAE contact number updated
l Consent (6.2) addition of questionnaire implied consent
explanation
l Section 7 publication policy updated
l Appendix 2 amendment history added
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Amendment
number
Protocol
version
number
Date of REC
favourable
opinion Details of changes made
l A number of appendices were removed from the protocol
as they were regarded as unnecessary (study letters, AEs,
questionnaires, letter of invitation, patient information sheets,
consent and assent forms, letter to GMP, poster, membership
card/birthday card)
AM14 4.0 25 November 2015 Updated to give patients the opportunity to be contacted with
regard to future studies
AM15 5.0 7 June 2016 Updated to further detail the qualitative aspects of the study.
Change of senior trial manager
AM16 6.0 13 June 2017 Section 3.2 updated under incidence of caries in primary and
secondary teeth, adding paragraph about radiographs
Sections 4.1 and 4.2: re-defined primary outcome to co-primary
outcomes and expanded statistical analysis methods
GMP, general medical practitioner.
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Appendix 3 Expected adverse events
(see Chapter 2)
Procedure
Adverse event
Common and well-understood
consequences of treatment
Less common and
unpleasant side effects Rare events
Fillings in teeth and crowns
on teeth (C+P)
l Occlusal discomfort
l Damage to adjacent teeth
l Caries progression
l Pain, pulpitis
l Localised reaction to
bonding agents or
filling materials
l Dental abscess
l Facial swelling
Trauma to soft
tissues
Crowns on teeth
(Hall Technique)
l Immediate gingival
discomfort/pain
l Occlusal discomfort
l Longer lasting
gingival pain
l Pulpitis
l Dental abscess
l Facial swelling
Localised reaction to
crowns
Inhalational sedation Dizziness and nausea Under- or over-
sedation
Local anaesthetic Pain at site of injection (during or
immediately following injection)
Self-inflicted trauma to soft
tissues
l Trismus
l Prolonged
altered sensation
l Swelling
l Haematoma
l Allergic reaction
Extraction of tooth l Pain around site
l Swelling
l Early and delayed post
extraction bleeding
l Infection of socket
Temporomandibular
joint pain
Fluoride varnish l Nausea post
application
l Allergic reaction
Fissure sealants Caries progression
Acid etch on teeth prior to
restoration or fissure sealant
Discomfort and minor
irritation of oral tissues
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Appendix 4 Trial results and clinical effectiveness
(see Chapter 3)
Recruitment and baseline characteristics
TABLE 22 Distribution of randomised participants by site (all randomised analysis set, n= 1144)
Centre Practice code
Number of children
randomised
Children as % of
clinical centre’s
total participants
Total number of children per clinical
centre (% of the 1144 randomised)
Scotland 1 03 23 7.5 307 (26.84)
1 04 37 12.1
1 06 18 5.9
1 07 18 5.9
1 09 9 2.9
1 11 2 0.7
1 13 15 4.9
1 14 17 5.5
1 15 2 0.7
1 16 4 1.3
1 17 31 10.1
1 18 9 2.9
1 19 6 2.0
1 20 1 0.3
1 21 17 5.5
1 22 9 2.9
1 23 24 7.8
1 24 1 0.3
1 27 1 0.3
1 30 2 0.7
1 31 21 6.8
1 32 2 0.7
1 36 9 2.9
1 37 19 6.2
1 38 10 3.3
North-east 2 01 4 1.3 315 (27.53)
2 02 38 12.1
2 03 31 9.8
2 04 9 2.9
2 06 26 8.3
2 07 2 0.6
2 08 6 1.9
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TABLE 22 Distribution of randomised participants by site (all randomised analysis set, n= 1144) (continued )
Centre Practice code
Number of children
randomised
Children as % of
clinical centre’s
total participants
Total number of children per clinical
centre (% of the 1144 randomised)
2 09 7 2.2
2 11 22 7.0
2 12 21 6.7
2 13 33 10.5
2 14 15 4.8
2 15 14 4.4
2 16 27 8.6
2 17 17 5.4
2 18 5 1.6
2 19 16 5.1
2 20 8 2.5
2 22 14 4.4
Yorkshire 3 01 20 11.7 171 (14.95)
3 03 4 2.3
3 06 21 12.3
3 07 2 1.2
3 08 2 1.2
3 11 5 2.9
3 12 24 14.0
3 13 32 18.7
3 16 21 12.3
3 17 3 1.8
3 18 22 12.9
3 21 4 2.3
3 22 11 6.4
Wales 4 01 13 10.4 125 (10.93)
4 03 55 44.0
4 04 29 23.2
4 05 28 22.4
London 5 02 32 14.2 226 (19.76)
5 03 33 14.6
5 06 7 3.1
5 09 39 17.3
5 10 35 15.5
5 11 13 5.8
5 14 5 2.2
5 15 40 17.7
5 16 13 5.8
5 18 3 1.3
5 24 6 2.7
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TABLE 23 Withdrawals: time in study (months), by randomised treatment arm (ITT analysis set)
Time in study (months)
Treatment arm
Total (n= 118)C+P (n= 40) B+P (n= 35) PA (n= 43)
Minimum 0.0 0.0 0.0 0.0
Median (lower quartile, upper quartile) 9.8 (4.1, 14.9) 11.1 (1.0, 12.3) 8.6 (1.4, 18.0) 9.4 (1.4, 14.7)
Maximum 33.8 42.0 32.5 42.0
TABLE 24 Summary of caries experience in primary dentition at baseline, by randomised treatment arm, recorded
using ICDAS (ITT analysis set; n= 1006 ICDAS forms completed)
Primary dentition (maximum: 20 teeth)
Trial group
All (n= 1006)C+P (n= 339) B+P (n= 333) PA (n= 334)
Total number of primary teeth per child
Minimum 4.0 5.0 4.0 4.0
Median (IQR) 19.0 (14.0–20.0) 19.0 (15.0–20.0) 20.0 (14.0–20.0) 19.0 (15.0–20.0)
Mean (SD) 17.23 (3.40) 17.41 (3.35) 17.30 (3.39) 17.31 (3.38)
Maximum 20.0 20.0 20.0 20.0
Number of caries-free primary teeth (ICDAS summary code 00)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 14.0 (9.0–17.0) 14.0 (10.0–17.0) 13.0 (10.0–16.0) 14.0 (10.0–17.0)
Mean (SD) 12.87 (4.63) 13.22 (4.48) 13.00 (4.34) 13.03 (4.49)
Maximum 20.0 20.0 20.0 20.0
Number of primary teeth for which the highest surface caries severity code is ICDAS 0–2
d ICDAS 0–2
Minimum 1.0 1.0 0.0 0.0
Median (IQR) 15.0 (11.0–18.0) 16.0 (12.0–18.0) 16.0 (12.0–18.0) 16.0 (12.0–18.0)
Mean (SD) 14.53 (4.06) 14.83 (3.96) 14.75 (4.06) 14.70 (4.03)
Maximum 20.0 20.0 20.0 20.0
Number of primary teeth for which the highest surface caries severity code is ICDAS 3–4
d ICDAS 3–4
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 1.0 (0.0–2.0) 0.0 (0.0–2.0) 1.0 (0.0–2.0) 1.0 (0.0–2.0)
Mean (SD) 1.04 (1.45) 1.01 (1.43) 1.03 (1.29) 1.03 (1.39)
Maximum 9.0 8.0 6.0 9.0
Number of primary teeth for which the highest surface caries severity code is ICDAS 5–6
d ICDAS 5–6
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 1.0 (0.0–2.0) 1.0 (0.0–2.0) 1.0 (0.0–2.0) 1.0 (0.0–2.0)
Mean (SD) 1.65 (2.02) 1.57 (1.83) 1.48 (1.72) 1.57 (1.86)
Maximum 14.0 12.0 8.0 14.0
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TABLE 24 Summary of caries experience in primary dentition at baseline, by randomised treatment arm, recorded
using ICDAS (ITT analysis set; n= 1006 ICDAS forms completed) (continued )
Primary dentition (maximum: 20 teeth)
Trial group
All (n= 1006)C+P (n= 339) B+P (n= 333) PA (n= 334)
Number of primary teeth for which the highest surface caries severity code is ICDAS 4–6
d ICDAS 4–6 [equivalent to d3]
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 1.0 (1.0–3.0) 1.0 (1.0–3.0) 1.0 (0.0–3.0) 1.0 (1.0–3.0)
Mean (SD) 2.20 (2.40) 2.00 (2.02) 1.91 (2.00) 2.04 (2.15)
Maximum 14.0 12.0 11.0 14.0
Missing primary teeth due to caries (ICDAS summary code 97)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.22 (0.86) 0.31 (1.25) 0.21 (1.25) 0.24 (1.13)
Maximum 7.0 12.0 16.0 16.0
Filled (but not decayed) primary teeth (number of teeth with at least one surface with ICDAS restoration
code 3–7 and caries severity code 0–3)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.37 (0.89) 0.44 (0.98) 0.49 (1.12) 0.44 (1.00)
Maximum 7.0 5.0 6.0 7.0
d3mft
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 2.0 (1.0–4.0) 2.0 (1.0–4.0) 2.0 (1.0–4.0) 2.0 (1.0–4.0)
Mean (SD) 2.79 (2.69) 2.75 (2.71) 2.61 (2.57) 2.72 (2.66)
Maximum 14.0 19.0 19.0 19.0
TABLE 25 Summary of caries experience in first permanent molars at baseline, by randomised treatment arm
(ITT analysis set, n= 1006 ICDAS forms completed)
Permanent dentition: first permanent
molars – teeth 16/26/36/46
Trial group
All (n= 1006)C+P (n= 339) B+P (n= 333) PA (n= 334)
Total number of first permanent molars per child
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–4.0) 1.0 (0.0–4.0) 0.0 (0.0–4.0) 0.0 (0.0–4.0)
Mean (SD) 1.68 (1.89) 1.82 (1.87) 1.72 (1.89) 1.74 (1.88)
Maximum 4.0 4.0 4.0 4.0
Number of caries-free first permanent molars (ICDAS summary code 00)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–4.0) 1.0 (0.0–4.0) 0.0 (0.0–4.0) 0.0 (0.0–4.0)
Mean (SD) 1.39 (1.74) 1.62 (1.77) 1.49 (1.78) 1.50 (1.76)
Maximum 4.0 4.0 4.0 4.0
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TABLE 25 Summary of caries experience in first permanent molars at baseline, by randomised treatment arm
(ITT analysis set, n = 1006 ICDAS forms completed) (continued )
Permanent dentition: first permanent
molars – teeth 16/26/36/46
Trial group
All (n= 1006)C+P (n= 339) B+P (n= 333) PA (n= 334)
Number of first permanent molars for which the highest surface caries severity code is ICDAS 0–2
D ICDAS 0–2
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–4.0) 1.0 (0.0–4.0) 0.0 (0.0–4.0) 0.0 (0.0–4.0)
Mean (SD) 1.63 (1.85) 1.78 (1.84) 1.63 (1.85) 1.68 (1.84)
Maximum 4.0 4.0 4.0 4.0
Number of first permanent molars for which the highest surface caries severity code is ICDAS 3–4
D ICDAS 3–4
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.05 (0.30) 0.03 (0.16) 0.06 (0.37) 0.04 (0.29)
Maximum 4.0 1.0 4.0 4.0
Number of first permanent molars for which the highest surface caries severity code is ICDAS 5–6
D ICDAS 5–6
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.01 (0.09) 0.01 (0.11) 0.02 (0.22) 0.01 (0.15)
Maximum 1.0 1.0 3.0 3.0
Number of first permanent molars for which the highest surface caries severity code is ICDAS 4–6
D ICDAS 4–6 (equivalent to D3)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.02 (0.13) 0.02 (0.13) 0.06 (0.35) 0.03 (0.23)
Maximum 1.0 1.0 4.0 4.0
Missing first permanent molars due to caries (ICDAS summary code 97)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.000 (0.000) 0.003 (0.055) 0.000 (0.000) 0.001 (0.032)
Maximum 0.0 1.0 0.0 1.0
Filled (but not decayed) first permanent molars (number with at least one surface with ICDAS restoration code
3–7 and caries severity code 0–3)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.01 (0.18) 0.03 (0.24) 0.02 (0.18) 0.02 (0.20)
Maximum 3.0 3.0 2.0 3.0
D3MFT
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.03 (0.22) 0.05 (0.36) 0.08 (0.45) 0.05 (0.35)
Maximum 3.0 4.0 4.0 4.0
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Primary outcome-related
TABLE 26 Reasons for ‘major’ deviation from the randomised treatment arm’s operative treatment protocol (n= 429)
Reason for ‘major’ deviation
Trial arm, n (% of non-missing)
Total (n= 429),
n (% of non-missing)C+P (n= 195) B+P (n= 65) PA (n= 169)
Total (non-missing), n 188 65 164 417
Parent factors 33 (17.6) 29 (44.6) 55 (33.5) 117 (28.1)
Child pre co-operative for local anaesthetic 82 (43.6) 3 (4.6) 1 (0.6) 86 (20.6)
Dentist’s clinical judgement 23 (12.2) 19 (29.2) 78 (47.6) 120 (28.8)
Child anxiety 41 (21.8) 6 (9.2) 0 (0.0) 47 (11.3)
Food packing (PA arm only) 0 (0.0) 1 (1.5) 16 (9.8) 17 (4.1)
Child factors (not anxiety/co-operation) 5 (2.7) 5 (7.7) 6 (3.7) 16 (3.8)
Other 4 (2.1) 2 (3.1) 8 (4.9) 14 (3.4)
TABLE 27 Direction of ‘major’ deviations only (n= 429 ‘major’ deviations)
Arm randomised to Arm(s) treatment deviated toa
Number (%) of ‘major’
deviations by arm (n= 429)
Randomised arm deviated
from – group total, n (%)
C+P B+P 135 (69.2) 195 (45.5)
PAb 52 (26.7)
B+P and PAc 3 (1.5)
C+P and B+Pc 3 (1.5)
C+P and PAc 2 (1.0)
B+P C+P 52 (80.0) 65 (15.2)
PAc 10 (15.4)
C+P and B+Pc 1 (1.5)
C+P, B+P and PAb,c 1 (1.5)
C+P and PAb,c 1 (1.5)
PA C+P 90 (53.3) 169 (39.4)
B+P 71 (42.0)
B+P and PAb,c 4 (2.4)
C+P and PAc 3 (1.8)
C+P and B+Pc 1 (0.6)
a Any treatment provided by a FiCTION trial clinician that moved a participant’s treatment away from their randomised
treatment arm was designated a ‘major’ treatment deviation and required completion of a TDF by the treating clinician
(e.g. ‘prevention’ to ‘biological’).
b Best-practice prevention was an integral part of each treatment arm. A ‘major’ treatment deviation to the ‘prevention’
arm was true only if a clinician had attempted to deliver treatment to a participant by their designated ‘biological’ or
‘conventional’ arm, but had been unable to achieve completion of that treatment before moving towards PA
as contingency.
c When a deviation was necessary to deliver treatment, the deviation could be towards more than one arm in a single visit
(e.g. ‘prevention’ to ‘biological’ and ‘conventional’).
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TABLE 28 Planned sensitivity analysis: incidence of dental pain and/or dental sepsis restricted to participants with
at least 23 months’ follow-up (n= 797)
Outcome
Trial arm, n (%)
Total (n= 797), n (%)C+P (n= 269) B+P (n= 267) PA (n= 261)
Dental pain ever 102 (37.9) 97 (36.3) 116 (44.4) 315 (39.5)
Dental sepsis ever 73 (27.1) 74 (27.7) 76 (29.1) 223 (28.0)
Dental pain and/or dental sepsis ever 121 (45.0) 122 (45.7) 130 (49.8) 374 (46.9)a
a When participants with < 23 months’ follow-up are excluded, the overall incidence of dental pain and/or dental sepsis
increases from 42.5% to 46.9%, owing to a lower proportion of participants with < 23 months’ follow-up having
experienced dental pain and/or sepsis. Of the 261 participants excluded from this analysis set, 75 (28.7%) were in the
study for < 6 months.
TABLE 29 Incidence of dental pain and/or dental sepsis (PP analysis set, n= 940)
Outcome
Trial arm, n (%)
Total (n= 940), n (%)C+P (n= 311) B+P (n= 329) PA (n= 300)
Dental pain ever 106 (34.1) 103 (31.3) 109 (36.3) 318 (33.8)
Dental sepsis ever 77 (24.8) 78 (23.7) 76 (25.3) 231 (24.6)
Dental pain and/or dental sepsis ever 124 (39.9) 127 (38.6) 126 (42.0) 377 (40.1)
TABLE 30 Estimates of the risk difference over the follow-up period in dental pain and/or dental sepsis between
randomised treatment arms using logistic regression
Analysis set Model Trial arm Risk difference 97.5% CI p-value
ITT Unadjusted (n = 1058) C+P 0.00
B+P –0.02 –0.10 to 0.06 0.6
PA 0.04 –0.05 to 0.12 0.3
Adjusted (n = 1057) C+P 0.00
B+P –0.02 –0.10 to 0.06 0.6
PA 0.04 –0.04 to 0.12 0.2
ITT, at least 23 months in study Unadjusted (n = 797) C+P 0.00
B+P 0.005 –0.09 to 0.10 0.9
PA 0.05 –0.04 to 0.14 0.2
Adjusted (n = 797) C+P 0.00
B+P 0.01 –0.09 to 0.10 0.9
PA 0.05 –0.04 to 0.14 0.2
PP Unadjusted (n = 940) C+P 0.00
B+P –0.01 –0.10 to 0.07 0.7
PA 0.02 –0.07 to 0.10 0.7
Adjusted (n = 939) C+P 0.00
B+P –0.01 –0.09 to 0.08 0.9
PA 0.02 –0.06 to 0.11 0.5
Note
Unadjusted models include a random effect for practice and adjusted models include age in years, time in trial in years and
a random effect for practice.
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TABLE 31 Planned sensitivity analysis: number of episodes of dental pain and/or dental sepsis restricted to at least
23 months’ follow-up (n= 797)
Outcome
Trial arm
Total (n= 797)C+P (n= 269) B+P (n= 267) PA (n= 261)
Number of episodes of dental pain and/or dental sepsis
Minimum 0 0 0 0
Median (IQR) 0 (0–1) 0 (0–1) 1 (0–1) 0 (0–1)
Mean (SD) 0.66 (0.97) 0.67 (0.92) 0.84 (1.06) 0.72 (0.99)
Maximum 7 6 5 7
Number, n (%)
0 148 (55.0) 145 (54.3) 130 (49.8) 423 (53.1)
1 88 (32.7) 85 (31.8) 74 (28.4) 247 (31.0)
2 18 (6.7) 22 (8.2) 36 (13.8) 76 (9.5)
3 12 (4.5) 13 (4.9) 14 (5.4) 39 (4.9)
4 1 (0.4) 1 (0.4) 5 (1.9) 7 (0.9)
5 0 (0.0) 0 (0.0) 2 (0.8) 2 (0.3)
6 1 (0.4) 1 (0.4) 0 (0.0) 2 (0.3)
7 1 (0.4) 0 (0.0) 0 (0.0) 1 (0.1)
TABLE 32 Number of episodes of dental pain and/or dental sepsis (PP analysis set)
Outcome
Trial arm
Total (n= 940)C+P (n= 311) B+P (n= 329) PA (n= 300)
Number of episodes of dental pain and/or dental sepsis
Minimum 0 0 0 0
Median (IQR) 0 (0–1) 0 (0–1) 0 (0–1) 0 (0–1)
Mean (SD) 0.57 (0.89) 0.57 (0.87) 0.66 (0.94) 0.59 (0.90)
Maximum 7 6 5 7
Number, n (%)
0 187 (60.1) 202 (61.4) 174 (58.0) 563 (59.9)
1 92 (29.6) 87 (26.4) 76 (25.3) 255 (27.1)
2 18 (5.8) 25 (7.6) 34 (11.3) 77 (8.2)
3 11 (3.5) 13 (4.0) 12 (4.0) 36 (3.8)
4 2 (0.6) 1 (0.3) 3 (1.0) 6 (0.6)
5 0 (0.0) 0 (0.0) 1 (0.3) 1 (0.1)
6 0 (0.0) 1 (0.3) 0 (0.0) 1 (0.1)
7 1 (0.3) 0 (0.0) 0 (0.0) 1 (0.1)
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TABLE 33 Estimates of the IRR over the follow-up period in episodes of dental pain and/or dental sepsis between
randomised treatment arms using negative binomial regression
Analysis set Model Trial arm IRR 97.5% CI p-value
ITT Unadjusted (n = 1058) C+P 1.00
B+P 0.94 0.74 to 1.21 0.6
PA 1.17 0.93 to 1.48 0.1
Adjusted (n = 1057) C+P 1.00
B+P 0.95 0.75 to 1.21 0.6
PA 1.18 0.94 to 1.48 0.1
ITT, at least 23 months in study Unadjusted (n = 797) C+P 1.00
B+P 1.02 0.78 to 1.32 0.9
PA 1.27 0.98 to 1.64 0.04
Adjusted (n = 797) C+P 1.00
B+P 1.02 0.78 to 1.33 0.9
PA 1.26 0.98 to 1.63 0.04
PP Unadjusted (n = 940) C+P 1.00
B+P 1.01 0.78 to 1.32 > 0.9
PA 1.15 0.89 to 1.50 0.2
Adjusted (n = 939) C+P 1.00
B+P 1.03 0.80 to 1.34 0.8
PA 1.17 0.90 to 1.51 0.2
Note
Unadjusted models include a random effect for practice and adjusted models include age in years, time in trial in years and
a random effect for practice.
TABLE 34 Kaplan–Meier estimates of probability of being dental pain and/or dental sepsis free, by year and
treatment arm (ITT analysis set, n= 1058)
Trial
arm
Interval
in years
Number
at risk
Number of episodes
of first dental pain
and/or dental sepsis
Censored
(last CRF, no
episode), n
Probability of remaining
pain/sepsis free beyond
the end of the interval 97.5% CI
B+P 0 1 352 70 41 0.79 0.74 to 0.83
1 2 241 40 26 0.65 0.59 to 0.70
2 3 175 25 86 0.53 0.46 to 0.59
3 4 64 6 58 0.44 0.35 to 0.52
C+P 0 1 352 79 30 0.77 0.72 to 0.81
1 2 243 38 27 0.64 0.58 to 0.69
2 3 178 26 92 0.51 0.45 to 0.57
3 4 60 5 54 0.44 0.35 to 0.51
4 5 1 0 1 0.44 0.35 to 0.51
PA 0 1 354 95 40 0.72 0.66 to 0.76
1 2 219 45 24 0.56 0.50 to 0.61
2 3 150 18 77 0.47 0.41 to 0.53
3 4 55 3 52 0.42 0.35 to 0.49
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TABLE 35 Summary statistics, time to first episode (ITT analysis set, n= 1058)
Dental pain and/or dental
sepsis free survival (years)
Trial arm
Total (n= 1058)C+P (n= 352) B+P (n= 352) PA (n= 354)
n 352 352 354 1058
Median (97.5% CI) 3.1 (2.8 to a) 3.6 (2.7 to a) 2.8 (1.8 to a) 3.1 (2.8 to 3.6)
Lower quartile (97.5% CI) 1.1 (0.7 to 1.5) 1.3 (0.9 to 1.6) 0.9 (0.6 to 1.1) 1.0 (0.9 to 1.2)
Upper quartile (97.5% CI) a 3.7 (3.7 to a) 3.6 (3.6 to a) a (3.7 to a)
a Cannot be estimated because too few participants were followed up at this time who went on to experience a first
episode of dental pain and/or dental sepsis.
TABLE 36 Exploratory univariate logistic regression models for dental pain and/or sepsis
Variable n Risk ratio 97.5% CI p-value
Age (years) 1057 0.99 0.92 to 1.06 0.6
Ethnicity (white) 955 1.08 0.85 to 1.37 0.6
Water fluoridation (p.p.m.)a 1058 0.75 0.49 to 1.15 0.4
Index of deprivation (deciles)a 1058 1.03 0.98 to 1.07 0.3
Number of decayed teeth at baseline
from ICDAS charting (level 5/6 cavitation)
1006 1.12 1.09 to 1.16 < 0.001
a These variables were measured at the dental practice level.
Note
Each row is a different univariate model
TABLE 37 Exploratory multivariable model adjusted for age, time in trial, number of decayed teeth at baseline,
ethnicity, index of deprivation and water fluoridation (n= 922)
Trial arm Risk difference 97.5% CI p-value
C+P 0.00
B+P –0.0006 –0.08 to 0.08 > 0.9
PA 0.07 –0.01 to 0.16 0.06
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Secondary outcomes: part 1 – caries progression
TABLE 38 Summary of caries experience in primary dentition at final visit, by randomised treatment arm, for those
children (n= 653 of the ITT analysis set) who had both baseline and final visit ICDAS charts completed
Primary dentition (maximum: 20 teeth)
Trial arm
All (n= 653)C+P (n= 228) B+P (n= 216) PA (n= 209)
Total number of primary teeth per child
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 11.0 (6.0–12.0) 10.5 (8.0–12.0) 10.0 (6.0–12.0) 11.0 (7.0–12.0)
Mean (SD) 9.60 (4.51) 10.15 (4.86) 9.36 (4.76) 9.71 (4.71)
Maximum 20.0 20.0 20.0 20.0
Number of caries-free primary teeth (ICDAS summary code 00)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 7.0 (1.5–11.0) 7.0 (2.0–10.5) 7.0 (2.0–10.0) 7.0 (2.0–10.0)
Mean (SD) 6.48 (4.96) 6.98 (5.38) 6.39 (4.69) 6.62 (5.02)
Maximum 18.0 20.0 19.0 20.0
Number of primary teeth for which the highest surface caries severity code is ICDAS 0–2
d ICDAS 0–2
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 9.0 (3.0–12.0) 9.0 (4.0–11.0) 8.0 (4.0–11.0) 9.0 (4.0–11.0)
Mean (SD) 7.69 (5.16) 8.12 (5.33) 7.47 (4.91) 7.76 (5.14)
Maximum 20.0 20.0 19.0 20.0
Number of primary teeth for which the highest surface caries severity code is ICDAS 3–4
d ICDAS 3–4
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–1.0) 0.0 (0.0–1.0) 0.0 (0.0–1.0) 0.0 (0.0–1.0)
Mean (SD) 0.49 (1.00) 0.54 (1.08) 0.55 (1.08) 0.52 (1.05)
Maximum 6.0 9.0 8.0 9.0
Number of primary teeth for which the highest surface caries severity code is ICDAS 5–6
d ICDAS 5–6
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–1.0) 0.0 (0.0–1.0) 0.0 (0.0–1.0) 0.0 (0.0–1.0)
Mean (SD) 0.61 (1.36) 0.67 (1.40) 0.87 (1.70) 0.71 (1.49)
Maximum 10.0 9.0 9.0 10.0
Number of primary teeth for which the highest surface caries severity code is ICDAS 4–6
d ICDAS 4–6 [equivalent to d3]
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–1.0) 0.0 (0.0–1.0) 0.0 (0.0–1.0) 0.0 (0.0–1.0)
Mean (SD) 0.79 (1.52) 0.90 (1.72) 1.06 (1.89) 0.91 (1.71)
Maximum 10.0 9.0 9.0 10.0
continued
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TABLE 38 Summary of caries experience in primary dentition at final visit, by randomised treatment arm, for those
children (n= 653 of the ITT analysis set) who had both baseline and final visit ICDAS charts completed (continued )
Primary dentition (maximum: 20 teeth)
Trial arm
All (n= 653)C+P (n= 228) B+P (n= 216) PA (n= 209)
Missing primary teeth due to caries (ICDAS summary code 97)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.28 (1.07) 0.19 (0.84) 0.28 (1.26) 0.25 (1.07)
Maximum 8.0 8.0 10.0 10.0
Filled (but not decayed) primary teeth (number of teeth with at least one surface with ICDAS restoration code
of 3–7 and caries severity code of 0–3)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 1.0 (0.0–2.0) 1.0 (0.0–2.0) 1.0 (0.0–2.0) 1.0 (0.0–2.0)
Mean (SD) 1.12 (1.15) 1.19 (1.14) 1.20 (1.19) 1.17 (1.16)
Maximum 5.0 5.0 5.0 5.0
d3mft
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 2.0 (1.0–3.0) 2.0 (1.0–3.0) 2.0 (0.0–4.0) 2.0 (1.0–3.0)
Mean (SD) 2.19 (2.18) 2.28 (2.21) 2.54 (2.70) 2.33 (2.37)
Maximum 11.0 12.0 16.0 16.0
TABLE 39 Summary of caries experience in first permanent molars at final visit, by randomised treatment arm,
for those children (n= 653 of the ITT analysis set) who had both baseline and final visit ICDAS charts completed
Permanent dentition: first permanent
molars – teeth 16/26/36/46
Trial arm
All (n= 653)C+P (n= 228) B+P (n= 216) PA (n= 209)
Total number of first permanent molars per child
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 4.0 (4.0–4.0) 4.0 (4.0–4.0) 4.0 (4.0–4.0) 4.0 (4.0–4.0)
Mean (SD) 3.74 (0.87) 3.63 (1.00) 3.73 (0.95) 3.70 (0.94)
Maximum 4.0 4.0 4.0 4.0
Number of caries-free first permanent molars (ICDAS summary code 00)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 4.0 (2.0–4.0) 4.0 (2.0–4.0) 4.0 (2.0–4.0) 4.0 (2.0–4.0)
Mean (SD) 3.05 (1.41) 3.05 (1.36) 3.08 (1.37) 3.06 (1.38)
Maximum 4.0 4.0 4.0 4.0
Number of first permanent molars for which the highest surface caries severity code is ICDAS 0–2
D ICDAS 0–2
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 4.0 (4.0–4.0) 4.0 (3.0–4.0) 4.0 (4.0–4.0) 4.0 (4.0–4.0)
Mean (SD) 3.65 (0.92) 3.50 (1.03) 3.63 (0.99) 3.59 (0.98)
Maximum 4.0 4.0 4.0 4.0
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TABLE 39 Summary of caries experience in first permanent molars at final visit, by randomised treatment arm,
for those children (n= 653 of the ITT analysis set) who had both baseline and final visit ICDAS charts completed
(continued )
Permanent dentition: first permanent
molars – teeth 16/26/36/46
Trial arm
All (n= 653)C+P (n= 228) B+P (n= 216) PA (n= 209)
Number of first permanent molars for which the highest surface caries severity code is ICDAS 3–4
D ICDAS 3–4
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.08 (0.33) 0.09 (0.32) 0.03 (0.21) 0.07 (0.30)
Maximum 3.0 2.0 2.0 3.0
Number of first permanent molars for which the highest surface caries severity code is ICDAS 5–6
D ICDAS 5–6
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.01 (0.11) 0.04 (0.21) 0.07 (0.30) 0.04 (0.22)
Maximum 1.0 2.0 2.0 2.0
Number of first permanent molars for which the highest surface caries severity code is ICDAS 4–6
D ICDAS 4–6 [equivalent to D3]
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.02 (0.13) 0.06 (0.30) 0.07 (0.30) 0.05 (0.26)
Maximum 1.0 2.0 2.0 2.0
Missing first permanent molars due to caries (ICDAS summary code 97)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.004 (0.066) 0.000 (0.000) 0.000 (0.000) 0.002 (0.039)
Maximum 1.0 0.0 0.0 1.0
Filled (but not decayed) first permanent molars (number with at least one surface with ICDAS restoration code
of 3–7 and caries severity code of 0–3)
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.12 (0.47) 0.13 (0.50) 0.12 (0.50) 0.13 (0.49)
Maximum 4.0 4.0 3.0 4.0
D3MFT
Minimum 0.0 0.0 0.0 0.0
Median (IQR) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Mean (SD) 0.14 (0.52) 0.20 (0.64) 0.19 (0.60) 0.18 (0.59)
Maximum 4.0 4.0 3.0 4.0
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TABLE 41 Summary of progression and number of progressed teeth (that were sound or had reversible caries at
baseline) by arm (n= 653)
Outcome
Trial arm
Total (n= 653)C+P (n= 228) B+P (n= 216) PA (n= 209)
Primary dentition
Progression, n (%)
Yes 132 (57.9) 133 (61.6) 134 (64.1) 399 (61.1)
Number of progressed primary teeth that were sound or had reversible caries at baseline
Minimum 0 0 0 0
Median (IQR) 1 (0–2) 1 (0–2) 1 (0–2) 1 (0–2)
Mean (SD) 1.2 (1.3) 1.2 (1.3) 1.4 (1.4) 1.3 (1.4)
Maximum 6 6 6 6
Number, n (%)
0 96 (42.1) 83 (38.4) 75 (35.9) 254 (38.9)
1 56 (24.6) 59 (27.3) 52 (24.9) 167 (25.6)
2 36 (15.8) 38 (17.6) 36 (17.2) 110 (16.8)
3 25 (11.0) 21 (9.7) 24 (11.5) 70 (10.7)
4 10 (4.4) 10 (4.6) 17 (8.1) 37 (5.7)
5 3 (1.3) 3 (1.4) 2 (1.0) 8 (1.2)
6 2 (0.9) 2 (0.9) 3 (1.4) 7 (1.1)
First permanent molars
Progression, n (%)
Yes 21 (9.2) 26 (12.0) 24 (11.5) 71 (10.9)
Number of progressed first permanent molars
Minimum 0 0 0 0
Median (IQR) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
Mean (SD) 0.1 (0.5) 0.2 (0.6) 0.2 (0.6) 0.2 (0.6)
Maximum 4 4 3 4
Number, n (%)
0 207 (90.8) 190 (88.0) 185 (88.5) 582 (89.1)
1 14 (6.1) 17 (7.9) 13 (6.2) 44 (6.7)
2 5 (2.2) 3 (1.4) 6 (2.9) 14 (2.1)
3 0 (0.0) 4 (1.9) 5 (2.4) 9 (1.4)
4 2 (0.9) 2 (0.9) 0 (0.0) 4 (0.6)
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Secondary outcomes: part 2 (child- and parent-reported outcomes) – oral
health-related quality of life
TABLE 42 Summary of the number of parent ‘baseline’ and ‘final assessment’ questionnaires for which a P-CPQ-16
score could be calculated after imputation (ITT analysis set, n= 1058)
ITT analysis set
participants
(n = 1058) CRFs (N)
Parent
questionnaires (N)
Both baseline
and final parent
questionnaires (n)
Non-missing
P-CPQ-16 score
after imputation,a
n/N (%)
Both baseline and
final P-CPQ-16
score, n/N (%)
Baseline 1058 984 627 923/1058 (87.2) 560/1058 (52.9)
Final 711 (final visit
attended)
664 630b/711 (88.6)
a Based on the rule of at least two questions answered in each of four subdomains.
b There were 70 final assessment P-CPQ-16 scores after imputation that did not have a corresponding baseline P-CPQ-16
score after imputation; 36 had both baseline and final questionnaires and therefore were lost owing to the imputation
rules (i.e. because of the number of missing data on the P-CPQ-16 at one or both time points) and 34 had only a
final questionnaire.
TABLE 43 Mean difference in P-CPQ-16 score between randomised treatment arms at final visit, adjusted for
baseline, age at randomisation and time in the triala (n= 560)
Variable Mean difference 97.5% CI p-value
Baseline P-CPQ-16 score 0.39 0.30 to 0.48 < 0.001
Arm (compared with C+P arm)
B+P 0.27b –1.08 to 1.62 0.7
PA 0.17b –1.20 to 1.53 0.8
Age (years) at randomisation –0.08 –0.52 to 0.36 0.7
Time in trial (years) 0.10 –1.42 to 1.62 0.9
a A random effect for practice is also included, although this was not significant.
b A positive difference indicates a higher mean score on the P-CPQ-16 for the given arm.
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Dental anxiety
Child questionnaires: returns, Modified Child Dental Anxiety Scale (faces) completeness
and reliability
TABLE 47 Summary of the number of child questionnaires (ITT analysis set, n= 1058)
ITT analysis set participants
(n= 1058) CRFs (N)
Child questionnaires,
n/N (%)
Baselinea 1058 1045/1058 (98.8)
Total 7713 6793/7713 (88.1)
a The definition of a baseline child questionnaire was as follows: first questionnaire by date. If date was missing but
baseline was circled then it was counted as baseline.
TABLE 48 Distribution of number of missing MCDASf items (ITT analysis set, n= 6793)
Number of missing items Baseline, n (% of 1045) All visits, n (% of 6793)
0 865 (82.8) 6032 (88.8)
1 72 (6.9) 277 (4.1)
2 25 (2.4) 108 (1.6)
3 27 (2.6) 115 (1.7)
4 35 (3.4) 112 (1.7)
5 2 (0.2) 23 (0.3)
6 19 (1.8) 126 (1.9)
TABLE 49 Baseline and all-visit MCDASf score by intervention arm (ITT analysis set, n = 1058)
MCDASf scorea C+P B+P PA Total
Baseline (n = 1045)
n 336 324 329 989
Mean (SD) 13.8 (4.9) 14.2 (5.3) 14.3 (5.3) 14.1 (5.1)
Median (IQR) 14 (10–17) 14 (10.8–18) 14 (10–18) 14 (10–18)
Range 6–28 6–28 6–30 6–30
All visits except baseline (n = 5748)
n 1986 1850 1707 5543
Mean (SD) 15.1 (5.3) 15.1 (5.5) 15.3 (5.5) 15.2 (5.5)
Median (IQR) 15 (11–19) 15 (11–19) 15 (11–19) 15 (11–19)
Range 6–30 6–30 6–30 6–30
a A lower score indicates less worry.
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Child-reported anticipatory anxiety and worry: Q4 and Q6 (child questionnaire)
TABLE 50 Mean difference in MCDASf score between randomised treatment arms, adjusted for baseline, age at
randomisation and time in triala (n= 5300b)
Variable Mean difference 97.5% CI p-value
Baseline MCDASf 0.40 0.35 to 0.46 < 0.001
Arm
C+P (reference category) 0.00
B+P –0.07 –0.74 to 0.59 0.8
PA 0.22 –0.44 to 0.89 0.5
Time in study (years) 0.17 –0.22 to 0.56 0.5
Age (years) –0.12 –0.35 to 0.10 0.2
a A random effect is included to account for participants within practices.
b The reason that n = 5300 in this model is because of the exclusion of participants with either a missing baseline score or
a baseline score only and no subsequent measures.
TABLE 51 Number of missing items (ITT analysis set, n= 6793 questionnaires)
Question n (% of 6793)
Q4. Before you saw the dentist today, were you? Not worried, a little worried, very worried 167 (2.5)
Q6. Thinking about your visit to the dentist today, were you? Not worried, a little worried, very worried 306 (4.5)
TABLE 52 Descriptive statistics for Q4: before you saw the dentist today, were you?
Q4: Before you saw the dentist today, were you? C+P B+P PA Total
Baseline (N = 1045)
n 344 337 340 1021
Not worried, n (%) 243 (70.6) 237 (70.3) 240 (70.6) 720 (70.5)
A little worried, n (%) 82 (23.6) 83 (24.6) 69 (20.3) 233 (22.8)
Very worried, n (%) 20 (5.8) 17 (5.0) 31 (9.1) 68 (6.7)
All visits excluding baseline (N = 5748)
n 1990 1888 1727 5605
Not worried, n (%) 1303 (65.5) 1232 (65.3) 1194 (69.1) 3729 (66.5)
A little worried, n (%) 586 (29.5) 550 (29.1) 444 (25.7) 1580 (28.2)
Very worried, n (%) 101 (5.1) 106 (5.6) 89 (5.2) 296 (5.3)
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Parent-reported child anticipatory anxiety and worry
TABLE 53 Child-reported pre-treatment anticipatory anxiety between randomised treatment arms adjusted for
baseline, age at randomisation and time in triala (n= 5496b)
Trial arm Risk difference 97.5% CI p-value
C+P (reference category) 0.00
B+P 0.02 –0.04 to 0.07 0.5
PA –0.03 –0.09 to 0.02 0.1
a Random effects were also included to account for the nested structure of the repeated measures within children and
children within dental practices.
b The reason that n = 5496 in this model is because of the exclusion of participants with either a missing baseline score or
a baseline score only and no subsequent measures.
TABLE 54 Descriptive statistics for question: before seeing the dentist today, do you think your child was?
(ITT analysis set)
Before seeing the dentist today, do you think your
child was? C+P B+P PA Total
Baseline (N = 1044)
n 306 314 309 929
Not at all worried, n (%) 215 (70.3) 206 (65.6) 199 (64.4) 620 (66.7)
Very slightly worried, n (%) 57 (18.6) 75 (23.9) 65 (21.0) 197 (21.2)
Fairly worried, n (%) 16 (5.2) 19 (6.1) 22 (7.1) 57 (6.1)
Quite worried, n (%) 13 (4.3) 8 (2.6) 14 (4.5) 35 (3.8)
Very worried, n (%) 5 (1.6) 6 (1.9) 9 (2.9) 20 (2.2)
All visits excluding baseline (n = 5703)
n 1918 1848 1693 5459
Not at all worried, n (%) 1269 (66.2) 1277 (69.1) 1211 (71.5) 3757 (68.8)
Very slightly worried, n (%) 458 (23.9) 369 (20.0) 349 (20.6) 1176 (21.5)
Fairly worried, n (%) 114 (5.9) 124 (6.7) 74 (4.4) 312 (5.7)
Quite worried, n (%) 52 (2.7) 49 (2.7) 32 (1.9) 133 (2.4)
Very worried, n (%) 25 (1.3) 29 (1.6) 27 (1.6) 81 (1.5)
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Child-reported treatment-related anxiety and worry
TABLE 55 Parent-reported child pre-treatment worry between randomised treatment arms adjusted for baseline,
age at randomisation and time in triala (n= 4901b)
Trial arm Risk difference 97.5% CI p-value
C+P (reference category) 0.00
B+P –0.04 –0.09 to 0.02 > 0.9
PA –0.06 –0.11 to –0.003 0.02
a Random effects were also included to account for the nested structure of the repeated measures within children and
children within dental practices.
b The reason that n = 4901 in this model is because of the exclusion of participants with either a missing baseline score or
a baseline score only and no subsequent measures.
TABLE 56 Descriptive statistics of Q6: thinking about your visit to the dentist today, were you?
Q6: Thinking about your visit to
the dentist today, were you? C+P B+P PA Total
All visits (N = 6793)
n 2277 2188 2022 6487
Not worried, n (%) 1572 (69.0) 1514 (69.2) 1467 (72.6) 4553 (70.2)
A little worried, n (%) 571 (25.1) 540 (24.7) 439 (21.7) 1550 (23.9)
Very worried, n (%) 134 (5.9) 134 (6.1) 116 (5.7) 384 (5.9)
TABLE 57 Child-reported treatment-related anxiety between randomised treatment arms, adjusteda for age at
randomisation and time in trialb (n= 6487)
Trial arm Risk difference 97.5% CI p-value
C+P (reference category) 0.00
B+P –0.002 –0.05 to 0.04 > 0.9
PA –0.04 –0.08 to 0.01 0.06
a This model is not adjusted for baseline as ‘treatment-related’ questions were collected at every visit.
b Random effects were also included to account for the nested structure of the repeated measures within children and
children within dental practices.
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Parent-reported child treatment-related anxiety and worry
Child-, parent- and dentist-reported child discomfort during treatment
TABLE 58 Descriptive statistics for question: thinking about being at the dentist today, do you think your child was?
Thinking about being at the dentist today,
do you think your child was? C+P B+P PA Total
All visits (N = 6747)
n 2262 2188 2048 6498
1. Not at all worried, n (%) 1451 (64.2) 1474 (67.4) 1406 (68.7) 4331 (66.7)
2. Very slightly worried, n (%) 569 (25.2) 485 (22.2) 443 (21.6) 1497 (23.0)
3. Fairly worried, n (%) 117 (5.2) 133 (6.1) 108 (5.3) 358 (5.5)
4. Quite worried, n (%) 76 (3.4) 55 (2.5) 44 (2.2) 175 (2.7)
5. Very worried, n (%) 49 (2.2) 41 (1.9) 47 (2.3) 137 (2.1)
TABLE 59 Parent-reported child treatment-related worry between randomised treatment arms, adjusted for age at
randomisation and time in trialb (n= 6498)
Trial arm Risk difference 97.5% CI p-value
C+P (reference category) 0.00
B+P –0.04 –0.09 0.02 0.1
PA –0.04 –0.10 0.01 0.06
a This model is not adjusted for baseline as ‘treatment-related’ questions were collected at every visit.
b Random effects were also included to account for the nested structure of the repeated measures within children and
children within dental practices.
TABLE 60 Reports of child discomfort during treatment
Experience of discomfort during treatment C+P B+P PA Total
Child reported (n) 2278 2172 2018 6468
‘Not hurt at all’, n (%) 1551 (68.1) 1492 (68.7) 1528 (75.7) 4571 (70.7)
Parent reported (n) 2116 2062 1915 6039
‘Not at all painful’, n (%) 1536 (72.6) 1581 (76.7) 1596 (83.3) 4713 (77.4)
Dentist reported (n) 2706 2593 2414 7713
‘No apparent discomfort’, n (%) 1614 (62.6) 1640 (67.5) 1736 (75.7) 4990 (68.4)
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TABLE 61 Descriptive statistics of Q7: thinking about being at the dentist today, did it?
Q7: Thinking about being at the dentist today,
did it? C+P B+P PA Total
All visits (N = 6793)
n 2278 2172 2018 6468
Not hurt at all, n (%) 1551 (68.1) 1492 (68.7) 1528 (75.7) 4571 (70.7)
Hurt a little, n (%) 586 (25.7) 559 (25.7) 397 (19.7) 1542 (23.8)
Hurt a lot, n (%) 141 (6.2) 121 (5.6) 93 (4.6) 355 (5.5)
TABLE 62 Descriptive statistics: thinking about being at the dentist today, how do you think your child found the
treatment?
Thinking about being at the dentist today how
do you think your child found the treatment? C+P B+P PA Total
All visits (N = 6747)
n 2116 2062 1915 6093
Not at all painful 1536 (72.6) 1581 (76.7) 1596 (83.3) 4713 (77.4)
A little painful 476 (22.5) 394 (19.1) 259 (13.5) 1129 (18.5)
Somewhat painful 61 (2.9) 50 (2.4) 25 (1.3) 136 (2.2)
Painful 25 (1.2) 21 (1.0) 23 (1.2) 69 (1.1)
Very painful 18 (0.9) 16 (0.8) 12 (0.6) 46 (0.8)
TABLE 63 Dentist-reported child discomfort summarised by arm and overall
Discomfort
Trial arm, n (% of non-missing)
Total (N= 7713),
n (% of non-missing)C+P (N= 2706) B+P (N= 2593) PA (N= 2414)
No apparent discomfort 1614 (62.6) 1640 (67.5) 1736 (75.7) 4990 (68.4)
Very mild, almost trivial 453 (17.6) 429 (17.7) 313 (13.7) 1195 (16.4)
Mild, not significant 257 (10.0) 192 (7.9) 110 (4.8) 559 (7.7)
Moderate, but child coped 219 (8.5) 139 (5.7) 105 (4.6) 463 (6.3)
Significant and unacceptable 35 (1.4) 31 (1.3) 28 (1.2) 94 (1.3)
Total 2578 2431 2292 7301
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Dentist-reported child-behaviour and co-operation
TABLE 64 Dentist-reported child behaviour and compliance, summarised by arm and overall
Please rate the child’s behaviour during
the treatment session C+P (N= 2706) B+P (N= 2593) PA (N= 2414) Total (N= 7713)
1. The child refused treatment: cried
forcefully, fearful, evidence of extreme
negativism. It was very difficult to make
any progress, n (% of non-missing)
92 (3.6) 56 (2.3) 54 (2.4) 202 (2.8)
2. The child appeared reluctant to listen,
respond or to accept the treatment and had
some evidence of negative attitude. Some
progress was possible, n (% of non-missing)
181 (7.0) 137 (5.7) 105 (4.6) 423 (5.8)
3. The child was accepting the treatment but
was cautious. The child was willing to comply
with the dentist, but appeared to have some
reservations, n (% of non-missing)
875 (34.0) 740 (30.5) 623 (27.2) 2238 (30.7)
4. Child was completely co-operative; he/she
was interested in the dental procedure
and even enjoyed the experience,
n (% of non-missing)
1426 (55.4) 1492 (61.5) 1508 (65.9) 4426 (60.7)
Total non-missing (N) 2574 2425 2290 7289
TABLE 65 Dentist-reported difficulty providing treatment, summarised by arm and overall
Were there any difficulties providing
treatment? C+P (N= 2706) B+P (N= 2593) PA (N= 2414) Total (N= 7713)
Yes, n (% of non-missing) 594 (23.0) 493 (20.3) 399 (17.5) 1486 (20.4)
No, n (% of non-missing) 1987 (77.0) 1933 (79.7) 1888 (82.6) 5808 (79.6)
Total non-missing (N) 2581 2426 2287 7294
TABLE 66 Reasons for difficulty providing treatment, summarised by arm and overall
If yes please explain C+P (N= 2706) B+P (N= 2593) PA (N= 2414) Total (N= 7713)
Compliance of the child,
n (% of non-missing)
363 (61.1) 259 (52.5) 230 (57.6) 852 (57.3)
Compliance of the parent,
n (% of non-missing)
26 (4.4) 18 (3.7) 19 (4.8) 63 (4.2)
Small mouth, n (% of non-missing) 79 (13.3) 92 (18.7) 72 (18.0) 243 (16.4)
Moisture control, n (% of non-missing) 107 (18.0) 127 (25.8) 93 (23.3) 327 (22.0)
Unable to deliver local anaesthetic,
n (% of non-missing)
54 (9.1) 13 (2.6) 13 (3.3) 80 (5.4)
Other clinical (please list),
n (% of non-missing)
82 (13.8) 98 (19.9) 44 (11.0) 224 (15.1)
Total answered ‘yes’ to difficulties (N) 594 493 399 1486
Note
Percentages will not add to 100 as multiple options may have been selected for this question.
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TABLE 67 Use of inhalation sedation, summarised by arm and overall
Did you use inhalation sedation/relative
analgesia during treatment? C+P (N= 2706) B+P (N= 2593) PA (N= 2414) Total (N= 7713)
Yes, n (% of non-missing) 23 (0.9) 16 (0.6) 14 (0.6) 53 (0.7)
No, n (% of non-missing) 2657 (99.1) 2545 (99.4) 2366 (99.4) 7568 (99.3)
Total non-missing (N) 2680 2561 2380 7621
TABLE 68 Distribution of number of missing DDQ-8 items (ITT analysis set, n= 6747)
Number of missing items All visits, n (% of 6747)
0 6229 (92.3)
1 194 (2.9)
2 36 (0.5)
3 12 (0.2)
4 5 (0.1)
5 6 (0.1)
6 11 (0.2)
7 41 (0.6)
8 213 (3.2)
TABLE 69 Descriptive statistics of DDQ-8 over all visits by arm (ITT analysis set, n= 6747)
Overall DDQ-8a
score n C+P (n= 2347) n B+P (n= 2276) n PA (n= 2124) n Total (n= 6747)
Minimum 2254 0 2177 0 2040 0 6471 0
Median (IQR) 1 (0–3) 1 (0–3) 1 (0–3) 1 (0–3)
Mean (SD) 1.9 (2.4) 2.1 (2.4) 2.1 (2.5) 2.0 (2.4)
Maximum 16 16 15 16
a Lower scores indicate less dental discomfort.
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Appendix 5 Health economics (see Chapter 4)
Cost data collection (see Chapter 4, Cost data collection, and Costing
methods)
TABLE 70 Unit costs: microcosting
Resource Unit Cost (£) Source
Treatment provider
GDP Cost per minute 0.68 CRF (Q10a/11a)/PSSRU 2017119
Dental therapist Cost per minute 0.28 CRF (Q10a/11a)/Agenda for Change band 5 point 20120
Dental hygienist Cost per minute 0.28 CRF (Q10a)/Agenda for Change band 5 point 20120
Oral health educator Cost per minute 0.28 CRF (Q10a)/Agenda for Change band 5 point 20120
Childsmile/extended duty
dental nurse
Cost per minute 0.23 CRF (Q10a)/Agenda for Change band 4 point 14120
Vocational therapist Cost per minute 0.23 CRF (Q10a)/Agenda for Change band 4 mid-point120
Dental nurse Cost per minute 0.21 CRF (Q10a)/Agenda for Change band 4 point 1120
CT1a Cost per minute 0.35 CRF (Q10a)/Agenda for Change band 6 point 6/band 7 point 1120
Dental nurse trainee Cost per minute 0.16 CRF (Q10a)/Agenda for Change 75% of band 4 point 1120
Resources used at every visit
Resources at every visit Cost per visit 2.19 CRF completed/see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/
(accessed 22 February 2019)
Resources at every visit:
fluoride varnish
Cost per visit 1.74 CRF (Q10b)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Prevention
Fissure sealants of
permanent teeth (resin)
Cost per visit 3.99 CRF (Q10b)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Fluoride varnish Cost per visit 0.27 CRF (Q10b)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Operative treatment
Topical anaesthetic gel Cost per visit 0.05 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Local anaesthetic Cost per visit 1.08 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Fissure sealant: glass
ionomer
Cost per tooth 4.54 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Preformed metal crown Cost per tooth 14.48 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
continued
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TABLE 70 Unit costs: microcosting (continued )
Resource Unit Cost (£) Source
Hall Technique crown Cost per tooth 6.92 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Pulpotomy Cost per tooth 25.02 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Extraction Cost per tooth 2.58 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Opening a lesion Cost per tooth 2.55 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Filling
Amalgam Cost per tooth 4.11 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Glass ionomer Cost per tooth 4.54 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Composite Cost per tooth 3.48 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Compomer Cost per tooth 3.48 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
RMGI Cost per tooth 4.82 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Resources used to
administer a filling
Cost per tooth 5.10 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
More than one surface used
Filling: amalgam Cost per tooth 4.27 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Filling: glass ionomer Cost per tooth 5.09 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Filling: composite Cost per tooth 4.04 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Filling: compomer Cost per tooth 4.04 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Filling: RMGI Cost per tooth 5.38 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Filling: resources used to
administer a filling
Cost per tooth 5.38 CRF (Q12)/see the project web page: www.journalslibrary.
nihr.ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
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TABLE 70 Unit costs: microcosting (continued )
Resource Unit Cost (£) Source
Miscellaneous
Radiographs Cost per image 1.51 CRF (Q9)/see the project web page: www.journalslibrary.nihr.
ac.uk/programmes/hta/074403/#/ (accessed
22 February 2019)
Inhalation sedation
(excluding staff costs)
Cost per visit 59.76 CRF (Q17)/NICE 2010163 (inflated to current prices)
Medications
Paracetamol Cost per dose 0.04 CRF (Q20)/BNF164
Ibuprofen Cost per dose 0.09 CRF (Q20)/BNF164
Mouth rinse Cost per bottle 7.14 CRF (Q20)/BNF164
Mouth spray Cost per spray 4.64 CRF (Q20)/BNF164
Mouth gel Cost per tube 1.56 CRF (Q20)/BNF164
Bonjela® (Reckitt Benckiser
Group plc, Slough, UK)
Cost per tube 3.55 CRF (Q20)/BNF164
Amoxicillin Cost per dose 0.05 CRF (Q21)/BNF164
Penicillin Cost per dose 0.74 CRF (Q21)/BNF164
Metronidazole Cost per dose 1.03 CRF (Q21)/BNF164
Erythromycin Cost per dose 0.22 CRF (Q21)/BNF164
Grouping A Cost per referral 118.00 Patient referral form (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/personal communication (Ben Cole)
Grouping B Cost per referral 793.00 Patient referral form (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/personal communication (Ben Cole)
Grouping C Cost per referral 793.00 Patient referral form (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/personal communication (Ben Cole)
Grouping D Cost per referral 418.00 Patient referral form (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/personal communication (Ben Cole)
Grouping E Cost per referral 418.00 Patient referral form (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/personal communication (Ben Cole)
Grouping F Cost per referral 118.00 Patient referral form (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/personal communication (Ben Cole)
Time off paid work Cost per day 67.73 Parent questionnaire (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/;
accessed 22 February 2019)/ONS 2017124
Time off leisure activities Cost per day 39.84 Parent questionnaire (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/;
accessed 22 February 2019)/Department for Transport 2017116
Time off school Cost per day 39.84 Parent questionnaire (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/;
accessed 22 February 2019)/Department for Transport 2017116
continued
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TABLE 70 Unit costs: microcosting (continued )
Resource Unit Cost (£) Source
Additional child care Cost per day 24.90 Parent questionnaire (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/Family and Childcare Trust 2017126
Pain medication (over the counter)
Calprofen® (ibuprofen)
(Johnson & Johnson,
New Brunswick, NJ, USA)a
Cost per bottle 3.59 Parent questionnaire (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/www.lloydspharmacy.com/en/calprofen-
174-ibuprofen-3-months-100ml (accessed 8 December 2017)
Calpol® (paracetamol)
(Johnson & Johnson)a
Cost per bottle 2.99 Parent questionnaire (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/www.lloydspharmacy.com/en/calpol-sixplus-
suspension-sugar-free-strawberry-flavour-6-years-80ml
(accessed 8 December 2017)
Bonjelaa Cost per tube 2.99 Parent questionnaire (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/www.lloydspharmacy.com/en/bonjela-
teething-gel-15 g (accessed 8 December 2017)
Anbesol® (Alliance
Pharmaceuticals,
Chippenham, UK)a
Cost per tube 2.39 Parent questionnaire (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/www.lloydspharmacy.com/en/anbesol-
teething-gel-6007901–44 (accessed 8 December 2017)
Clove oila Cost per bottle 1.00 Parent questionnaire (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/www.lloydspharmacy.com/en/care-clove-oil-
10ml (accessed 8 December 2017)
Child’s soluble dispirina Cost per tablet 0.11 Parent questionnaire (see the project web page: www.
journalslibrary.nihr.ac.uk/programmes/hta/074403/#/; accessed
22 February 2019)/www.lloydspharmacy.com/en/disprin-
aspirin-32-soluble-tablets (accessed 8 December 2017)
ONS, Office for National Statistics; PSSRU, Personal Social Services Research Unit.
a CT1 is Dental Core Training, a period of postgraduate development that extends from the end of Dental Vocational
(foundation) Training to the start of Specialty Training.
b Liquid and gel medications were assumed to have a lifespan of at least 6 months, to prevent double-counting.
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TABLE 71 Unit costs: FFS
Resource Unit Cost (£) Source
Examination costs
(6–12 years)a
Cost per month 4.26 Statement of dental remuneration (page 41)122
Prevention
Fissure sealant Cost per tooth 8.75 CRF (Q10b)/statement of dental remuneration (page 43)122
Fluoride varnish Cost per course
of treatmentb
41.45 CRF (Q10b)/statement of dental remuneration (page 10)122
Operative treatment
Filling Cost per tooth 15.45 CRF (Q12)/statement of dental remuneration (page 43)122
Crown Cost per tooth 22.85 CRF (Q12)/statement of dental remuneration (page 43)122
Extraction (one tooth) Cost per course
of treatmentb
8.75 CRF (Q12)/statement of dental remuneration (page 50)122
Extraction (two teeth) Cost per course
of treatmentb
15.75 CRF (Q12)/statement of dental remuneration (page 50)122
Extraction Cost per visit 7.10 CRF (Q12)/statement of dental remuneration (page 51)122
Pulpotomy Cost per tooth 17.40 CRF (Q12)/statement of dental remuneration (page 43)122
Sedation Cost per visit 13.30 CRF (Q12)/statement of dental remuneration (page 53)122
Q, question.
a Basic fee for the care and treatment to Childsmile Practice standards. This includes examinations, oral hygiene advice,
tooth-brushing advice, dietary advice, radiographs, and all clinical prevention.
b Course of treatment is based on 5 months, as per the statement of dental remuneration.
TABLE 72 Unit costs: total UDA values
Resource Cost (£), mean (SD) Cost (£), median (IQR) Minimum (£) Maximum (£) Source
Total UDA value 29.68 (11.31) 28.01 (24.31–31.83) 21.45 98.74 British Dental
Association
website165
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Missing data (see Chapter 4, Data validity and completeness)
TABLE 73 Missing CRF data and assumptions
n (%)a
PA
PA missing
Assumed PA was not provided at that visit and would have been already provided as part of the child’s course
of treatment
14 (< 1)
PA pillars missing
Assumed they had pillars brushing and diet advice 9 (< 1)
PA staff
Student provided PA – assumed a GDP was present 7 (< 1)
Dental nurse provided PA – assumed no cost as dental nurse was assumed to be present for the duration of
the visit
151 (2)
Operative treatment
Operative treatment missing
Assumed no operative treatment provided 33 (< 1)
Operative treatment staff missing
Assumed to be the same as PA staff, if it was a GDP or therapist providing PA. This assumption was verified by
the data. In 90% of visits when both PA and operative treatment were provided, the PA staff were the same
staff providing operative treatment
68 (< 1)
Assumed to be a GDP 41 (< 1)
Restoration materials missingb
No assumptions could be made for materials used 125 (< 1)
Caries removal missingb
No assumptions were made to imply whether or not caries removal had been undertaken 417 (< 1)
Local anaesthetic missingb
No assumptions were made to imply whether or not local anaesthetic had been provided 221 (< 1)
Topical anaesthetic missingb
No assumptions were made to imply whether or not topical anaesthetic had been provided 236 (< 1)
Number of surfaces missingb
No assumptions were made to imply the number of surfaces treated 424 (< 1)
Number of extractions missingb
No assumptions were made to imply whether or not an extraction took place 245 (< 1)
Number of lesions opened missingb
No assumptions were made to imply whether or not lesions were opened 270 (< 1)
Other treatments
Number of radiographs missing
Assumed no radiographs were taken 18 (< 1)
Number of inhalation sedation missing
Assumed no inhalation sedation took place 92 (1)
APPENDIX 5
NIHR Journals Library www.journalslibrary.nihr.ac.uk
UNCORRECTED PROOF DATE: 11/18/2019 FILE: 07-44-03-2P.pdf
158
TABLE 73 Missing CRF data and assumptions (continued )
n (%)a
Time
Negative total visit time (start time > end time)
Issues with the 24-hour clock (e.g. 14.40–13.10 should be 14.40–15.10) 13 (< 1)
Outstanding negative times – if no operative treatment provided, we took the shortest treatment time 2 (< 1)
Outstanding negative times – if operative treatment provided, we took the longest treatment time 1 (< 1)
Outstanding negative times: total treatment time was – 2 minutes – assumed total treatment time = PA time,
as no operative treatment was provided
2 (< 1)
PA time > total visit time
No operative treatment provided: assumed total visit time = PA time 71 (1)
Operative treatment provided: total treatment time = total visit time and new total visit time = treatment time
(original visit time)+ PA time
17 (< 1)
Operative treatment provided but estimated total treatment time was not reflective of the treatment provided
(e.g. lesion opened to make cleansable): assumed PA time captured this
2 (< 1)
Missing PA time
Additional information in PA other details 9 (< 1)
Estimated time based on the pillars of PA provided and the PA time observed in the data for these pillars 384 (5)
PA was missing: assumed no PA provided, so time = 0 minutes 14 (< 1)
Missing total visit time
PA provided, PA time not missing and no operative treatment: assumed visit time = PA time 28 (< 1)
Assumed 10-minute appointments for one practice that said that was their policy and never recorded visit
times
24 (< 1)
Outstanding missing times: estimated based on treatments provided using clinical advice 75 (1)
Medications
Missing painkiller information
Assumed no painkillers were prescribed 90 (1)
Missing antibiotics information
Assumed no antibiotics were prescribed 102 (1)
a % of missing data is based on total number of visits (n = 7713).
b % of missing is based on 7713 visits and a maximum of 8 teeth treated.
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Resource use [see Chapter 3, Treatment received (intention-to-treat
analysis set, n = 1058) and Chapter 4, Resource use and costs]
TABLE 74 Total resource use per child per visit
Resource use (per visit) C+P, mean (SD) n B+P, mean (SD) n PA, mean (SD) n
Number of visits
Number of visits (all) (n = 1058) 7.69 (4.21) 352 7.37 (4.08) 352 6.82 (3.65) 354
Number of first visits (n = 1058) 1 (–) 352 1 (–) 352 1 (–) 354
Number of follow-up visits (n = 1006)a 6.96 (4.06) 338 6.73 (3.89) 333 6.15 (3.47) 335
Length of visits (minutes)
Length of visits (all) 21.76 (6.91) 352 21.24 (7.18) 352 20.11 (6.65) 354
Length of first visit 28.80 (11.93) 347 28.14 (11.14) 350 25.56 (10.20) 354
Length of follow-up visit 20.54 (6.99)b 338 19.38 (6.90) 333 18.64 (6.85) 335
Prevention
Prevention 0.79 (0.22) 352 0.79 (0.22) 352 0.85 (0.19) 354
Prevention at first visit 0.81 (0.39)c 350 0.83 (0.37) 351 0.91 (0.29) 353
Prevention at follow-up visits 0.79 (0.23)d 338 0.78 (0.23) 333 0.85 (0.21) 335
Prevention staff
GDP providing prevention at first visit 0.71 (0.46)e 349 0.72 (0.45) 349 0.77 (0.42) 344
Dental therapist providing prevention at
first visit
0.07 (0.25) 349 0.07 (0.25) 349 0.08 (0.26) 344
Dental hygienist providing prevention at
first visit
0.02 (0.13) 349 0.02 (0.14) 349 0.03 (0.17) 344
Oral health educator providing prevention
at first visit
0.01 (0.11) 349 0.02 (0.15) 349 0.04 (0.19) 344
Childsmile/extended duty dental nurse
providing prevention at first visit
0.03 (0.16) 349 0.02 (0.13) 349 0.03 (0.16) 344
Other staff (dental nurse) providing
prevention at first visit
0.01 (0.11) 350 0.01 (0.09) 351 0.01 (0.12) 353
Other staff (dental nurse trainee)
providing prevention at first visit
0 (–) 350 0 (–) 351 0 (–) 353
Other staff member (CT1) providing
prevention at first visit
0 (–) 350 0 (–) 351 0 (–) 353
Other staff member (dental student)
providing prevention at first visit
0 (–) 350 0 (–) 351 0 (–) 353
GDP providing prevention at follow-up
visits
0.69 (0.27)f 338 0.68 (0.27) 333 0.76 (0.26) 335
Dental therapist providing prevention at
follow-up visits
0.07 (0.14) 338 0.06 (0.13) 333 0.05 (0.12) 335
Dental hygienist providing prevention at
follow-up visits
0.01 (0.04) 338 0.01 (0.04) 333 0.01 (0.07) 335
Oral health educator providing prevention
at follow-up visits
0.01 (0.07) 338 0.01 (0.06) 333 0.01 (0.05) 335
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TABLE 74 Total resource use per child per visit (continued )
Resource use (per visit) C+P, mean (SD) n B+P, mean (SD) n PA, mean (SD) n
Childsmile/extended duty dental nurse
providing prevention at follow-up visits
0.02 (0.08) 338 0.01 (0.04) 333 0.02 (0.06) 335
Other staff member (dental nurse)
providing prevention at follow-up visits
0.03 (0.15) 338 0.02 (0.13) 333 0.03 (0.15) 335
Other staff member (dental nurse trainee)
providing prevention at follow-up visits
0 (–) 338 0 (–) 333 < 0.01 (0.01) 335
Other staff member (CT1) providing
prevention at follow-up visits
0 (–) 338 < 0.01 (< 0.01) 333 0 (–) 335
Other staff member (dental student)
providing prevention at follow-up visits
< 0.01 (0.01) 338 < 0.01 (0.01) 333 < 0.01 (0.01) 335
Prevention ‘pillars’ (components)
Brushing/plaque control advice provided
at first visit
0.76 (0.43)g 350 0.79 (0.41) 351 0.88 (0.32) 353
Fissure sealants provided at first visit 0.12 (0.33) 350 0.15 (0.35) 351 0.15 (0.36) 353
Fluoride varnish provided at first visit 0.53 (0.50) 350 0.56 (0.50) 351 0.74 (0.44) 353
Diet investigation/advice provided at first
visit
0.70 (0.46) 350 0.75 (0.43) 351 0.84 (0.37) 353
Brushing/plaque control advice provided
at follow-up visits
0.73 (0.26)h 338 0.71 (0.26) 333 0.78 (0.24) 335
Fissure sealants provided at follow-up
visits
0.13 (0.20) 338 0.15 (0.22) 333 0.16 (0.23) 335
Fluoride varnish provided at follow-up
visits
0.51 (0.31) 338 0.54 (0.31) 333 0.62 (0.31) 335
Diet investigation/advice provided at
follow-up visits
0.66 (0.29) 338 0.64 (0.30) 333 0.71 (0.29) 335
Prevention time (minutes)
Length of time providing prevention at
first visit)
10.18 (10.44)i 331 10.08 (8.75) 335 12.82 (8.03) 336
Length of time providing prevention at
follow-up visits
6.58 (4.21)
j
338 6.40 (3.96) 333 7.58 (4.16) 335
Operative treatment
Operative treatment at first visit 0.62 (0.49)k 349 0.63 (0.48) 351 0.16 (0.37) 353
Operative treatment at follow-up visits 0.36 (0.28)l 338 0.34 (0.26) 333 0.19 (0.24) 335
Operative treatment time (minutes)
Length of time providing operative
treatment at first visit
18.31 (11.21) 336 17.94 (11.27) 337 12.42 (10.48) 350
Length of time providing operative
treatment at follow-up visits
12.86 (7.08) 338 12.08 (6.47) 333 10.16 (6.55) 335
Operative treatment staff
GDP providing operative treatment
at first visit
0.58 (0.49)m 342 0.60 (0.49) 343 0.14 (0.34) 349
Dental therapist providing operative
treatment at first visit
0.04 (0.18) 342 0.03 (0.18) 343 0.02 (0.15) 349
GDP providing operative treatment
at follow-up visits
0.32 (0.29)n 338 0.29 (0.25) 333 0.17 (0.23) 335
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TABLE 74 Total resource use per child per visit (continued )
Resource use (per visit) C+P, mean (SD) n B+P, mean (SD) n PA, mean (SD) n
Dental therapist providing operative tx at
follow-up visits
0.03 (0.09) 338 0.03 (0.08) 333 0.01 (0.04) 335
Primary teeth treated
Number of primary teeth treated
operatively at first visit
0.98 (1.12)o 349 1.16 (1.32) 351 0.26 (0.70) 353
Number of surfaces treated at first visit 0.98 (1.05) 349 1.29 (1.50) 351 0.28 (0.80) 353
Number of primary teeth treated
operatively at follow-up visits
0.55 (0.59)p 338 0.50 (0.46) 333 0.29 (0.48) 335
Number of surfaces at follow-up visits 0.67 (0.71) 338 0.74 (0.77) 333 0.35 (0.53) 335
Operative treatment: caries removal
Average total complete caries removal per
treated primary tooth at first visit
0.46 (0.49)q 349 0.06 (0.22) 351 0.04 (0.19) 353
Average total partial caries removal per
treated primary tooth at first visit
0.08 (0.25) 349 0.31 (0.44) 351 0.05 (0.21) 353
Average total ‘none’ caries removal per
treated primary tooth at first visit
0.06 (0.24) 349 0.24 (0.41) 351 0.05 (0.21) 353
Average total complete caries removal per
treated primary tooth at follow-up visits
0.21 (0.23)r 338 0.05 (0.12) 333 0.06 (0.16) 335
Average total partial caries removal per
treated primary tooth at follow-up visits
0.05 (0.11) 338 0.11 (0.16) 333 0.04 (0.11) 335
Average total ‘none’ caries removal per
treated primary tooth at follow-up visits
0.06 (0.13) 338 0.12 (0.18) 333 0.05 (0.11) 335
Restorations
Restorations at first visit 0.58 (0.49)s 352 0.59 (0.49) 352 0.10 (0.30) 354
Average total amalgam restorations per
treated primary tooth at first visit
0.08 (0.26)t 349 0.01 (0.11) 351 0.01 (0.08) 353
Average total glass ionomer restorations
per treated primary tooth at first visit
0.13 (0.33) 349 0.15 (0.35) 351 0.05 (0.21) 353
Average total composite restorations per
treated primary tooth at first visit
0.17 (0.37) 349 0.07 (0.25) 351 0.01 (0.08) 353
Average total conventional preformed
metal crown restorations per treated
primary tooth at first visit
0.01 (0.10) 349 < 0.01 (0.05) 351 0 (–) 353
Average total Hall Technique preformed
metal crown restorations per treated
primary tooth at first visit
0.02 (0.12) 349 0.12 (0.32) 351 0.01 (0.10) 353
Average total compomer restorations per
treated primary tooth at first visit
0.04 (0.19) 349 0.03 (0.15) 351 0.01 (0.08) 353
Average total RMGI restorations per
treated primary tooth at first visit
0.13 (0.33) 349 0.12 (0.32) 351 0.01 (0.08) 353
Average total sealant only restorations per
treated primary tooth at first visit
0.02 (0.12) 349 0.08 (0.26) 351 0.01 (0.11) 353
Average total sealant over restoration per
treated primary tooth at first visit
0.01 (0.09) 349 0.04 (0.18) 351 0 (–) 353
Average total pulpotomy restorations per
treated primary tooth at first visit
0.01 (0.08) 349 < 0.01 (0.05) 351 0 (–) 353
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TABLE 74 Total resource use per child per visit (continued )
Resource use (per visit) C+P, mean (SD) n B+P, mean (SD) n PA, mean (SD) n
Average total restorations per treated
primary tooth at follow-up visits
0.30 (0.27)u 338 0.27 (0.24) 333 0.12 (0.21) 335
Average total amalgam restorations per
treated primary tooth at follow-up visits
0.03 (0.09)v 338 < 0.01 (0.03) 333 < 0.01 (0.04) 335
Average total glass ionomer restorations
per treated primary tooth at follow-up
visits
0.10 (0.19) 338 0.09 (0.17) 333 0.06 (0.15) 335
Average total composite restorations per
treated primary tooth at follow-up visits
0.05 (0.12) 338 0.03 (0.09) 333 0.01 (0.08) 335
Average total conventional preformed
metal crown restorations per treated
primary tooth at follow-up visits
0.01 (0.05) 338 < 0.01 (0.02) 333 < 0.01 (0.02) 335
Average total Hall Technique preformed
metal crown restorations per treated
primary tooth at follow-up visits
0.01 (0.06) 338 0.07 (0.14) 333 0.01 (0.07) 335
Average total compomer restorations per
treated primary tooth at follow-up visits
0.01 (0.06) 338 0.01 (0.03) 333 < 0.01 (0.03) 335
Average total RMGI restorations per
treated primary tooth at follow-up visits
0.07 (0.15) 338 0.06 (0.15) 333 0.03 (0.10) 335
Average total sealant only restorations per
treated primary tooth at follow-up visits
0.01 (0.06) 338 0.01 (0.05) 333 0.01 (0.03) 335
Average total sealant over restoration per
treated primary tooth at follow-up visits
< 0.01 (0.03) 338 0.01 (0.05) 333 < 0.01 (0.01) 335
Average total pulpotomy restorations per
treated primary tooth at follow-up visits
0.01 (0.04) 338 0.01 (0.06) 333 0.01 (0.04) 335
Local anaesthetic
Average total local anaesthetics attempted
per treated primary tooth at first visit
0.26 (0.43)w 349 0.02 (0.12) 351 0.02 (0.11) 353
Average total local anaesthetics achieved
per treated primary tooth at first visit
(successful)
0.22 (0.41)x 349 0.01 (0.10) 351 0.01 (0.11) 353
Average total local anaesthetics not
achieved per treated primary tooth at first
visit (unsuccessful)
0.03 (0.17) 349 < 0.01 (0.06) 351 < 0.01 (0.03) 353
Average total local anaesthetics not
attempted per treated primary tooth at
first visit
0.22 (0.41) 349 0.37 (0.48) 351 0.05 (0.22) 353
Average total local anaesthetics attempted
per treated primary tooth at follow-up
visits
0.13 (0.19)y 338 0.05 (0.10) 333 0.04 (0.11) 335
Average total local anaesthetics achieved
per treated primary tooth at follow-up
visits (successful)
0.12 (0.18)z 338 0.04 (0.10) 333 0.04 (0.10) 335
Average total local anaesthetics not
achieved per treated primary tooth at
follow-up visits (unsuccessful)
0.01 (0.07) 338 < 0.01 (0.03) 333 < 0.01 (0.02) 335
Average total local anaesthetics not
attempted per treated primary tooth at
follow-up visits
0.15 (0.21) 338 0.18 (0.21) 333 0.07 (0.15) 335
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TABLE 74 Total resource use per child per visit (continued )
Resource use (per visit) C+P, mean (SD) n B+P, mean (SD) n PA, mean (SD) n
Other procedures
Average total extractions per treated
primary tooth at first visit
0.01 (0.09)aa 349 0.01 (0.08) 351 0.01 (0.10) 353
Average total lesions opened per treated
primary tooth at first visit
0.01 (0.08) 349 0.02 (0.12) 351 0.04 (0.19) 353
Average total extractions per treated
primary tooth at follow-up visits
0.04 (0.11)bb 338 0.04 (0.10) 333 0.04 (0.11) 335
Average total lesions opened per treated
primary tooth at follow-up visits
0.01 (0.03) 338 0.01 (0.03) 333 0.02 (0.08) 335
Radiographs
Radiographs at first visit 0.18 (0.39)cc 350 0.18 (0.38) 351 0.19 (0.39) 353
Radiographs at follow-up visits 0.10 (0.15)dd 338 0.08 (0.14) 333 0.11 (0.17) 335
Inhalation sedation/relative analgesia
Inhalation sedation/relative analgesia at
first visit
0.01 (0.08) 345 0 (–) 347 < 0.01 (0.05) 348
Inhalation sedation/relative analgesia at
follow-up visits
0.01 (0.07) 338 0.01 (0.04) 333 0.01 (0.03) 335
Painkillers
Painkillers prescribed at first visit 0 (–)ee 344 0 (–) 346 0 (–) 349
Paracetamol prescribed at first visit 0 (–) 352 0 (–) 352 0 (–) 354
Ibuprofen prescribed at first visit 0 (–) 352 0 (–) 352 0 (–) 354
Painkillers prescribed at follow-up visits < 0.01 (0.03)ff 338 < 0.01 (0.03) 333 < 0.01 (0.01) 335
Paracetamol prescribed at follow-up visits < 0.01 (0.01) 338 < 0.01 (0.02) 333 < 0.01 (0.01) 335
Ibuprofen prescribed at follow-up visits < 0.01 (0.02) 338 < 0.01 (0.02) 333 < 0.01 (0.01) 335
Antibiotics
Antibiotics prescribed at first visit 0.01 (0.08)
gg
343 0.01 (0.09) 344 0.01 (0.12) 349
Amoxicillin prescribed at first visit 0.01 (0.08) 352 < 0.01 (0.05) 352 0.01 (0.12) 354
Penicillin prescribed at first visit 0 (–) 352 0 (–) 352 0 (–) 354
Metronidazole prescribed at first visit 0 (–) 352 0 (–) 352 0 (–) 354
Erythromycin prescribed at first visit 0 (–) 352 < 0.01 (0.05) 352 0 (–) 354
Antibiotics prescribed at follow-up visits 0.02 (0.08)hh 338 0.02 (0.07) 333 0.03 (0.10) 335
Amoxicillin prescribed at follow-up visits 0.02 (0.08) 338 0.02 (0.07) 333 0.03 (0.09) 335
Penicillin prescribed at follow-up visits < 0.01 (0.01) 338 0 (–) 333 < 0.01 (0.02) 335
Metronidazole prescribed at follow-up
visits
< 0.01 (0.01) 338 0 (–) 333 0 (–) 335
Erythromycin prescribed at follow-up visits 0 (–) 338 < 0.01 (0.01) 333 < 0.01 (0.02) 335
Referrals
Referrals 0.09 (0.30)ii 352 0.10 (0.35) 352 0.11 (0.36) 354
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TABLE 74 Total resource use per child per visit (continued )
Resource use (per visit) C+P, mean (SD) n B+P, mean (SD) n PA, mean (SD) n
Resource use
Referrals grouping – A 0.09 (0)jj 32 0.20 (0) 36 0.02 (0) 39
Referrals grouping – B 0.44 (0) 32 0.33 (0) 36 0.54 (0) 39
Referrals grouping – C 0.03 (0) 32 0 (–) 36 0.10 (0) 39
Referrals grouping – D 0.25 (0) 32 0.28 (0) 36 0.15 (0) 39
Referrals grouping – E 0.03 (0) 32 0.11 (0) 36 0.08 (0) 39
Referrals grouping – F 0.13 (0) 32 0.08 (0) 36 0.03 (0) 39
Referrals grouping – DNA 0.03 (0) 32 0 (–) 36 0.08 (0) 39
Parent questionnaire (excluding baseline)
Completed questionnaires 6.06 (3.90)kk 323 5.94 (3.87) 322 5.46 (3.41) 323
Self-reported toothaches 0.93 (1.48)ll 323 0.92 (1.45) 322 1.10 (1.43) 323
Children missing school because of child’s
toothache
0.17 (0.47)mm 323 0.22 (0.63) 322 0.22 (0.58) 323
Days missed from school because of
child’s toothache
1.27 (1.58)nn 45 1.29 (1.31) 49 1.23 (1.38) 53
Carers missing paid work because of
child’s toothache
0.07 (0.31) 323 0.08 (0.39) 322 0.07 (0.27) 323
Days missed from paid work because of
child’s toothache
1.25 (1.37) 18 1.50 (1.72) 20 0.70 (0.45) 22
Paid child care because of child’s
toothache
0.05 (0.26) 323 0.08 (0.32) 322 0.07 (0.29) 323
Days’ paid child care because of child’s
toothache
0.08 (0.68) 15 0.85 (0.87) 23 0.70 (0.57) 20
Self-reported painkillers taken because of
child’s toothache
0.50 (1.05) 323 0.52 (1.12) 322 0.52 (0.95) 323
Days taking painkillers because of child’s
toothache
3.33 (3.55) 92 3.10 (3.31) 88 2.40 (2.28) 111
Parents missing usual activities because of
child’s toothache
0.13 (0.48) 323 0.17 (0.51) 322 0.15 (0.45) 323
Days parents missed usual activities
because of child’s toothache
1.78 (1.55) 29 1.68 (1.41) 39 1.06 (0.77) 42
a Participants had only one visit (n = 52). Please note that all average totals reported for follow-up visits are slightly
underestimated; it assumes missing values are equivalent to 0. Imputations for missing values are accounted for in
Appendix 5, Table 73.
b Interpretation: on average, each follow-up visit was 20.5 minutes in duration.
c Interpretation: on average, 81% of children randomised to C+P had prevention at their first visit.
d Interpretation: on average, each child randomised to C+P had prevention at 79% of their follow-up visits.
e Interpretation: on average, 71% of children randomised to C+P had prevention provided by a GDP at their first visit.
f Interpretation: on average, each child randomised to C+P had prevention provided by a GDP at 66% of their
follow-up visits.
g Interpretation: on average, 76% of children randomised to C+P had the prevention pillar ‘brushing/plaque control
advice’ provided at their first visit.
h Interpretation: on average, each child randomised to C+P had the prevention pillar ‘brushing/plaque control advice’ at
73% of their follow-up visits.
i Interpretation: on average, each child randomised to C+P had 10 minutes of prevention at their first visit.
j Interpretation: on average, each child randomised to C+P received 6.5 minutes of prevention at each follow-up visit.
k Interpretation: on average, 62% of children randomised to C+P had operative treatment at their first visit.
l Interpretation: on average, each child randomised to C+P had operative treatment at 36% of their follow-up visits.
m Interpretation: on average, 58% of children randomised to C+P had operative treatment provided by a GDP at their
first visit.
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n Interpretation: on average, each child randomised to C+P had operative treatment provided by a GDP at 32% of their
follow-up visits.
o Interpretation: on average, each child randomised to C+P had 0.98 teeth treated operatively at their first visit.
p Interpretation: on average, each child randomised to C+P had half a primary tooth treated operatively at each follow-up
visit (or one primary tooth treated operatively for every two follow-up visits).
q Interpretation: on average, each child randomised to C+P had complete caries removal on 46% of their operatively
treated primary teeth at a first visit.
r Interpretation: on average, each child randomised to C+P had complete caries removal on 21% of their operatively
treated primary teeth at each follow-up visit.
s Interpretation: on average, 58% of children randomised to C+P had restorative treatment on an operatively treated
primary tooth at their first visit.
t Interpretation: on average, each child randomised to C+P had an amalgam restoration on 8% of their operatively
treated primary teeth at their first visit.
u Interpretation: on average, each child randomised to C+P had a restoration on at operatively treated primary tooth at
30% of their follow-up visits.
v Interpretation: on average, each child randomised to C+P had an amalgam restoration on 3% of their operatively
treated primary teeth at each follow-up visit.
w Interpretation: on average, each child randomised to C+P had a local anaesthetic attempted on 26% of their
operatively treated primary teeth at their first visit.
x Interpretation: on average, each child randomised to C+P had a successful local anaesthetic attempted on 22% of
their operatively treated primary teeth at their first visit.
y Interpretation: on average, each child randomised to C+P had a local anaesthetic attempted on 13% of their
operatively treated primary teeth at each follow-up visit.
z Interpretation: on average, each child randomised to C+P had a successful local anaesthetic attempted on 12% of
their operatively treated primary teeth at each follow-up visit.
aa Interpretation: on average, each child randomised to C+P had 1% of their operatively treated primary teeth extracted
at their first visit.
bb Interpretation: on average, each child randomised to C+P had 4% of their operatively treated primary teeth extracted
at each follow-up visit.
cc Interpretation: on average, 18% of children randomised to C+P had a radiograph taken at their first visit.
dd Interpretation: on average, each child randomised to C+P had a radiograph taken at 10% of their follow-up visits.
ee Interpretation: on average, no children randomised to C+P were prescribed any painkillers at their first visit.
ff Interpretation: on average, each child randomised to C+P was prescribed painkillers at < 1% of their follow-up visits.
gg Interpretation: on average, 1% of children randomised to C+P were prescribed antibiotics at their first visit.
hh Interpretation: on average, each child randomised to C+P was prescribed antibiotics at 2% of their follow-up visits.
ii Interpretation: on average, 9% of children randomised to C+P were referred for additional treatment.
jj Interpretation: on average, 9% of the referrals in the C+P arm were to ‘Group A’ – ‘Consultation only – 1 X ½ hour
appointment at Dental Hospital for assessment (+/- radiographs)’.
kk Interpretation: on average, parents/carers of children randomised to C+P completed six parent questionnaires.
ll Interpretation: on average, 93% of parents/carers of children randomised to C+P reported their child
experiencing toothache.
mm Interpretation: on average, 17% of parents/carers of children randomised to C+P reported their child missing school
because of toothache.
nn Interpretation: on average, each child randomised to C+P who missed school because of toothache missed at least 1
day of school.
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Appendix 6 Qualitative study (see Chapter 5)
TABLE 81 Demographics of child–parent dyads participating in the qualitative exploration of the treatment
acceptability of the three FiCTION trial arms
Code Participant
Age of the
child (years) Sex Research arm
FiCTION trial
clinical centre
Treatment
deviation
LC01 Child 5 Female PA Yorkshire Y
LP01 Parent Female
LC02 Child 6 Male C+P Yorkshire N
LP02 Parent Female
LC03 Child 6 Male C+P Yorkshire Y
LP03 Parent Male
LC04 Child 6 Female B+P Yorkshire N
LP04 Parent Female
LC05 Child 6 Female B+P Yorkshire N
LP05 Parent Female
LC06 Child 7 Female B+P Yorkshire Y
LP06 Parent Female
LC07 Child 8 Male B+P Yorkshire Y
LP07 Parent Male
LC08 Child 11 Male C+P Yorkshire N
LP08 Parent Female
SC01 Child 9 Female B+P Scotland N
SP01 Parent Female
SC02 Child 9 Female PA Scotland N
SP02 Parent Female
SC03 Child 9 Female PA Scotland N
SP03 Parent Male
SC04 Child 8 Male PA Scotland N
SP04 Parent Female
SC05 Child 10 Female C+P Scotland N
SP05 Parent Female
N, no; Y, yes.
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TABLE 82 Dental professional participant characteristics
Code
Professional
role
Public or general
dental service Sex
Patients
recruited (n)
Research
experience
Time (years)
since qualifying
FiCTION
trial region
D01 Dentist Community Female 17 Yes 37 Scotland
D02 Dentist General Female 24 Yes 30 Scotland
D03 Dentist Community Male 4 No 17 Scotland
D04 Dentist General Female 23 No 20 Scotland
D05 Dentist General Female 36 Yes 18 Scotland
E01 Dentist General Male 2 No 10 Scotland
G01 Dentist General Female 24 Yes 20 Scotland
L01 Dentist Community Female 22 Yes 14 Yorkshire
L02 Dental nurse Community Female 22 No 25+ Yorkshire
LDN01 Dentist General Male 37 No 27 South-east
N01 Dentist General Male 20 No 17 North-east
N02 Dentist General Female 14 Yes 16 North-east
N03 Dentist General Male 14 No 2 North-east
N04 Senior dental
nurse
General Female 30 No 15 North-east
N05 Practice
manager
General Female 24 No 13 North-east
N06 Dentist General Male 30 No 36 North-east
N07 Dentist General Male 30 Yes 16 North-east
N08 Dentist General Female 15 No 7 North-east
N09 Dental
therapist
General Female 17 No 4 North-east
N10 Dentist General Male 17 No 17 North-east
N11 Dental
therapist
General Male 17 No 2 North-east
N12 Dentist General Female 17 No 10 North-east
N13 Dental nurse General Female 17 Yes 8 North-east
S01 Dentist General Female 4 No 16 Yorkshire
S02 Dental nurse General Female 4 No Not given Yorkshire
S03 Practice
manager
General Male 4 No N/A Yorkshire
S04 Dentist Community Female 22 Yes 14 Yorkshire
S05 Dentist General Female 21 No 11 Yorkshire
S06 Dentist General Female 21 No 8 Yorkshire
S07 Dentist General Male 32 Yes 15 Yorkshire
S08 Practice
manager
General Female 32 No N/A Yorkshire
N/A, not applicable.
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